Pharmaceutical Benefits Scheme (PBS) | Home
TABLE 1
2006 COMMUNITY PRESCRIPTION NUMBERS, TOGETHER WITH GOVERNMENT AND PATIENT COSTS FOR PBS-LISTED DRUGS
Table 1 includes an estimate of community (non-public hospital) prescription numbers for the 2006 calendar year, costs (government and patient contribution) for the items with
a four digit PBS/RPBS code, together with the defined daily dose (DDD) where assigned. There is no cost information available for items with a five digit Amfac drug code. Table 1 exclude the presentation of information on any item with an estimated community use of less than 110 prescriptions in 2006.
The prescription items are arranged by ATC code on generic name, and by form and strength using either the PBS drug code (4 digit) or, for non-PBS items, the Amfac drug code (5 digit). Consult the index (page 255) by generic drug name to obtain the appropriate ATC code.
An index by 2nd level of the ATC classification follows:
AlimentAry trAct And metAbolism PAge no
|A01 |STOMATOLOGICAL PREPARATIONS |39 |
|A02 |DRUGS FOR ACID RELATED DISORDERS |40 |
|A03 |DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |42 |
|A04 |ANTIEMETICS AND ANTINAUSEANTS |44 |
|A05 |BILE AND LIVER THERAPY |45 |
|A06 |LAXATIVES |46 |
|A07 |ANTIDIARRHOEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |48 |
|A08 |ANTIOBESITY PREPARATIONS, EXCLUDING DIET PRODUCTS |49 |
|A09 |DIGESTIVES, INCLUDING ENZYMES |50 |
|A10 |DRUGS USED IN DIABETES |51 |
|A11 |VITAMINS |53 |
|A12 |MINERAL SUPPLEMENTS |54 |
|A14 |ANABOLIC AGENTS FOR SYSTEMIC USE |55 |
blood And blood forming orgAns
|B01 |ANTITHROMBOTIC AGENTS |56 |
|B02 |ANTIHAEMORRHAGICS |58 |
|B03 |ANTIANAEMIC PREPARATIONS |59 |
|B05 |BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS |60 |
|B06 |OTHER HAEMATOLOGICAL AGENTS |61 |
| |
|cArdiovAsculAr system |
|C01 |CARDIAC THERAPY |62 |
|C02 |ANTIHYPERTENSIVES |64 |
|C03 |DIURETICS |65 |
|C04 |PERIPHERAL VASODILATORS |66 |
|C05 |VASOPROTECTIVES |67 |
|C07 |BETA BLOCKING AGENTS |68 |
|C08 |CALCIUM CHANNEL BLOCKERS |69 |
|C09 |AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |70 |
|C10 |LIPID MODIFYING AGENTS |73 |
dermAtologicAls
D01 ANTIFUNGALS FOR DERMATOLOGICAL USE 75
D02 EMOLLIENTS AND PROTECTIVES 77
D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS 78
D04 ANTIPRURITICS, INCLUDING ANTIHISTAMINES, ANAESTHETICS ETC 79
D05 ANTIPSORIATICS 80
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS
FOR DERMATOLOGICAL USE 81
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS 82
D08 ANTISEPTICS AND DISINFECTANTS 84
D09 MEDICATED DRESSINGS 85
D10 ANTI-ACNE PREPARATIONS 86
D11 OTHER DERMATOLOGICAL PREPARATIONS 87
genitourinAry system And sex hormone
|G01 |GYNAECOLOGICAL ANTIINFECTIVES AND8ANTISEPTICS |88 |
|G02 |OTHER GYNAECOLOGICAL |89 |
|G03 |SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |90 |
|G04 |UROLOGICALS |95 |
systemic hormonAl PrePArAtions, excluding sex hormones And insulins
|H01 |PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES |97 |
|H02 |CORTICOSTEROIDS FOR SYSTEMIC USE |98 |
|H03 |THYROID THERAPY |99 |
|H04 |PANCREATIC HORMONES |100 |
|H05 |CALCIUM HOMEOSTASIS |101 |
| |
|generAl Antiinfectives for systemic use |
|J01 |ANTIBACTERIALS FOR SYSTEMIC USE |102 |
|J02 |ANTIMYCOTICS FOR SYSTEMIC USE |107 |
|J04 |ANTIMYCOBACTERIALS |108 |
|J05 |ANTIVIRALS FOR SYSTEMIC USE |109 |
|J07 |VACCINES |110 |
| |
|AntineoPlAstic And immunomodulAting Agents |
|L01 |ANTINEOPLASTIC AGENTS |113 |
|L02 |ENDOCRINE THERAPY |118 |
|L03 |IMMUNOSTIMULANTS |119 |
|L04 |IMMUNO-SUPPRESSIVE AGENTS |120 |
| |
|musculo-skeletAl system |
|M01 |ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS |122 |
|M02 |TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |125 |
|M03 |MUSCLE RELAXANTS |126 |
|M04 |ANTIGOUT PREPARATIONS |127 |
|M05 |DRUGS FOR TREATMENT OF BONE DISEASES |128 |
| |
|nervous system |
|N01 |ANAESTHETICS |129 |
|N02 |ANALGESICS |130 |
|N03 |ANTIEPILEPTICS |137 |
|N04 |ANTI-PARKINSON DRUGS |140 |
|N05 |PSYCHOLEPTICS |142 |
|N06 |PSYCHOANALEPTICS |147 |
|N07 |OTHER NERVOUS SYSTEM DRUGS |150 |
| |
|AntiPArAsitic Products, insecticides And rePellents |
|P01 |ANTIPROTOZOALS |152 |
|P02 |ANTHELMINTICS |153 |
|P03 |ECTOPARASITICIDES, INCLUDING SCABICIDES, INSECTICIDES AND REPELLENTS | |
| | |154 |
resPirAtory system
|R01 |NASAL PREPARATIONS |155 |
|R03 |DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |158 |
|R05 |COUGH AND COLD PREPARATIONS |161 |
|R06 |ANTIHISTAMINES FOR SYSTEMIC USE |163 |
| |
|sensory orgAns |
|S01 |OPHTHALMOLOGICALS |166 |
|S02 |OTOLOGICALS |171 |
|S03 |OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |171 |
|vArious | | |
|V01 |ALLERGENS |172 |
|V03 |ALL OTHER THERAPEUTIC PRODUCTS |173 |
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
STOMATOLOGICAL PREPARATIONS
stomatoLogicaL preparations
ANTIINFECTIVES FOR LOCAL ORAL TREATMENT
A01AB04 AMPHOTERICIN
|2931 |Lozenge 10mg |40.00 |MG |140,791 |1,272,026 |
|3306 |Lozenge 10mg |40.00 |MG |5,746 |50,761 |
|A01AB03 |CHLORHEXIDINE | | | | |
| |4161 Mouth wash 2mg per mL (0.2%) 250mL |30.00 |MG |4,482 |50,080 |
|A01AB09 |MICONAZOLE | | | | |
| |13832 Oral gel 20mg per mL (2%) 20g |0.20 |GM |10,001 |– |
| |14054 Oral gel 40mg per mL (2%) 40g |0.20 |GM |5,321 |– |
|A01AB11 |NYSTATIN | | | | |
| |3033 Oral suspension 100,000 units per mL 24mL |1500.00 |TE |148,247 |1,410,096 |
| |3343 Oral suspension 100,000 units per mL 24mL |1500.00 |TE |760 |7,097 |
CORTICOSTEROIDS FOR LOCAL ORAL TREATMENT
A01AC01 TRIAMCINOLONE ACETONIDE with PECTIN
11075 Paste 1% 5gm – – 33,956 –
OTHER AGENTS FOR LOCAL ORAL TREATMENT
A01AD02 BENZYDAMINE HYDROCHLORIDE
A01AD02
A01AD11 CHOLINE SALICYLATE with CETALKONIUM CHLORIDE
12855 Gel 10g 1 – – 4,305 –
A01AD11 CHOLINE SALICYLATE with CETALKONIUM CHLORIDE with MENTHOL and GLYCEROL with ETHANOL
16097 Jelly 87mg-100ug-570ug-46mg – – 216 –
A01AD11 SALIVA SUBSTITUTE
4568 Solution 25mL – – 378 3,203
4569 Solution 100mL – – 558 6,889
A01AD11 VARIOUS
5334 Spray 10mg per mL 100mL – – 223 2,616
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ALIMENTARY TRACT AND METABOLISM
DRUGS FOR ACID RELATED DISORDERS
antacids
ALUMINIUM COMPOUNDS
A02AB01 ALUMINIUM HYDROXIDE
10038 Tablet 600mg 100 – – 1,057 –
CALCIUM COMPOUNDS
A02AC10 CALCIUM CARBONATE with GLYCINE
4055 Tablet 420mg-180mg – – 942 18,499
COMBS.AND COMPLEXES OF ALUMINIUM,CALCIUM AND MAGNESIUM COMPOUNDS
A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE
|2157 |Oral suspension 200mg-200mg per 5mL 500mL |– |– |86,479 |1,097,603 |
|2576 |Tablet 200mg-200mg |– |– |45,896 |579,546 |
|4117 |Tablet 400mg-400mg-30mg |– |– |1,552 |37,166 |
|4118 |Oral suspension 400mg-400mg-30mg per 5mL |– |– |2,661 |49,180 |
|A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with SIMETHICONE |
| |11196 Mixture 750mL 1 – – 220 |– |
| |4453 Tablet 400mg-400mg-40mg 200 – – 1,359 |58,956 |
|A02AD |ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE | |
| |2159 Oral suspension 250mg-120mg-120mg per 5mL – – 28,409 | |
| | |360,254 |
ANTACIDS, OTHER COMBINATIONS
A02AX ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with OXETHAZAINE
16009 Mixture 500mL 1 – – 697 –
drugs for peptic uLcer and gord
H2-RECEPTOR ANTAGONISTS
A02BA01 CIMETIDINE
A02BA03
A02BA04
A02BA02
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
DRUGS FOR ACID RELATED DISORDERS
drugs for peptic uLcer and gord
PROSTAGLANDINS
A02BB01 MISOPROSTOL
1648 Tablet 200ug 0.80 MG 2,569 131,206
PROTON PUMP INHIBITORS
A02BC05 ESOMEPRAZOLE
A02BC03
A02BC01
A02BC02
A02BC04
COMBINATIONS FOR ERADICATION OF HELICOBACTER PYLORI
A02BD06 ESOMEPRAZOLE AMOXICILAN and CLARITHROMYCIN
A02BD05
OTHER DRUGS FOR PEPTIC ULCER AND GORD
A02BX13 SODIUM ALGINATE with CALCIUM CARBONATE and SODIUM BICARBONATE
A02BX02
antifLatuLents
ANTIFLATULENTS
A02DA PEPPERMINT OIL
13371 Capsule 0.2mL 21 – – 403 –
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
drugs for functionaL BoWeL disorders
SYNT ANTICHOLIN,ESTERS WITH TERTIARY AMINO GROUP
A03AA04 MEBEVERINE HYDROCHLORIDE
|4328 |Tablet 135mg |0.30 |GM |70,896 |2,016,065 |
|12730 |Tablet 135mg 30 |0.30 |GM |24,187 |– |
|14130 |Tablet 135mg 30 |0.30 |GM |4,800 |– |
SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMPOUND
A03AB05 PROPANTHELINE
1953 Tablet 15mg 60.00 MG 35,653 825,236
DRUGS ACTING ON SEROTONIN RECEPTORS
A03AE02 TEGASEROD
|17465 |Tablet 6mg 30 |– |– |3,243 |– |
|17466 |Tablet 6mg 60 |– |– |3,896 |– |
OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERS
A03AX13 SIMETHICONE
13445 Capsule 100mg 30 – – 902 –
BeLLadonna and deriVatiVes pLain
BELLADONNA ALKALOIDS TERTIARY AMINES
A03BA01 ATROPINE
1089 Injection 600ug in 1mL 1.50 MG 2,098 27,482
3453 Injection 600ug in 1mL 1.50 MG 11,890 149,406
A03BA04 HYOSCYAMINE HYDROBROMIDE with ATROPINE SULPHATE and HYOSCINE HYDROBROMIDE
15792 Tablet 92.5ug-13.5ug 1.00 MG 120 –
A03BA04 HYOSCYAMINE SULPHATE with ATROPINE SULPHATE with HYOSCINE HYDROBROMIDE
10631 Mixture 100mL 1 1.00 MG 310 –
10632 Drop 30mL 1 1.00 MG 259 –
A03BA KAOLIN with PECTIN with HYOSCYAMINE SULPHATE with ATROPINE SULPHATE with HYOSCINE HYDROBROMIDE
10629 Suspension 200mL 1 – – 365 –
BELLADONNA ALKALOIDS SEMISYNT QUATER AMMONIUM COMPOUND
A03BB01 HYOSCINE BUTYLBROMIDE
A03BB HYOSCINE HYDROBROMIDE
10972 Ampoule 400ug 5 – – 2,568 –
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
propuLsiVes
PROPULSIVES
A03FA03 DOMPERIDONE
A03FA01 METOCLOPRAMIDE HYDROCHLORIDE
|1205 |Syrup 5mg per 5mL 100mL |30.00 |MG |26,225 |215,003 |
|1206 |Injection 10mg in 2mL |30.00 |MG |36,570 |511,117 |
|1207 |Tablet 10mg |30.00 |MG |687,062 |4,772,615 |
|3476 |Injection 10mg in 2mL |30.00 |MG |31,898 |364,097 |
|5151 |Tablet 10mg |30.00 |MG |482 |3,173 |
|11138 |Tablet 10mg 100 |30.00 |MG |6,690 |– |
|17364 |Injection 10mg in 2mL 10 |30.00 |MG |112 |– |
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ALIMENTARY TRACT AND METABOLISM
ANTIEMETICS AND ANTINAUSEANTS
antiemetics and antinauseants
SEROTONIN (5HT3) ANTAGONISTS
A04AA04 DOLASETRON MESYLATE
A04AA02
A04AA01
A04AA03
VARIOUS ANTIEMETICS
A04AD12 APREPITANT
|5888 |Pack 1 cap 125mg and 2 cap 80mg |95.00 |MG |2,597 |311,760 |
|8808 |Pack 1 cap 125mg and 2 cap 80mg |95.00 |MG |8,489 |1,263,048 |
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
BILE AND LIVER THERAPY
BiLe therapY
BILE ACID PREPARATIONS
A05AA02 URSODEOXYCHOLIC ACID
8448 Capsule 250mg 100 0.75 GM 22,612 5,505,540
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ALIMENTARY TRACT AND METABOLISM
LAXATIVES
LaXatiVes
SOFTENERS EMOLLIENTS
A06AA02 DOCUSATE SODIUM
A06AA POLOXALKOL
10469 Drop 10% 30mL 1 – – 357 –
CONTACT LAXATIVES
A06AB02 BISACODYL
|1258 |Suppositories 10mg 12 |10.00 |MG |1,369 |23,510 |
|1259 |Tablet 5mg |10.00 |MG |36,328 |474,878 |
|1260 |Suppositories 10mg 10 |10.00 |MG |44,955 |931,624 |
|3250 |Suppositories 10mg 10 |10.00 |MG |684 |31,744 |
|5303 |Suppositories 10mg 10 |10.00 |MG |264 |6,254 |
|5307 |Suppositories 10mg 10 |10.00 |MG |238 |2,195 |
|10635 |Tablet 5mg 200 |10.00 |MG |322 |– |
|12669 |Tablet 5mg 50 |10.00 |MG |2,511 |– |
|A06AB52 |DOCUSATE SODIUM with BISACODYL | | | |
| |1125 Suppositories 100mg-10mg 5 10.00 |MG |1,633 |34,505 |
|A06AB56 |DOCUSATE SODIUM with SENNA | | | |
| |4198 Tablet 50mg-8mg – |– |258,245 |3,270,597 |
| |12753 Tablet 30 – |– |17,614 |– |
|A06AB04 |PHENOLPHTHALEIN with LIQUID PARAFFIN | | | |
| |10107 Mixture 200mL 1 0.20 |GM |818 |– |
| |10108 Mixture 500mL 1 0.20 |GM |12,581 |– |
| |10120 Mixture 500mL 1 0.20 |GM |1,275 |– |
|A06AB06 |SENNA STANDARDISED | | | |
| |4455 Tablet 7.5mg – |– |15,416 |169,641 |
| |11880 Granules 150g 1 – |– |6,263 |– |
|A06AB58 |SODIUM PICOSULFATE with MAGNESIUM CARBONATE | | | |
| |18511 Sachet 20g 2 – |– |633 |– |
BULK PRODUCERS
A06AC51 ISPAGHULA COMBINATIONS
4416 Oral Powder 440g – – 2,053 39,656
A06AC01 PSYLLIUM HYDROPHILIC MUCILLOID
A06AC53
A06AC53
5322 Granules 620mg-80mg per g (62%-8%) 500g – – 646 22,697
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
LAXATIVES
LaXatiVes
OSMOTICALLY ACTING LAXATIVES
A06AD11 LACTULOSE
A06AD11 LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSE
10693 Syrup 200mL 1 6.70 GM 1,167 –
A06AD15 MACROGAL
5389 Sachets powder 13.125g with electrolytes 30 10.00 GM 1,193 34,964
5390 Sachets powder 13.125g with electrolytes 30 10.00 GM 1,220 41,517
8612 Sachets powder 13.125g with electrolytes 30 10.00 GM 189,503 4,363,028
A06AD SORBITOL
14787 Liquid 70% 500mL – – 14,769 –
ENEMAS
A06AG02 BISACODYL
1263 Enemas 10mg in 5mL 25 – – 9,485 355,250
3263 Enemas 10mg in 5mL 25 – – 3,094 175,127
5302 Enemas 10mg in 5mL 25 10.00 MG 687 42,003
A06AG20 COMBINATION (SORBITOL/SODIUM CITRATE/SODIUM LAVRYL SULFOACETATE)
| |2091 |Enemas 3.125g-450mg-45mg in 5mL 12 |– |– |42,938 |1,436,912 |
| |3274 |Enemas 3.125g-450mg-45mg in 5mL 12 |– |– |3,705 |203,206 |
| |4462 |Enemas 3.125g-450mg-45mg in 5mL 4 |– |– |2,933 |31,187 |
| |5331 |Enemas 3.125g-450mg-45mg in 5mL 12 |– |– |1,015 |52,079 |
| |5332 |Enemas 3.125g-450mg-45mg in 5mL 12 |– |– |276 |18,201 |
|A06AG01 |SODIUM |PHOSPHATE | | | | |
| |15629 |Laxative Mixt 3.3G/5mL |– |– |7,387 |– |
OTHER LAXATIVES
A06AX01 GLYCEROL
|2555 |Suppositories 700mg (for infants) 12 |– |– |580 |7,606 |
|2556 |Suppositories 1.g (for children) 12 |– |– |651 |9,203 |
|2557 |Suppositories 2.8g (for adults) 12 |– |– |8,464 |122,586 |
|3267 |Suppositories 2.8g (for adults) 12 |– |– |215 |5,271 |
|4246 |Suppositories 2.8g (for adults) 12 |– |– |487 |6,893 |
|13916 |Suppositories adult size 2.7g 12 |– |– |112 |– |
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ALIMENTARY TRACT AND METABOLISM
ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
intestinaL antiinfectiVes
ANTIBIOTICS
A07AA01 NEOMYCIN SULPHATE
A07AA02
intestinaL adsorBents
OTHER INTESTINAL ADSORBENTS
A07BC02 KAOLIN with ALUMINIUM HYDROXIDE
12714 Mixture 200m 1 – – 480 –
eLectroLYtes With carBohYdrates
ORAL REHYDRATION SALT FORMULATIONS
A07CA ELECTROLYTE REPLACEMENT (ORAL)
3196 Sachets of powder for oral solution 4.87g 10 – – 25,988 355,990
antipropuLsiVes
ANTIPROPULSIVES
A07DA01 DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE
A07DA03
intestinaL antiinfLammatorY agents
CORTICOSTEROIDS FOR LOCAL USE
A07EA02 HYDROCORTISONE ACETATE
A07EA01
AMINOSALICYLIC ACID AND SIMILAR AGENTS
A07EC04 BALSALAZIDE
8845 Capsule 750mg 6.75 GM 6,937 1,027,130
A07EC02 MESALAZINE
A07EC03
A07EC01 SULPHASALAZINE
|2093 |Tablet 500mg |2.00 |GM |24,610 |1,286,898 |
|2096 |Tablet 500mg (enteric coated) |2.00 |GM |194,252 |11,148,368 |
|11849 |Suppositories 10 |2.00 |GM |934 |– |
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
antioBesitY preparations eXcL diet products
CENTRALLY ACTING ANTIOBESITY PRODUCTS
A08AA03 DIETHYLPROPION
A08AA01
A08AA10
PERIPHERALLY ACTING ANTIOBESITY PRODUCTS
A08AB01 ORLISTAT
|4570 |Capsule 120mg 84 |0.36 |GM |23,906 |3,034,572 |
|18494 |Capsule 120mg 84 |0.36 |GM |7,917 |– |
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ALIMENTARY TRACT AND METABOLISM
DIGESTIVES INCL ENZYMES
digestiVes incL enZYmes
ENZYME PREPARATIONS
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
|2495 |Capsule providing >10,000 BP units lipase activity |– |– |9,189 |1,605,591 |
|8020 |Capsule (containing enteric coated microspheres) |– |– |12,602 |2,127,046 |
|8021 |Capsule (containing enteric coated microspheres) |– |– |24,852 |4,094,575 |
|8366 |Capsule providing >25,000 BP units lipase activity |– |– |1,805 |266,469 |
|8556 |Capsule (containing enteric coated microspheres) |– |– |11,640 |1,354,643 |
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
ANTIDIABETIC THERAPY
insuLins and anaLogues
INSULINS AND ANALOGUES FAST-ACTING
|A10AB02 |INSULIN (BEEF) | | | | |
| |1713 Injection 100 units per mL 10mL |40.00 |IE |738 |99,145 |
|A10AB01 |INSULIN (HUMAN) | | | | |
| |1531 Injection 100 units per mL 10mL |40.00 |IE |22,727 |2,847,196 |
| |1762 Injection 100 units per mL 3mL 5 |40.00 |IE |33,857 |7,400,222 |
|A10AB05 |INSULIN ASPART | | | | |
| |8435 Injection (human) 100 units per mL, 3mL, 5 |40.00 |IE |75,496 |19,784,899 |
| |8571 Injection (human) 100 units per mL,10mL, 5 |40.00 |IE |9,296 |1,466,770 |
|A10AB04 |INSULIN LISPRO | | | | |
| |8084 Injection 100 units per mL, 10mL |40.00 |IE |9,909 |1,583,638 |
| |8212 Injection 100 units per mL 3mL 5 |40.00 |IE |28,682 |7,605,132 |
INSULINS AND ANALOGUES INTERMEDIATE-ACTING
A10AC02 INSULIN (BEEF)
A10AC01
INSULINS AND ANALOGUES INTERMEDIATE ACTING COMBINED WITH FAST-ACTING
|A10AD01 |INSULIN |(HUMAN) | | | | |
| |1425 |Injection 100 units per mL (50 units-50 units) |40.00 |IE |1,674 |225,760 |
| |1426 |Injection 100 units per ml (30 units-70 units) |40.00 |IE |24,352 |3,233,861 |
| |1763 |Injection 100 units per mL (30 units-70 units) |40.00 |IE |120,094 |26,720,423 |
| |2062 |Injection 100 units per mL (50 units-50 units) |40.00 |IE |6,974 |1,557,943 |
| |8006 |Injection 100 units per mL (20 units-80 units) |40.00 |IE |7,039 |1,576,934 |
|A10AD30 |INSULIN |ASPART/PROTAMINE ASPART | | | | |
| |8609 |Injection (human analogue) 30/70 units per mL |40.00 |IE |83,817 |22,043,250 |
|A10AD04 |INSULIN |LISPRO | | | | |
| |8390 |Injection (human analogue) 100 units per mL 3mL 5|40.00 |IE |12,681 |3,359,880 |
| |8874 |Inj (human analogue) 100 units(50/50)per mL 3mL 5|40.00 |IE |632 |163,807 |
INSULINS AND ANALOGUES LONG-ACTING
A10AE05 INSULIN DETEMIR
A10AE04
oraL BLood gLucose LoWering drugs
BIGUANIDES
A10BA02 METFORMIN HYDROCHLORIDE
|1801 |Tablet 850mg |2.00 |GM |469,549 |6,659,015 |
|2430 |Tablet 500mg |2.00 |GM |1,998,713 |27,601,741 |
|8607 |Tablet 1000mg |2.00 |GM |903,565 |18,065,739 |
|8884 |Tablet 500mg (extended release) 9 0 |2.00 |GM |112,677 |1,448,640 |
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ALIMENTARY TRACT AND METABOLISM
ANTIDIABETIC THERAPY
oraL BLood gLucose LoWering drugs
SULFONAMIDES UREA DERIVATIVES
|A10BB01 |GLIBENCLAMIDE | | | | |
| |2939 Tablet 5mg |10.00 |MG |181,922 |1,874,725 |
|A10BB09 |GLICLAZIDE | | | | |
| |2449 Tablet 80mg |0.16 |GM |643,280 |9,387,252 |
| |8535 Tablet 30mg (modified release) |0.16 |GM |850,966 |12,540,157 |
|A10BB12 |GLIMEPIRIDE | | | | |
| |8450 Tablet 1mg 30 |2.00 |MG |88,725 |765,425 |
| |8451 Tablet 2mg 30 |2.00 |MG |123,801 |1,477,770 |
| |8452 Tablet 4mg 30 |2.00 |MG |275,944 |4,466,131 |
| |8533 Tablet 3mg 30 |2.00 |MG |40,761 |567,151 |
|A10BB07 |GLIPIZIDE | | | | |
| |2440 Tablet 5mg 100 |10.00 |MG |98,384 |1,060,162 |
BIGUANIDES AND SULFONAMIDES IN COMBINATION
A10BD02 METFORMIN and SULFONAMIDES
|8810 |Tablet Metformin 500mg/glibenclamide 2.5mg, 90 |– |– |32,965 |540,105 |
|8811 |Tablet Metformin 500mg/glibenclamide 5mg, 90 |– |– |43,734 |775,038 |
|8838 |Tablet Metformin 250mg/glibenclamide 1.25, 90 |– |– |3,549 |47,744 |
ALPHA GLUCOSIDASE INHIBITORS
A10BF01 ACARBOSE
|8188 |Tablet 50mg |0.30 |GM |31,272 |919,225 |
|8189 |Tablet 100mg |0.30 |GM |28,846 |1,173,834 |
THIAZOLIDINEDIONES
A10BG03 PIOGLITAZONE HYDROCHLORIDE
A10BG02
OTHER BLOOD GLUCOSE LOWERING DRUGS
A10BX02 REPAGLINIDE
|16646 |Tablet 1mg 90 |6.00 |MG |535 |– |
|16647 |Tablet 2mg 90 |6.00 |MG |892 |– |
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
VITAMINS
muLtiVitamins comBinations
MULTIVITAMINS WITH MINERALS
A11AA03
A11AA01
Vitamin a and d incL comBinations of the tWo
VITAMIN A PLAIN
A11CA01 VITAMIN A
12182 Capsule 50 000 units 100 50.00 TE 1,002 –
VITAMIN D AND ANALOGUES
A11CC04 CALCITRIOL
A11CC01
Vitamin B1,pLain and in comB. With Vitamin B6 and B12
THIAMINE (VITAMIN B1) PLAIN
A11DA01 THIAMINE HYDROCHLORIDE
|1070 |Tablet 100mg |50.00 |MG |6,921 |64,784 |
|4043 |Tablet 100mg |50.00 |MG |36,087 |336,416 |
Vitamin B-compLeX incL comBinations
VITAMIN B-COMPLEX PLAIN
A11EA VITAMIN B GROUP COMPLEX
4493 Oral liquid 200mL – – 21,376 250,170
VITAMIN B-COMPLEX WITH VITAMIN C
A11EB VITAMIN B with C
14139 Tablet 90 – – 823 –
ascorBic acid (Vitamin c) incL. comBinations
ASCORBIC ACID (VITAMIN C) PLAIN
A11GA01 ASCORBIC ACID
4565 Tablet 250mg (sugar free) 100 200.00 MG 190 1,437
other pLain Vitamin preparations
OTHER PLAIN VITAMIN PREPARATIONS
A11HA02 PYRIDOXINE HYDROCHLORIDE
|11648 |Tablet 25mg 100 |160.00 |MG |2,082 |– |
|11649 |Tablet 100mg 50 |160.00 |MG |1,211 |– |
|18583 |Tablet 25mg 100 |160.00 |MG |280 |– |
other Vitamin products comBinations
VITAMINS WITH MINERALS
A11JB VITAMINS with MINERALS
|10099 |Capsule 30 |– |– |6,368 |– |
|12946 |Capsule 100 |– |– |710 |– |
|12947 |Capsule 100 |– |– |1,017 |– |
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
MINERAL SUPPLEMENTS
caLcium
CALCIUM
|A12AA20 |CALCIUM (DIFFERENT SALTS IN COMBINATION) | | | | |
| |15690 Compound effervescent tablet equivalent to 1g |0.50 |GM |487 |– |
|A12AA04 |CALCIUM CARBONATE | | | | |
| |3116 Tablet (chewable) 500mg (as carbonate) |3.00 |GM |5,681 |81,317 |
| |3117 Tablet 600mg (as carbonate) |3.00 |GM |167,796 |2,291,363 |
|A12AA |CALCIUM CITRATE | | | | |
| |8560 Tablet 250mg (as citrate) |– |– |9,794 |125,221 |
CALCIUM, COMBINATIONS WITH OTHER DRUGS
A12AX CALCIUM CARBONATE with CHOLECALCIFEROL
10600 Tablet 600mg 60 3.00 10,543 –
potassium
POTASSIUM
A12BA01 POTASSIUM CHLORIDE
|2642 |Tablet 600 mg (sustained release) |3.00 |GM |319,807 |3,427,451 |
|3012 |Effervescent tabs 14mmol K,8mmol Cl ions |3.00 |GM |29,845 |343,980 |
other mineraL suppLements
ZINC
A12CB01 ZINC SULPHATE
12264 Capsule 50mg 100 0.60 GM 575 –
MAGNESIUM
A12CC05 MAGNESIUM ASPARTATE
|4321 |Tablet 500mg |– |– |21,757 |308,235 |
|11226 |Tablet 100 |– |– |9,310 |– |
SELENIUM
A12CE01 SELENIUM
12016 Tablet 50ug 100 0.20 MG 567 –
A
2006
atc code form and strength ddd units scripts cost($)
ALIMENTARY TRACT AND METABOLISM
ANABOLIC AGENTS FOR SYSTEMIC USE
anaBoLic steroids
ANDROSTAN DERIVATIVES
A14AA08 OXANDROLONE
2545 Tablet 2.5mg – – 192 190,647
ESTREN DERIVATIVES
A14AB01 NANDROLONE DECANOATE
|1671 |Injection 50mg in 1mL disposable syringe |2.00 |MG |19,616 |388,837 |
|18759 |Injection 50mg in 1mL disposable syringe |2.00 |MG |918 |– |
| B | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
BLOOD AND BLOOD FORMING ORGANS
ANTITHROMBOTIC AGENTS
antithromBotic agents
VITAMIN K ANTAGONISTS
B01AA02 PHENINDIONE
|14975 |Tablet 10mg |0.10 |GM |599 |– |
|B01AA03 WARFA |RIN | | | | |
|2209 |Tablet 2mg |7.50 |MG |867,386 |6,957,290 |
|2211 |Tablet 5mg |7.50 |MG |591,099 |5,149,869 |
|2843 |Tablet 1mg |7.50 |MG |970,749 |7,607,838 |
|2844 |Tablet 3mg |7.50 |MG |287,499 |2,366,805 |
|HEPARIN GROUP | | | | | |
|B01AB04 DALTEPARIN |
|2816 |Inj 5,000 units (anti-Xa) in 0.2mL syringe |2.50 |TE |9,906 |628,808 |
|8269 |Inj 10,000 units (anti-Xa) in 1mL syringe |2.50 |TE |215 |45,582 |
|8271 |Inj 7,500 units (anti-Xa) in 0.75mL syringe |2.50 |TE |478 |80,759 |
|8603 |Inj 2,500 units (anti-Xa) in 0.2mL syringe |2.50 |TE |6,808 |370,260 |
|8641 |Inj 2,500 units (anti-Xa) in 0.2mL syringe |2.50 |TE |503 |47,841 |
|8642 |Inj 5,000 units (anti-Xa) in 0.2mL syringe |2.50 |TE |1,044 |102,162 |
|8643 |Inj 7,500 units (anti-Xa) in 0.75mL syringe |2.50 |TE |118 |22,127 |
|B01AB05 ENOXAPARIN |
|8262 |Inj 60mg (6000u anti-Xa) in 0.6mL syringe |2.00 |TE |25,546 |2,683,041 |
|8263 |Inj 80mg (8000u anti-Xa) in 0.8mL syringe |2.00 |TE |34,588 |4,228,157 |
|8264 |Inj 100mg (10000u anti-Xa) in 1 mL syringe |2.00 |TE |31,140 |4,723,524 |
|8510 |Inj 40mg (4000u anti-Xa) in 0.4 mL syringe |2.00 |TE |88,329 |5,388,594 |
|8558 |Inj 20mg (2000u anti-Xa) in 0.2mL syringe |2.00 |TE |39,186 |2,139,166 |
|8639 |Inj 40mg (4000u anti-Xa) in 0.4mL syringe |2.00 |TE |11,569 |1,100,766 |
|8640 |Inj 60mg (6000u anti-Xa) in 0.6mL syringe |2.00 |TE |6,168 |889,256 |
|8716 |Inj 20mg (2000u anti-Xa) in 0.2mL syringe |2.00 |TE |3,978 |355,180 |
|B01AB01 HEPARIN SODIUM |
|1076 |Injection 35,000 units in 35mL 12 |10.00 |TE |1,523 |182,539 |
|1463 |Injection 5,000 units in 5mL |10.00 |TE |3,635 |177,936 |
|1466 |Injection 5,000 units in 0.2mL |10.00 |TE |24,141 |290,985 |
|1467 |Injection 5,000 units in 1mL |10.00 |TE |2,583 |31,325 |
|19835 |Injection 5,000 units in 1mL 5 |10.00 |TE |185 |– |
B
2006
atc code form and strength ddd units scripts cost($)
BLOOD AND BLOOD FORMING ORGANS
ANTITHROMBOTIC AGENTS
antithromBotic agents
PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN
|B01AC13 ABCIXIMAB |
| |8048 |I.V.injection 10mg in 5mL |25.00 |MG |2,458 |3,954,137 |
|B01AC06 |ASPIRIN | | | | | |
| |4076 |Tablet 100mg (enteric coated) |0.10 |GM |28,211 |351,630 |
| |4077 |Tablet 100mg (enteric coated) |0.10 |GM |105,081 |1,242,656 |
| |4078 |Capsule 100mg (enteric coated pellets) |0.10 |GM |17,754 |228,489 |
| |8202 |Tablet 100mg |0.10 |GM |1,148,219 |7,602,726 |
| |10544 |Tablet 100mg 30 |0.10 |GM |15,035 |– |
| |10599 |Tablet 100mg 28 |0.10 |GM |17,996 |– |
| |13020 |Capsule 100mg 28 |0.10 |GM |1,064 |– |
|B01AC04 CLOPIDOGREL |
|4179 |Tablet 75mg (base) 28 |75.00 |MG |97,103 |8,104,456 |
|8358 |Tablet 75mg |75.00 |MG |2,190,391 |181,768,389 |
|B01AC07 DIPYRIDAMOLE |
|8335 |Capsule 200mg (sustained release) |0.40 |GM |60,353 |2,024,646 |
|13040 |Tablet 100mg 100 |0.40 |GM |927 |– |
|B01AC30 |DIPYRIDAMOLE with ASPRIN | | | | |
| |8382 Capsule 200mg (sustained release) 25mg |– |– |419,977 |13,827,607 |
|B01AC16 |EPTIFIBATIDE | | | | |
| |8683 Solution for I.V. injection 20mg (base) in 10mL |0.20 |GM |127 |30,958 |
| |8684 Solution for I.V. infusion 75mg (base) in 100mL |0.20 |GM |131 |99,310 |
|B01AC11 |ILOPROST | | | | |
| |6456 Solution for inhalation 20ug (base) in 2mL, 30 |0.15 |MG |207 |579,619 |
|B01AC05 |TICLOPIDINE HYDROCHLORIDE | | | | |
| |2095 Tablet 250mg |0.50 |GM |3,738 |561,697 |
|B01AC17 |TIROFIBAN | | | | |
| |8350 Solution concentrate I.V. infusion 12.5mg in 50mL |10.00 |MG |1,900 |824,917 |
|ENZYMES | | | | | |
|B01AD11 |TENECTEPLASE | | | | |
| |8527 Powder for injection 50mg with solvent |40.00 |MG |223 |478,153 |
DIRECT THROMBIN INHIBITORS
B01AE06 BIVALIRUDIN
8844 Powder for I.V. injection 250mg (base) 0.25 GM 813 622,575
OTHER ANTITHROMBOTIC AGENTS
B01AX05 FONDAPARINUX SODIUM
8775 Injection 2.5mg in 0.5mL prefilled syringe 2.50 MG 153 18,046
B
2006
atc code form and strength ddd units scripts cost($)
BLOOD AND BLOOD FORMING ORGANS
ANTIHAEMORRHAGICS
antifiBrinoLYtics
AMINO ACIDS
B02AA02 TRANEXAMIC ACID
2180 Tablet 500mg 2.00 GM 31,013 1,556,937
Vitamin K and other haemostatics
VITAMIN K
B02BA01 PHYTOMENADIONE
|11080 |Tablet 10mg 100 |20.00 |MG |853 |– |
|16049 |Ampoule 10mg/mL 5 |20.00 |MG |581 |– |
B
2006
atc code form and strength ddd units scripts cost($)
BLOOD AND BLOOD FORMING ORGANS
ANTIANAEMIC PREPARATIONS
iron preparations
IRON BIVALENT, ORAL PREPARATIONS
B03AA07 FERROUS SULPHATE DRIED
|8815 |Oral liquid 30mg per mL, 250mL |0.20 |GM |34,711 |599,251 |
|16996 |Tablet |0.20 |GM |53,143 |– |
IRON TRIVALENT, PARENTERAL PREPARATIONS
B03AC03 IRON POLYMALTOSE COMPLEX
B03AC02
IRON IN COMBINATION WITH FOLIC ACID
B03AD02 FERROUS FUMARATE WITH FOLIC ACID
B03AD03
Vitamin B12 and foLic acid
VITAMIN B12 (CYANOCOBALAMIN AND DERIVATIVES)
B03BA01 CYANOCOBALAMIN
B03BA03
FOLIC ACID AND DERIVATIVES
B03BB01 FOLIC ACID
|1437 |Tablet 5mg |– |– |131,805 |1,523,586 |
|2958 |Tablet 500ug |0.40 |MG |50,398 |573,021 |
other antianaemic preparations
OTHER ANTIANAEMIC PREPARATIONS
B03XA02 DARBEPOETIN ALPHA
B03XA01
| A | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
BLood and reLated products
BLOOD SUBSTITUTES AND PLASMA PROTEIN FRACTIONS
B05AA06 GELATIN SUCCINYLATED
8444 I.V. infusion 20g per 500mL,500mL – – 6,072 235,909
i.V. soLutions
SOLUTIONS FOR PARENTERAL NUTRITION
B05BA03 GLUCOSE
2245 I.V. infusion 278mmol per l (5%), 1 l – – 1,560 35,891
SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE
|B05BB01 |SODIUM |CHLORIDE | | | | |
| |2260 |I.V. infusion 513mmol per l (3%) 1L |– |– |148 |10,162 |
| |2264 |I.V. infusion 154mmol per l (0.9% ) 1L |– |– |28,784 |985,032 |
| |18528 |Ampoule 0.9% 10mL 50 |– |– |228 |– |
|B05BB02 |SODIUM |CHLORIDE with GLUCOSE | | | | |
| |2281 |I.V. infusion 31mmol-222mmol per l (0.18%-4%) 1L |– |– |5,752 |136,702 |
|B05BB01 |SODIUM |LACTATE COMPOUND | | | | |
| |2286 |I.V. infusion 1L |– |– |12,913 |297,976 |
irrigating soLutions
SALT SOLUTIONS
B05CB01 SODIUM CHLORIDE
|4460 |Irrigation solution 9mg per mL (0 .9%) 500mL |– |– |945 |8,418 |
|4461 |Irrigation solution 9mg per mL (0 .9%) 1L |– |– |527 |5,382 |
B
2006
atc code form and strength ddd units scripts cost($)
BLOOD AND BLOOD FORMING ORGANS
OTHER HAEMATOLOGICAL AGENTS
other haematoLogicaL agents
ENZYMES
B06AA03 HYALURONIDASE
10985 Ampoule 1500u 5 – – 787 –
| C | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
CARDIOVASCULAR SYSTEM
CARDIAC THERAPY
cardiac gLYcosides DIGITALIS GLYCOSIDES C01AA05 DIGOXIN
antiarrhYthmics cLass i and iii
ANTIARRHYTHMICS CLASS IA
C01BA03 DISOPYRAMIDE
C01BA01
ANTIARRHYTHMICS CLASS IB
C01BB01 LIGNOCAINE HYDROCHLORIDE
C01BB02
ANTIARRHYTHMICS CLASS IC
C01BC04 FLECAINIDE ACETATE
|1088 |Tablet 50mg 60 |0.20 |GM |51,183 |1,987,320 |
|1090 |Tablet 100mg |0.20 |GM |87,540 |4,160,061 |
ANTIARRHYTHMICS CLASS III
C01BD01 AMIODARONE HYDROCHLORIDE
|2343 |Tablet 200mg |0.20 |GM |286,571 |7,207,638 |
|2344 |Tablet 100mg |0.20 |GM |114,836 |1,876,327 |
cardiac stimuLants eXcL. cardiac gLYcosides
ADRENERGIC AGENTS
C01CA24 ADRENALINE
|1016 |Injection 1mg in 1mL (1 in 1,000) |0.50 |MG |3,214 |61,015 |
|3451 |Injection 1mg in 1mL (1 in 1,000) |0.50 |MG |21,201 |347,205 |
|8697 |I.M. injection 150mg in 0.3mL syringe |0.50 |MG |14,718 |2,521,672 |
|8698 |I.M. injection 300mg in 0.3mL syringe |0.50 |MG |26,254 |3,274,997 |
|13437 |Syrng 1/10000 1 |0.50 |MG |126 |– |
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
CARDIAC THERAPY
VasodiLators used in cardic diseases
ORGANIC NITRATES
C01DA02
C01DA08
C01DA14
OTHER VASODILATORS USED IN CARDIAC DISEASES
C01DX16 NICORANDIL
|8228 |Tablet 10mg |40.00 |MG |134,324 |2,837,456 |
|8229 |Tablet 20mg |40.00 |MG |62,052 |1,713,152 |
| C | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
CARDIOVASCULAR SYSTEM
ANTIHYPERTENSIVES
antiadrenergic agents centraLLY acting
METHYLDOPA
C02AB01 METHYLDOPA
1629 Tablet 250mg 1.00 GM 156,051 2,026,787
IMIDAZOLINE RECEPTOR AGONISTS
C02AC01 CLONIDINE
C02AC05
antiadrenergic agents peripheraLLY acting
ALPHA - ADRENOCEPTOR BLOCKING AGENTS
C02CA01 PRAZOSIN HYDROCHLORIDE
|1478 |Tablet 5mg (base) |5.00 |MG |137,697 |3,309,514 |
|1479 |Tablet 1mg (base) |5.00 |MG |268,744 |3,498,335 |
|1480 |Tablet 2mg (base) |5.00 |MG |159,136 |2,558,422 |
arterioLar smooth muscLe agents acting on
HYDRAZINOPHTHALAZINE DERIVATIVES
C02DB02 HYDRALAZINE HYDROCHLORIDE
|1639 |Tablet 50mg |0.10 |GM |19,996 |306,310 |
|1640 |Tablet 25mg |0.10 |GM |23,567 |317,762 |
PYRIMIDINE DERIVATIVES
C02DC01 MINOXIDIL
2313 Tablet 10mg 20.00 MG 4,160 237,100
other antihYpertensiVes
OTHER ANTHIYPERTENSIVES
C02KX01 BOSENTAN
|6429 |Tablet 62.5mg (base) 60 |250.00 |MG |369 |1,133,195 |
|6430 |Tablet 125mg (base) 60 |250.00 |MG |3,631 |11,977,536 |
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
DIURETICS
LoW-ceiLing diuretics thiaZides
THIAZIDES PLAIN
C03AA03 HYDROCHLOROTHIAZIDE
1484 Tablet 25mg 25.00 MG 82,434 1,592,346
LoW-ceiLing diuretics eXcL. thiaZides
SULFONAMIDES PLAIN
C03BA04 CHLORTHALIDONE
C03BA11
high-ceiLing diuretics
SULFONAMIDES PLAIN
C03CA02 BUMETANIDE
C03CA01
ARYLOXYACETIC ACID DERIVATIVES
C03CC01 ETHACRYNIC ACID
8748 Tablet 25mg 50.00 MG 1,861 101,283
potassium-sparing agents
ALDOSTERONE ANTAGONISTS
C03DA04 EPLERENONE
C03DA01
OTHER POTASSIUM-SPARING AGENTS
C03DB01 AMILORIDE HYDROCHLORIDE
3109 Tablet 5mg 10.00 MG 28,080 241,916
diuretics and potassium-sparing agents in comB
LOW-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS
C03EA01 HYDROCHLOROTHIAZIDE with AMILORIDE HYDROCHLORIDE
C03EA01
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
PERIPHERAL VASODILATORS
peripheraL VasodiLators
PURINE DERIVATIVES
C04AD03 OXPENTIFYLLINE
|12650 |Tablet 400mg 90 |1.00 |GM |615 |– |
|17632 |Tablet 400mg 50 |1.00 |GM |3,847 |– |
OTHER PERIPHERAL VASODILATORS
C04AX02 PHENOXYBENZAMINE HYDROCHLORIDE
1862 Capsule 10mg 30 30.00 MG 2,696 148,412
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
antihaemorrhoidaLs for topicaL use
PRODUCTS CONTAINING CORTICOSTEROIDS
C05AA01 HYDROCORTISONE, LIGNOCAINE BASE, ALUMINIUM SUBACETATE and ZINC OXIDE
14653 Ointment 2.5mg-50mg-35mg-180mg per g – – 2,695 –
C05AA04 PREDNISOLONE HEXANOATE, CINCHOCAINE HYDROCHLORIDE and CLEMIZOLE UNDECYLENATE
14656 Ointment 1.9mg-5mg-10mg per g (0.16-0.5%-1%) – – 8,769 – 14657 Ointment 1.9mg-5mg-10mg per g (0.195-0.5%-1%) – – 9,167 – 14658 Suppositories 1.3mg-1mg-5mg 12 – – 6,066 –
PRODUCTS CONTAINING LOCAL ANESTHETICS
C05AD03 ADRENALINE EPHEDRINE BENZOCAINE ZINC OXIDE
13134 Ointment 50g 1 – – 3,293 –
OTHER ANTIHAEMORRHOIDALS FOR TOPICAL USE
C05AX04 ZINC OXIDE
|4039 |Compound ointment 50g |– |– |3,477 |44,247 |
|4040 |Compound suppositories, 12 |– |– |2,260 |27,286 |
antiVaricose therapY
HEPARINS OR HEPARINOIDS FOR TOPICAL USE
C05BA01 HEPARINOID
C05BA01
capiLLarY staBiLiZing agents
BIOFLAVONOIDS
C05CA02 HYDROXYETHYLRUTOSIDES
|13500 |Capsule 250mg 50 |– |– |235 |– |
|16101 |Capsule 250mg 100 |– |– |563 |– |
| C | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
CARDIOVASCULAR SYSTEM
BETA BLOCKING AGENTS
Beta BLocKing agents pLain
BETA BLOCKING AGENTS PLAIN NON-SELECTIVE
C07AA02 OXPRENOLOL HYDROCHLORIDE
C07AA03
C07AA05
C07AA07
BETA BLOCKING AGENTS PLAIN SELECTIVE
C07AB03 ATENOLOL
| |1081 Tablet 50mg |0.08 |GM |4,142,821 |43,555,913 |
|C07AB07 |BISOPROLOL | | | | |
|8604 |Tablet 2.5mg |10.00 |MG |64,949 |3,864,553 |
|8605 |Tablet 5mg |10.00 |MG |56,497 |4,182,198 |
|8606 |Tablet 10mg |10.00 |MG |48,639 |4,069,114 |
|C07AB02 METOPROLOL SUCCINATE |
|8732 |Tablet 23.75mg (controlled release) 15 |150.00 |MG |9,670 |321,684 |
|8733 |Tablet 47.5mg (controlled release) 30 |150.00 |MG |19,074 |1,467,535 |
|8734 |Tablet 95mg (controlled release) 30 |150.00 |MG |17,538 |1,650,079 |
|8735 |Tablet 190mg (controlled release) 30 |150.00 |MG |13,058 |1,443,328 |
|8818 |Pack 15 23.75mg, 47.5mg, 95mg, 15/15/15 45 |150.00 |MG |247 |23,364 |
|C07AB02 METOPROLOL TARTRATE |
|1324 |Tablet 50mg |150.00 |MG |989,023 |10,545,887 |
|1325 |Tablet 100mg |150.00 |MG |479,312 |5,959,075 |
ALPHA- AND BETA- ADRENOCEPTOR BLOCKING AGENTS
C07AG02 CARVEDILOL
C07AG01
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
CALCIUM CHANNEL BLOCKERS
seLectiVe caLcium channeL BLocKers With mainLY VascuLar effects
DIHYDROPYRIDINE DERIVATIVES
C08CA01 AMLODIPINE
C08CA02
C08CA13
C08CA05
seLectiVe caLcium channeL BLocKers With direct cardiac effects
PHENYLALKYLAMINE DERIVATIVES
C08DA01 VERAPAMIL HYDROCHLORIDE
|1241 |Tablet 240mg (sustained release) |0.24 |GM |728,545 |13,447,385 |
|1248 |Tablet 40mg |0.24 |GM |39,086 |454,269 |
|1250 |Tablet 80mg |0.24 |GM |39,965 |668,750 |
|1253 |Tablet 160mg |0.24 |GM |19,585 |409,025 |
|1254 |Tablet 120mg |0.24 |GM |6,300 |138,372 |
|2206 |Capsule 160mg (sustained release) |0.24 |GM |56,364 |754,466 |
|2207 |Capsule 240mg (sustained release) |0.24 |GM |85,201 |1,574,091 |
|2208 |Capsule 180mg (sustained release) |0.24 |GM |217,621 |3,268,632 |
|3494 |Injection 5mg in 2mL |0.24 |GM |3,970 |43,062 |
BENZOTHIAZEPINE DERIVATIVES
C08DB01 DILTIAZEM HYDROCHLORIDE
|1312 |Capsule 180mg controlled delivery |0.24 |GM |532,029 |11,363,383 |
|1313 |Capsule 240mg controlled delivery |0.24 |GM |539,267 |14,516,649 |
|1335 |Tablet 60mg |0.24 |GM |69,611 |1,380,099 |
|8480 |Capsule 360mg controlled delivery 30 |0.24 |GM |280,393 |9,285,282 |
non-seLectiVe caLcium channeL BLocKers
OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
C08EX02 PERHEXILINE MALEATE
1822 Tablet 100mg 0.20 GM 31,826 1,687,012
| C | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
angiotensin-conVerting enZYme (ace) inhiBitors, pLain
CONVERTING ENZYME BLOCKERS
C09AA01 CAPTOPRIL
C09AA02
C09AA09
C09AA03
C09AA04
C09AA06
C09AA05
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
angiotensin-conVerting enZYme (ace) inhiBitors, pLain
CONVERTING ENZYME BLOCKERS
C09AA10 TRANDOLAPRIL
|2791 |Capsule 500ug |2.00 |MG |39,112 |559,080 |
|2792 |Capsule 1mg |2.00 |MG |126,252 |2,511,289 |
|2793 |Capsule 2mg |2.00 |MG |309,443 |7,202,855 |
|8758 |Capsule 4mg 28 |2.00 |MG |105,004 |3,647,047 |
ace inhiBitors, comBinations
ANGIOTENSIN-CONVERTING ENZYME BLOCKERS AND DIURETICS
|C09BA02 |ENALAPRIL and HYDROCHLOROTHIAZIDE | | | | |
| |8477 Tablet 20mg-6mg |– |– |164,935 |4,834,739 |
|C09BA09 |FOSINOPRIL with HYDROCHLOROTHIAZIDE | | | | |
| |8400 Tablet 10mg-12.5mg |– |– |93,625 |2,078,747 |
| |8401 Tablet 20mg-12.5mg |– |– |476,043 |14,413,237 |
|C09BA04 |PERINDOPRIL and INDAPAMIDE | | | | |
| |8449 Tablet 4mg (erbumine salt)-1.25mg 30 |– |– |1,806,531 |56,857,295 |
|C09BA06 |QUINAPRIL and HYDROCHLOROTHIAZIDE | | | | |
| |8589 Tablet 10mg(base) / 12.5mg 30 |– |– |24,495 |584,663 |
| |8590 Tablet 20mg(base) / 12.5mg 30 |– |– |97,398 |2,673,763 |
angiotensin ii antagonists
ANGIOTENSIN II ANTAGONISTS PLAIN
C09CA06 CANDESARTAN
|8295 |Tablet 4mg 30 |8.00 |MG |245,877 |4,745,799 |
|8296 |Tablet 8mg 30 |8.00 |MG |682,170 |15,745,454 |
|8297 |Tablet 16mg 30 |8.00 |MG |771,693 |22,742,501 |
|8889 |Tablet 32mg 30 |8.00 |MG |49,922 |2,238,867 |
|C09CA02 EPROSARTAN |
|8397 |Tablet 400mg (base) 56 |0.60 |GM |28,035 |776,719 |
|8447 |Tablet 600mg (base) 28 |0.60 |GM |106,425 |3,052,238 |
|C09CA04 IRBESARTAN |
|8246 |Tablet 75mg |150.00 |MG |462,215 |8,959,230 |
|8247 |Tablet 150mg |150.00 |MG |1,771,018 |41,357,438 |
|8248 |Tablet 300mg |150.00 |MG |1,699,110 |48,404,153 |
|C09CA01 |LOSARTAN | | | | |
| |16073 Tablet 50mg 30 |0.05 |GM |3,893 |– |
|C09CA07 |TELMISARTAN | | | | |
| |8355 Tablet 40mg |40.00 |MG |654,210 |12,897,153 |
| |8356 Tablet 80mg |40.00 |MG |654,105 |17,604,577 |
C
2006
atc code form and strength ddd units scripts cost($)
ANGIOTENSIN II ANTAGONISTS COMBINATIONS
ANGIOTENSIN II ANTAGONISTS AND DIURETICS
cardioVascuLar sYstem
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
|C09DA06 |CANDESARTAN with HYDROCHLOROTHIAZIDE | | | | |
| |8504 Tablet 16mg-12.5mg |– |– |891,893 |27,564,386 |
|C09DA02 |EPROSARTAN and DIURETICS | | | | |
| |8624 Tablet 600mg (base) -12.5mg 28 |– |– |97,273 |2,937,912 |
|C09DA04 |IRBESARTAN with HYDROCHLOROTHIAZIDE | | | | |
| |8404 Tablet 150mg-12.5mg |– |– |769,142 |19,548,424 |
| |8405 Tablet 300mg-12.5mg |– |– |2,444,138 |74,220,476 |
|C09DA02 |TELMISARTAN and DIURETICS | | | | |
| |8622 Tablet 40mg-12.5mg 28 |– |– |117,901 |2,549,803 |
| |8623 Tablet 80mg-12.5mg 28 |– |– |517,933 |14,807,779 |
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS PLAIN
Lipid modifYing agents pLain
HMG REDUCTASE INHIBITORS
C10AA05 ATORVASTATIN
C10AB04 GEMFIBROZIL
1453 Tablet 600mg 1.20 GM 327,324 12,951,320
BILE ACID SEQUESTRANTS
C10AC01 CHOLESTYRAMINE
|2967 |Sachets 4.7g(equiv to 4 g cholestyramine) |14.00 |GM |27,005 |1,489,380 |
|2978 |Sachets 9.4g equiv to 8 g cholestyramine) |14.00 |GM |11,125 |626,336 |
|C10AC02 |COLESTIPOL HYDROCHLORIDE | | | | |
|1224 |Sachets 5g 120 |20.00 |GM |1,364 |92,188 |
NICOTINIC ACID AND DERIVATIVES
C10AD02 NICOTINIC ACID
19191 Tablet 250mg 2.00 GM 8,015 –
OTHER LIPID MODIFYING AGENTS
C10AX09 EZETIMIBE
8757 Tablet 10mg 30 10.00 MG 627,226 44,423,810
C
2006
atc code form and strength ddd units scripts cost($)
CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS PLAIN
Lipid modifYing agents comBinations
HMG COA REDUCTASE INHIBITORS IN COMBINATION WITH OTHER LIPID MOD AGENTS
C10BA02 SIMVASTATIN and EZETIMIBE
|8881 |Tablet 40mg -10mg 30 |– |– |61,761 |8,151,904 |
|8882 |Tablet 80mg -10mg 30 |– |– |47,723 |7,592,283 |
|19529 |Tablet 20mg -10mg 30 |– |– |320 |– |
HMG COA REDUCTASE INHIBITORS, OTHER COMBINATIONS
C10BX03 ATORVASTATIN AND AMLODIPINE
|9049 |Tablet 5mg (base) 10mg (base) 30 |– |– |254 |14,323 |
|9050 |Tablet 5mg (base) 20mg (base) 30 |– |– |592 |43,498 |
|9051 |Tablet 5mg (base) 40mg (base) 30 |– |– |684 |65,050 |
|9053 |Tablet 10mg (base) 10mg (base) 30 |– |– |211 |14,332 |
|9054 |Tablet 10mg (base) 20mg (base) 30 |– |– |537 |45,711 |
|9055 |Tablet 10mg (base) 40mg (base) 30 |– |– |675 |72,098 |
|9056 |Tablet 10mg (base) 80mg (base) 30 |– |– |230 |31,974 |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
ANTIFUNGALS FOR DERMATOLOGICAL USE
antifungaLs for topicaL use
ANTIBIOTICS
D01AA01 NYSTATIN
4001 Cream 100,000 units per g 15g – – 1,634 15,591
IMIDAZOLE DERIVATIVES
D01AC10 BIFONAZOLE
D01AC01
D01AC03 ECONAZOLE NITRATE
15470 Cream 10 mg per g (1%), 20 g – – 3,305 –
D01AC08 KETOCONAZOLE
D01AC02
D01AC02
D01AC52
17966 Cream 1% 1g/100g 30g – – 25,735 –
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
ANTIFUNGALS FOR DERMATOLOGICAL USE
antifungaLs for topicaL use
OTHER ANTIFUNGALS FOR TOPICAL USE
|D01AE16 |AMOROLFINE | | | | |
| |4010 Nail treatment kit containing 50mg (base) per mL |– |– |11,088 |1,012,429 |
|D01AE14 |CICLOPIROX | | | | |
| |4106 Shampoo 15mg per g (1.5%), 60mL |– |– |347 |5,709 |
|D01AE15 |TERBINAFINE | | | | |
| |4463 Gel 10mg per g (1%) 15g |– |– |1,009 |21,422 |
| |4473 Cream 10mg per g (1%), 15g |– |– |17,761 |370,307 |
|D01AE18 |TOLNAFTATE | | | | |
| |4481 Spray aerosol 10mg per g (1%) 100g |– |– |921 |12,157 |
| |12867 Powder 1%20g 1 |– |– |194 |– |
antifungaLs for sYstemic use
ANTIFUNGALS FOR SYSTEMIC USE
D01BA01 GRISEOFULVIN
D01BA02
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
EMOLLIENTS AND PROTECTIVES
emoLLients and protectiVes
SILICONE PRODUCTS
D02AA DIMETHICONE and GLYCEROL
D02AA
SOFT PARAFFIN AND FAT PRODUCTS
|D02AC |DEWAXED OIL with LANOLIN | |
| |10031 Oil 375mL 1 – – 224 |– |
|D02AC |DEWAXED OIL with SOLUBLE KERATIN with LANOLIN with MINERAL OIL with POLYETHYLENE GLYCOL | |
| |10147 Ltn 250mL 1 – – 564 | |
| | |– |
|D02AC |PARAFFIN | |
| |4041 Ointment 100g – – 787 |8,783 |
CARBAMIDE PRODUCTS
D02AE01 UREA
|4042 |Cream 100mg per g (10%) 100g |– |– |36,237 |390,974 |
|13630 |Cream 100g 1 |– |– |148 |– |
OTHER EMOLLIENTS AND PROTECTIVES
|D02AX |BATH EMOLLIENT | | | | |
| |4122 Bath oil 500mL |– |– |10,565 |179,344 |
|D02AX |CARMELLOSE SODIUM with PECTIN and GELATIN | | | | |
| |4518 Paste 167mg-167mg-167mg per g |– |– |369 |4,135 |
| |14151 Paste 167mg-167mg-167mg per g |– |– |126 |– |
|D02AX |CETOMACROGOL | | | | |
| |15823 Sorbolene crm 100g |– |– |1,053 |– |
|D02AX |CETOMACROGOL with GLYCERINE | | | | |
| |11020 Cream 100g 1 |– |– |229 |– |
|D02AX |DEWAXED OIL with LANOLIN | | | | |
| |4107 Lotion 500mL |– |– |5,065 |78,839 |
protectiVes against uV-radiation
PROTECTIVES AGAINST UV-RADIATION FOR TOPICAL USE
D02BA SUNSCREENS
|4543 |Solid stick 4.5g |– |– |1,164 |12,002 |
|4544 |Cream 100g |– |– |14,483 |205,056 |
|4546 |Lotion (non-alcoholic) 125mL |– |– |3,749 |55,489 |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
PREPARATIONS FOR TREATMENT OF WOUNDS & ULCERS
cicatriZants
OTHER CICATRIZANTS
D03AX07 GLYCERYL TRINITRATE
16349 Ointment 0.2% 30g 1 – – 7,167 –
D03AX VITAMIN A
16106 Ointment 50g – – 3,195 –
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.
antipruritics,incL antihist,anesthet,etc.
ANAESTHETICS FOR TOPICAL USE
D04AB01
D04AB01
OTHER ANTIPRURITICS
|D04AX |CROTAMITON | | | | |
| |12933 Cream 10%20g 1 |– |– |511 |– |
|D04AX |PINE TAR and TRIETHANOLAMINE | | | | |
| |4408 Solution 23mg-60mg per mL (2.3%-6%) 500mL |– |– |2,495 |45,930 |
| D | |
| | |2006 | |
|atc |code form and strength |ddd units scripts |cost($) |
DERMATOLOGICALS
ANTIPSORIATICS
antipsoriatics for topicaL use
TARS
|D05AA |ALLANTOIN, SULPHUR, PHENOL, COAL TAR SOLUTION and MENTHOL | |
| |4505 Gel 25mg-5mg-5mg-0.05mL-7.5mg – – 185 |3,173 |
|D05AA |PINE TAR with GLYCEROL | |
| |12682 Gel 100g 1 – – 587 |– |
|D05AA |TARS | |
| |8864 Gel 10mg per g (1%) 100mL – – 8,887 |311,809 |
ANTRACEN DERIVATIVES
D05AC01 DITHRANOL with SALICYLIC ACID
17059 Ointment 1.0% 50g 1 – – 407 –
OTHER ANTIPSORIATICS FOR TOPICAL USE
D05AX02 CALCIPOTRIOL
D05AX05
antipsoriatics for sYtemic use
RETINOIDS FOR TREATMENT OF PSORIASIS
D05BB02 ACITRETIN
|2019 |Capsule 10mg |35.00 |MG |6,686 |1,382,424 |
|2020 |Capsule 25mg |35.00 |MG |7,538 |2,994,400 |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
ANTIBIOTICS AND CHEMOTHER. FOR DERMATOLOGICAL USE
antiBiotics for topicaL use
OTHER ANTIBIOTICS FOR TOPICAL USE
D06AX POLYMIXIN B SULPHATE with NEOMYCIN with BACITRACIN
11330 Ointment 15g 1 – – 840 –
chemotherapeutics for topicaL use
SULFONAMIDES
D06BA51 SILVER SULPHADIAZINE with CHLORHEXIDINE GLUCONATE
D06BB01 IDOXURIDINE with LIGNOCAINE with BENZALKONIUM CHLORIDE
12214 Cream 5g 1 – – 135 –
D06BB10 IMIQUIMOD
D06BB04
OTHER CHEMOTHERAPEUTICS
D06BX01 METRONIDAZOLE
|4030 |Gel 7.5mg per g (0.75%) 50g |– |– |14,325 |407,711 |
|4340 |Cream 7.5mg per g (0.75%) 30g |– |– |22,419 |440,887 |
|17694 |Gel 0.75% 30g 1 |– |– |32,515 |– |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
corticosteroids, pLain
CORTICOSTEROIDS, WEAK (GROUP I)
D07AA02 HYDROCORTISONE
|1495 |Cream 10mg per g (1%) 50g |– |– |125,807 |925,591 |
|2881 |Cream 10mg per g (1%) 50g |– |– |225,669 |1,657,633 |
|2882 |Topical ointment 10mg per g (1%) 50g |– |– |54,619 |403,638 |
|2887 |Cream 10mg per g (1%) 30g |– |– |114,331 |783,492 |
|2888 |Topical ointment 10mg per g (1%) 30g |– |– |32,045 |219,768 |
|5111 |Cream 10 mg per g (1%), 30g |– |– |171 |1,167 |
|10719 |Cream 0.5% 30g 1 |– |– |2,491 |– |
|16165 |Cream 10mg per g (1%) 30g |– |– |115 |– |
|16625 |Cream 1%30g 1 |– |– |35,911 |– |
|16626 |Cream 0.5%30g 1 |– |– |557 |– |
|16627 |Cream 1%30g 1 |– |– |14,525 |– |
CORTICOSTEROIDS, MODERATELY POTENT (GROUP II)
D07AB09 TRIAMCINOLONE ACETONIDE
|2117 |Cream 200ug per g (0.02%) 100g |– |– |329,188 |4,456,267 |
|2118 |Ointment 200ug per g (0.02%) 100g |– |– |60,384 |819,286 |
CORTICOSTEROIDS, POTENT (GROUP III)
D07AC01 BETAMETHASONE
D07AC14
D07AC13
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
corticosteroids, comB With antiseptics
CORTICOSTEROIDS, WEAK, COMB WITH ANTISEPTICS
D07BA04 HYDROCORTISONE and CLIOQUINOL
|16100 |Cream 1%-1% 30gm |– |– |8,315 |– |
|17035 |Cream 1%-1% 60gm |– |– |4,385 |– |
corticosteroids, comB With antiBiotics
CORTICOSTEROIDS, WEAK, COMB WITH ANTIBIOTICS
D07CA01 HYDROCORTISONE and CLOTRIMAZOLE
13540 Cream 1%30g 1 – – 89,928 –
CORTICOSTEROIDS,MODERATELY POTENT,COMB. WITH ANTIBIOTICS
D07CB01 TRIAMCINOLONE ACETONIDE with NEOMYCIN with GRAMICIDIN with NYSTATIN
|4482 |Ointment 1 mg-2.5 mg (base)-250 ug- |– |– |60,439 |913,860 |
|11072 |Ointment 30g 1 |– |– |17,965 |– |
corticosteroids, other comBinations
CORTICOSTEROIDS, WEAK, OTHER COMBINATIONS
D07XA01 HYDROCORTISONE with CLOTRIMAZOLE
16834 Cream 1% 50g 1 – – 37,180 –
CORTICOSTEROIDS, POTENT, OTHER COMBINATIONS
D07XC01 BETAMETHOSONE/CALCIPOTRIOL
|18741 |Ointment 500ug per g 15g |– |– |6,990 |– |
|18742 |Ointment 500ug per g 30g |– |– |13,583 |– |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
ANTISEPTICS AND DISINFECTANTS
antiseptics and disinfectants
BIGUANIDES AND AMIDINES
D08AC52 CHLORHEXIDINE with CETRIMIDE
11861 liquid 250mL 1 – – 112 –
PHENOL AND DERIVATIVES
D08AE04 TRICLOSAN with ENTSUFON
11586 Lotion 200mL 1 – – 263 –
IODINE PRODUCTS
D08AG02 POVIDONE IODINE
|4411 |Solution 100mg per mL (10%) 100mL |– |– |5,631 |106,115 |
|10226 |Ointment 25g 1 |– |– |596 |– |
|10230 |Solution 15mL 1 |– |– |1,054 |– |
|16104 |Powder 20g 1 |– |– |263 |– |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
MEDICATED DRESSINGS
medicated dressings
OINTMENT DRESSINGS WITH ANTIINFECTIVES
D09AA CADEXOMER IODINE
4932 Tube 10g 4 – – 485 42,447
4933 Tube 20g 2 – – 209 19,092
D09AA09 POVIDONE-IODINE
4779 Sterile sachets 22.5cm x 7.5cm 12 – – 189 5,854
ZINC BANDAGES
D09AB01 BANDAGE ZINC PASTE
4750 Bandage 7.5cm x 6m – – 321 22,072
SOFT PARAFFIN DRESSINGS
D09AX SOFT PARAFFIN DRESSING
|4759 |Sterile sachets 10cm x 10cm 10 |– |– |2,513 |44,303 |
|4845 |Sterile sachets 10cm x 10cm 10 |– |– |1,657 |34,075 |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
ANTI-ACNE PREPARATIONS
anti-acne preparations for topicaL use
RETINOIDS FOR TOPICAL USE IN ACNE
D10AD03 ADAPALENE
D10AD04 ISOTRETINOIN
14786 Gel 0.05% 30g – – 8,824 –
D10AD01 TRETINOIN
D10AE51 CLINDAMYCIN with Benzpylperoxide
19649 Gel 1%-5% 25g 1 – – 14,568 –
ANTIINFECTIVES FOR TREATMENT OF ACNE
D10AF01 CLINDAMYCIN
D10AF02
OTHER ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10AX01 ALUMINIUM CHLORIDE
D10AX03
anti-acne preparations for sYstemic use
RETINOIDS FOR TREATMENT OF ACNE
D10BA01 ISOTRETINOIN
|2591 |Capsule 10mg |30.00 |MG |6,359 |612,279 |
|2592 |Capsule 20mg |30.00 |MG |126,792 |18,674,110 |
D
2006
atc code form and strength ddd units scripts cost($)
DERMATOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
other dermatoLogicaL preparations
ANTIHIDROTICS
D11AA DIPHEMANIL METHYLSULPHATE
4191 Dusting powder 20mg per g (2%) 50g – – 6,994 111,410
MEDICATED SHAMPOOS
D11AC30 OTHERS
4405 Scalp cleanser 3mg-3mg-1mg-3mg-10mg per mL – – 588 11,207
D11AC30 PINE TAR, CADE OIL, COAL TAR SOLUTION, ARACHIS OIL EXTRACT OF CRUDE COAL TAR OIL and OLEYL ALCOHOL
4409 Scalp cleanser 3mg-3mg-1mg-3mg-10mg per mL – – 183 3,536
D11AC30 SALICYLIC ACID BENZALKONIUM CHLORIDE ALCOHOL and POLYOXYETHYLENE ETHERS
| |4445 Scalp cleanser 20mg-2mg-130mg-216mg per mL – – 454 |7,541 |
|D11AC30 |SALICYLIC ACID, BENZALKONIUM CHLORIDE, ALCOHOL, COAL TAR and | |
| |POLYOXYETHYLENE ETHERS | |
| |4560 Scalp cleanser 20mg-2mg-130mg-50mg-216mg – – 4,030 |69,053 |
|D11AC30 |SALICYLIC ACID, COAL TAR SOLUTION, PINE TAR and UNDECYLENAMIDE | |
| |4447 Scalp cleanser 20mg-10mg-10mg-10mg per mL – – 1,857 |29,499 |
|D11AC03 |SELENIUM SULFIDE | |
| |4452 Shampoo 25mg per mL (2.5%) 125mL – – 1,041 |13,147 |
| |11876 Shampoo 2.5% 200m 1 – – 130 |– |
WART AND ANTI-CORN PREPARATIONS
D11AF PODOPHYLLUM RESIN with SALICYLIC ACID
11612 Ointment 10g 1 – – 2,873 –
OTHER DERMATOLOGICALS
D11AX ALLANTOIN, GLYCEROL and ICHTHAMMOL
|4280 |Ointment 5mg-10mg per g(0.5%-1%-1 %), 50g |– |– |376 |5,427 |
|4281 |Cream 5mg-10mg-10mg per g(0.5%-1%-1%),50g |– |– |848 |13,645 |
|D11AX |CATIONIC CONDITIONER with PANTHENOL | | | | |
| |4519 Solution 250mL |– |– |434 |5,155 |
|D11AX16 |EFLORNITHINE | | | | |
| |19662 Cream 11.5%,30 g, 1 |– |– |616 |– |
|D11AX |HYDROLYZED COLLAGEN PROTEINS | | | | |
| |4271 Hair conditioner 250mL |– |– |1,331 |15,354 |
|D11AX05 |MAGNESIUM SULFATE | | | | |
| |12530 Pst 100g 1 |– |– |319 |– |
|D11AX01 |MINOXIDIL | | | | |
| |17460 Solution 5% 60mL |– |– |722 |– |
|D11AX15 |PIMECROLIMUS | | | | |
| |8802 Cream 10mg per g (1%) 15g |– |– |21,813 |701,398 |
| |18308 Cream 1% 30g,1 |– |– |9,803 |– |
|D11AX |SKIN CLEANSER | | | | |
| |4549 Lotion 500mL |– |– |15,353 |285,002 |
|D11AX |ZINC OXIDE, STARCH and CHLORPHENESIN | | | | |
| |4497 Dusting powder 100g |– |– |1,097 |11,786 |
G
2006
atc code form and strength ddd units scripts cost($)
GENITO URINARY SYSTEM AND SEX HORMONES
GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
antiinfectiVes/antisept.,eXcL. comB. With corticosteroids
ANTIBIOTICS
G01AA10 CLINDAMYCIN
15081 Vaginal cream 2% 40gm 0.10 GM 13,109 –
G01AA01 NYSTATIN
4012 Cream pessaries 100,000 units, 15 100.00 TE 3,125 36,473
4013 Vaginal cream 100,000 units per dose, 15 doses, 100.00 TE 10,260 124,033
ORGANIC ACIDS
G01AD02 RICINOLEIC ACID, ACETIC ACID and HYDROXYQUINOLINE SULPHATE
4434 Vaginal jelly 7mg-9.4mg-250ug per g – – 741 19,796
IMIDAZOLE DERIVATIVES
G01AF02 CLOTRIMAZOLE
G01AF05
G01AF04
G
2006
atc code form and strength ddd units scripts cost($)
GENITO URINARY SYSTEM AND SEX HORMONES
OTHER GYNAECOLOGICALS
contraceptiVes for topicaL use
INTRAUTERINE CONTRACEPTIVES
G02BA03 PLASTIC IUD with PROGASTERONE
8633 Intrauterine drug 52mg releasing 20ug per 24 hours – – 46,147 9,995,209
G02BA02 POLYETHYLENE COPPER
13296 Intrauterine device 1 – – 934 –
other gYnaecoLogicaLs
PROLACTIN INHIBITORS
|G02CB01 |BROMOCRIPTINE MESYLATE | | | | |
| |1444 Tablet 2.5mg |5.00 |MG |3,778 |72,715 |
|G02CB03 |CABERGOLINE | | | | |
| |8114 Tablet 0.5mg |0.50 |MG |27,531 |2,531,835 |
| |8115 Tablet 0.5mg |0.50 |MG |1,635 |66,834 |
|G02CB04 |QUINAGOLIDE | | | | |
| |8822 Tablet 75ug (base) |75.00 |UG |415 |29,019 |
| G | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
hormonaL contraceptiVes for sYstemic use
PROGESTOGENS AND ESTROGENS, FIXED COMBINATIONS
G03AC08 ETONOGESTREL
8487 Subcutaneous implant 68mg 0.07 MG 59,298 12,893,231
G03AC03 LEVONORGESTREL
|2913 |Tablets 30ug 28 |0.03 |MG |115,118 |1,770,152 |
|17548 |Tablet 0.75mg 2 |– |– |50,228 |– |
|19155 |Tablet 0.75mg 2 |– |– |43,793 |– |
|19549 |Tablet 0.75mg 2 |– |– |38,915 |– |
|G03AC06 |MEDROXYPROGESTERONE | | | | |
| |3118 Injection 150mg in 1mL |1.67 |MG |236,203 |3,129,007 |
|G03AC01 |NORETHISTERONE | | | | |
| |1967 Tablets 350ug 28 |– |– |27,251 |421,965 |
G
2006
atc code form and strength ddd units scripts cost($)
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
androgens
3-OXOANDROSTEN (4) DERIVATIVES
G03BA03 TESTOSTERONE
|2101 |Injection 250mg |18.00 |MG |43,126 |1,358,913 |
|2114 |Injection 250mg in 1mL |18.00 |MG |10,403 |328,396 |
|2115 |Capsule 40mg |120.00 |MG |31,064 |1,557,525 |
|2670 |Injection 100mg |18.00 |MG |5,969 |113,757 |
|8098 |Subcutaneous implant 100mg |18.00 |MG |1,763 |279,327 |
|8099 |Subcutaneous implant 200mg |18.00 |MG |4,441 |1,125,332 |
|8460 |Transdermal patch 12.2mg (2.5mg per 24 hr) 60 |3.00 |MG |4,471 |457,791 |
|8619 |Transdermal patch 24.3mg (5mg per 24 hr) 30 |3.00 |MG |9,062 |923,592 |
|8830 |Transdermal gel 50mg in 5mg sachet 30 |50.00 |MG |35,984 |3,765,895 |
|9004 |Injection 1000 mg in 4mL |18.00 |MG |3,958 |581,723 |
|16153 |Cream 2%, 50g |– |– |938 |– |
|16326 |Cream 1%, 50g |– |– |1,742 |– |
|17178 |Cream 5%, 50g |– |– |1,713 |– |
estrogens
NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN
G03CA03 OESTRADIOL
|1742 |Vaginal tablets 25ug |0.03 |MG |401,891 |8,001,037 |
|1743 |Transdermal patches 2mg 8 |0.05 |MG |72,859 |1,187,371 |
|1744 |Transdermal patches 4mg 8 |0.05 |MG |87,190 |1,420,246 |
|1745 |Transdermal patches 8mg 8 |0.05 |MG |27,543 |513,610 |
|8012 |Transdermal patches 3.28mg |0.05 |MG |31,925 |519,557 |
|8013 |Transdermal patches 4.33mg(releasing 50ug/24hrs) |0.05 |MG |38,373 |623,327 |
|8014 |Transdermal patches 6.57mg(releasing 50ug/24hrs) |0.05 |MG |17,586 |325,807 |
|8041 |Transdermal patches 8.66mg(releasing 100ug/24hrs) |0.05 |MG |12,008 |228,426 |
|8082 |Transdermal patches 4mg(releasing 50ug/24hrs) |0.05 |MG |570 |9,300 |
|8125 |Transdermal patches 3.9mg(releasing 50ug/24hrs) |0.05 |MG |59,917 |973,759 |
|8126 |Transdermal patches 7.8mg(releasing 100ug/24hrs) |0.05 |MG |18,888 |359,088 |
|8140 |Transdermal patches 1.5mg(releasing 50ug/24hrs) |0.05 |MG |19,898 |324,275 |
|8194 |Transdermal patches 2mg(releasing approx. 25ug) |0.05 |MG |333 |5,380 |
|8195 |Transdermal patches 8mg(releasing approx. 100ug) |0.05 |MG |549 |10,190 |
|8286 |Transdermal gel 1mg in 1g sachet 28 |1.00 |MG |86,717 |1,495,452 |
|8311 |Transdermal pat 750ug (rel 25ug/24 hrs) |0.05 |MG |11,247 |182,897 |
|8312 |Transdermal patch 3mg (rel 100ug/24 hrs) |0.05 |MG |8,133 |152,658 |
|8485 |Transdermal patches 2mg(releasing 25ug/24hrs) |0.05 |MG |24,937 |406,338 |
|8486 |Transdermal patches 5.7mg(releasing 75ug/24hrs) |0.05 |MG |8,849 |165,094 |
|8645 |Nasal spray 150 ug per actuation, 60 actuat, 4.2mL |0.30 |MG |17,366 |374,060 |
|8761 |Transdermal patches 3.9mg(releasing 25ug/24hrs) |0.05 |MG |7,017 |114,103 |
|8762 |Transdermal patches 5.85mg(releasing 37.5ug/24hrs) |0.05 |MG |4,887 |79,312 |
|8763 |Transdermal patches 7.8mg(releasing 500ug/24hrs) |0.05 |MG |16,190 |262,569 |
|8764 |Transdermal patches 1.17mg(releasing 75ug/24hrs) |0.05 |MG |5,558 |103,350 |
|8765 |Transdermal patches 1.56mg(releasing 100ug/24hrs) |0.05 |MG |5,930 |110,391 |
|16209 |Tablet 1mg 28 |2.00 |MG |5,830 |– |
|16210 |Tablet 2mg 28 |2.00 |MG |10,750 |– |
|16211 |Tablet 4mg 28 |2.00 |MG |236 |– |
| G | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
estrogens
NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN
G03CA03 OESTRADIOL VALERATE
PREGNEN (4) DERIVATIVES
G03DA02 MEDROXYPROGESTERONE
G03DA04
PREGNADIEN DERIVATIVES
G03DB01 DYDROGESTERONE
1350 Tablet 10mg 10.00 MG 10,675 158,708
G
2006
atc code form and strength ddd units scripts cost($)
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
progestogens
ESTREN DERIVATIVES
|G03DC02 NORETHISTERONE |
|2993 |Tablet 5mg |5.00 |MG |152,962 |5,157,987 |
|G03DC05 TIBOLONE |
|16835 Tablet 2.5mg 28 2.50 MG 252,018 – |
| | | | | | |
progestogens and estrogens in comBination
PROGESTOGENS AND ESTROGENS,FIXED COMBINATIONS
G03FA12 MEDROXYPROGESTERONE AND ESTROGEN
G03FA01
PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS
|G03FB08 |DYDROGESTERONE AND ESTROGEN | | | |
| |8244 tabs estradiol 2mg+est/dydro 2mg/10mg,28mg(14/14) 2.00 |MG |6,074 |98,300 |
|G03FB06 |MEDROXYPROGESTERONE AND ESTROGEN | | | |
| |19194 Pack 14 tablets oestrogens 625ug 0.63 |MG |1,849 |– |
| |19195 Pack 14 tab oestrogens 625ug,14 tab medroxypr 0.63 |MG |719 |– |
|G03FB05 |OESTRADIOL with NORETHISTERONE ACETATE | | | |
|1764 |Tablets sequential pack 2mg-1mg |2.00 |MG |97,967 |1,588,898 |
|8029 |Pack containing 4 transdermal patches oestradiol |0.05 |MG |16,635 |308,032 |
|8425 |Transdermal patch 4 4.33mg, 4 620ug/2.7mg |0.05 |MG |12,916 |239,697 |
|8426 |Transdermal patch 4 4.33mg, 4 510ug/4.8mg |0.05 |MG |10,594 |195,100 |
|8427 |Transdermal patch 620ug/2.7mg, 8 |0.05 |MG |63,278 |1,168,801 |
|8428 |Transdermal patch 510ug/4.8mg, 8 |0.05 |MG |29,224 |538,993 |
|19192 |Tablets sequential pack 4mg-1mg |2.00 |MG |1,482 |– |
gonadotrophins and other oVuLation stimuLants
GONADOTROPHINS
G03GA05 FOLLITROPIN ALFA
|8713 |Injection 300i.u. in 0.5mL multi-dose cartridge |75.00 |IE |796 |468,230 |
|8714 |Injection 450i.u. in 0.75mL multi-dose cartridge|75.00 |IE |308 |214,066 |
|8715 |Injection 900i.u. in 1.5mL multi-dose cartridge |75.00 |IE |797 |914,553 |
|G03GA06 FOLLITROPIN BETA |
| |8565 |Soln for injection 300iu in 0.36mL mulit-dose |75.00 |IE |994 |540,517 |
| | |cart | | | | |
| |8566 |Soln for injection 600iu in 0.75mL mulit-dose |75.00 |IE |1,899 |1,399,733 |
| | |cart | | | | |
| |8871 |Soln for injection 900iu in 1.08mL mulit-dose |75.00 |IE |446 |510,290 |
| | |cart | | | | |
|G03GA01 |HUMAN |CHORIONIC GONADOTROPHIN | | | | |
| |1579 |Ampoules pdr for inj. 500units 1ml solvent 3/3 |250.00 |IE |196 |15,429 |
| |1581 |Ampoules pdr for inj. 1500units 1ml solvent 3/3 |250.00 |IE |5,535 |304,256 |
| |6181 |Ampoules pdr for inj. 5000units 1ml solvent 3/3 |250.00 |IE |733 |– |
| G | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
gonadotrophins and other oVuLation stimuLants
OVULATION STIMULANTS, SYNTHETIC
G03GB02 CLOMIPHENE CITRATE
1211 Tablet 50mg 9.00 MG 38,729 1,535,035
antiandrogens
ANTIANDROGENS, PLAIN PREPARATIONS
G03HA01 CYPROTERONE ACETATE
|1269 |Tablet 50mg |0.10 |GM |22,480 |1,850,111 |
|1270 |Tablet 50mg |0.10 |GM |12,443 |3,406,294 |
|8019 |Tablet 100mg |0.10 |GM |40,652 |12,271,174 |
|12897 |Tablet 10mg 15 |0.10 |GM |431 |– |
ANTIANDROGENS AND ESTROGENS
G03HB01 CYPROTERONE and OESTROGEN
|8062 |Tablet 2mg 11 / 2mg + 1mg 10 |– |– |4,940 |80,012 |
|14126 |Tablet 35ug/2mg 28 1 |– |– |25,198 |– |
|14127 |Tablet 35ug/2mg 28 3 |– |– |138,183 |– |
|15418 |Tablet 28 1 |– |– |16,523 |– |
|15419 |Tablet 28 3 |– |– |81,675 |– |
|17090 |Tablet 28 1 |– |– |14,432 |– |
|17091 |Tablet 28 3 |– |– |80,571 |– |
|18070 |Tablet 35ug/2mg 28 1 |– |– |18,917 |– |
|18071 |Tablet 35ug/2mg 28 3 |– |– |159,105 |– |
|19849 |Tablet 2mg 11 / 2mg + 1mg 1 |– |– |944 |– |
other seX horm. & moduLators of the genitaL sYstem
ANTIGONADOTROPINS AND SIMILAR AGENTS
G03XA01 DANAZOL
G03XA02
ANTIGONADOTROPINS AND SIMILAR AGENTS
G03XC01 RALOXIFENE
8363 Tablet 60mg 28 60.00 MG 339,802 19,838,425
G
2006
atc code form and strength ddd units scripts cost($)
GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
other uroLogicaLs, incL. antispasmodics
URINARY ANTISPASMODICS
G04BD04 OXYBUTYNIN
G04BD07
DRUGS USED IN ERECTILE DYSFUNCTION
G04BE01 ALPROSTADIL
G04BE03
G04BE08
G04BE09
OTHER UROLOGICALS
|G04BX |SODIUM |BICARBONATE | | | | |
| |4458 |Capsule 840 mg |– |– |16,960 |217,070 |
|G04BX |SODIUM |CITRO-TARTRATE | | | | |
| |4047 |Sachets cont. oral effervescent powder 4g 25 |– |– |244 |2,927 |
| |4048 |Sachets cont. oral effervescent powder 4g 28 |– |– |638 |7,621 |
| |4049 |Sachets cont. oral effervescent powder 4g 28 |– |– |37,103 |446,148 |
| |19768 |Sachets cont. oral effervescent powder 4g 28 |– |– |428 |– |
drugs used in Benign prostatic hYpertrophY
ALPHA-ADRENORECEPTOR ANTAGONISTS
G04CA02 TAMSULOSIN
G04CA03
G
2006
atc code form and strength ddd units scripts cost($)
GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
drugs used in Benign prostatic hYpertrophY
TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS
G04CB01 FINASTERIDE
|4233 |Tablet 5mg |5.00 |MG |36,427 |3,572,425 |
|16113 |Tablet 1mg 28 |– |– |61,743 |– |
H
2006
atc code form and strength ddd units scripts cost($)
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES
PITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUES
anterior pituitarY LoBe hormones and anaLogues
ACTH
H01AA02 TETRACOSACTRIN
2832 Injection 1mg in 1mL 0.25 MG 407 23,960
SOMATROPIN AND ANALOGUES
H01AC01 SOMATROPIN
|6266 |Injection 4mg vial with 3.5mL diluent |2.00 |IE |141 |– |
|6330 |Injection 5mg (15iu) in 1mL cartridge |2.00 |IE |135 |– |
posterior pituitarY LoBe hormones
VASOPRESSIN AND ANALOGUES
H01BA02 DESMOPRESSIN
|2129 |Intranasal solution 100ug per mL 2.5mL |25.00 |UG |3,537 |608,892 |
|8662 |Tablet 200mg 90 |400.00 |UG |3,347 |535,750 |
|8663 |Tablet 200mg 30 |400.00 |UG |12,187 |912,828 |
|8711 |Nasal spray (pump pack) 10ug per mL 5, 60 act |6mL 25.00 |UG |11,833 |2,030,852 |
|8712 |Nasal spray (pump pack) 10ug per mL 5, 60 act |6mL 25.00 |UG |38,062 |3,573,416 |
|13826 |Injection 1mL 4ug/mL 10 |4.00 |UG |143 |– |
hYpothaLamic hormones
GONADOTROPHIN-RELEASING HORMONES
H01CA02 NAFARELIN
2962 Nasal spray (pump pack) 200 ug base per dose 60 0.40 MG 2,528 242,737
ANTIGROWTH HORMONE
H01CB03 LANREOTIDE
H01CB02
| H | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES
CORTICOSTEROIDS FOR SYSTEMIC USE
corticosteroids for sYstemic use, pLain
MINERALOCORTICOIDS
H02AA02 FLUDROCORTISONE ACETATE
1433 Tablet 100ug 0.10 MG 23,274 378,649
GLUCOCORTICOIDS
|H02AB01 |BETAMETHASONE | | | | |
| |2694 Injection 3mg-3.9mg (equiv.to 5.7 mg) in 1ml |1.50 |MG |63,078 |1,547,510 |
|H02AB16 |BUDESONIDE | | | | |
| |16038 Capsule 3mg 90 |9.00 |MG |2,221 |– |
|H02AB10 |CORTISONE | | | | |
| |1246 Tablet 5mg |37.50 |MG |9,353 |177,581 |
| |1247 Tablet 25mg |37.50 |MG |31,302 |463,682 |
|H02AB02 |DEXAMETHASONE | | | | |
| |1291 Injection 8mg in 2mL |1.50 |MG |9,874 |224,066 |
| |1292 Tablet 500ug |1.50 |MG |24,331 |178,195 |
| |2507 Tablet 4mg |1.50 |MG |85,535 |869,227 |
| |2509 Injection 4mg in 1mL |1.50 |MG |8,502 |133,809 |
| |3472 Injection 4mg in 1mL |1.50 |MG |8,312 |116,272 |
|H02AB09 |HYDROCORTISONE | | | | |
| |1499 Tablet 4mg |30.00 |MG |18,857 |238,202 |
| |1500 Tablet 20mg |30.00 |MG |16,495 |222,265 |
| |1501 Injection equivalent to 100mg with 2ml solvent |30.00 |MG |2,126 |35,370 |
| |1510 Injection equivalent to 100mg with 2ml solvent |30.00 |MG |11,352 |413,390 |
| |1511 Injection equivalent to 250mg with 2ml solvent |30.00 |MG |491 |28,154 |
| |3096 Injection equivalent to 250mg with 2ml solvent |30.00 |MG |603 |8,940 |
| |3470 Injection equivalent to 100mg with 2ml solvent |30.00 |MG |10,858 |164,035 |
| |3471 Injection equivalent to 250mg with 2ml solvent |30.00 |MG |9,827 |138,509 |
|H02AB04 |METHYLPREDNISOLONE | | | | |
| |1928 Injection 40mg in 1mL |20.00 |MG |49,226 |1,142,462 |
| |2981 Injection equiv to 40mg methylprednisolone |20.00 |MG |4,893 |309,372 |
| |8834 Injection equiv to 1g methylprednisolone = diluent |20.00 |MG |1,354 |269,868 |
|H02AB06 |PREDNISOLONE | | | | |
| |1916 Tablet 25mg |10.00 |MG |429,077 |4,268,755 |
| |1917 Tablet 5mg |10.00 |MG |627,408 |4,904,278 |
| |3152 Tablet 1mg |10.00 |MG |201,313 |1,484,150 |
| |8285 Oral solution equiv to 5mg prednisolone per mL |10.00 |MG |287,577 |3,756,452 |
|H02AB07 |PREDNISONE | | | | |
| |1934 Tablet 1mg |10.00 |MG |104,667 |772,839 |
| |1935 Tablet 5mg |10.00 |MG |324,668 |2,545,755 |
| |1936 Tablet 25mg |10.00 |MG |204,425 |2,046,711 |
|H02AB08 |TRIAMCINOLONE ACETONIDE | | | | |
| |2990 Injection 10mg in 1mL |7.50 |MG |27,042 |664,774 |
| |11073 Ampoule 40mg per ml 5 |7.50 |MG |681 |– |
H
2006
atc code form and strength ddd units scripts cost($)
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES
THYROID THERAPY
thYroid preparations
THYROID HORMONES
H03AA02
H03AA01
antithYroid preparations
THIOURACILS
H03BA02 PROPYLTHIOURACIL
1955 Tablet 50mg 0.10 GM 15,413 504,947
SULPHUR-CONTAINING IMIDAZOLE DERIVATIVES
H03BB01 CARBIMAZOLE
1153 Tablet 5mg 15.00 MG 65,370 1,833,426
H
2006
atc code form and strength ddd units scripts cost($)
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES
PANCREATIC HORMONES
gLYcogenoLYtic hormones
GLYCOGENOLYTIC HORMONES
H04AA01 GLUCAGON HYDROCHLORIDE
|1449 |Injection set containing 1mg (1 i.u.) |1.00 |MG |26,131 |1,052,579 |
|3467 |Injection set containing 1mg (1 i.u.) |1.00 |MG |17,065 |680,665 |
H
2006
atc code form and strength ddd units scripts cost($)
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES
CALCIUM HOMEOSTASIS
anti-parathYroid agents
CALCITONIN PREPARATIONS
H05BA01 CALCITONIN (SALMON SYNTHETIC)
|2995 |Injection (salmon) 50iu in 1mL ampoule |100.00 |IE |119 |24,787 |
|2997 |Injection (salmon) 100iu in 1mL ampoule |100.00 |IE |303 |66,282 |
| J | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
tetracYcLines
TETRACYCLINES
J01AA02 DOXYCYCLINE
J01AA08
J01AA07
Beta-Lactam antiBacteriaLs,peniciLLins
PENICILLINS WITH EXTENDED SPECTRUM
J01CA04 AMOXYCILLIN
J01CA01
J01CA04
J
2006
atc code form and strength ddd units scripts cost($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
Beta-Lactam antiBacteriaLs,peniciLLins
BETA-LACTAMASE SENSITIVE PENICILLINS
J01CE08 BENZATHINE PENICILLIN
J01CE10
J01CE01
J01CE02 PHENOXYMETHYLPENICILLIN
J01CE09
BETA-LACTAMASE RESISTANT PENICILLINS
J01CF01 DICLOXACILLIN
J01CF05
J
2006
atc code form and strength ddd units scripts cost($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
Beta-Lactam antiBacteriaLs,peniciLLins
COMBINATIONS OF PENICILLINS, INCL.BETA-LACTAMASE INHIBITORS
J01CR02 AMOXYCILLIN with CLAVULANIC ACID
J01CR03 TICARCILLIN with CLAVULANIC ACID
2179 Injection 3g-100mg (solvent required) 15.00 GM 23,984 3,946,938
other Beta-Lactam antiBacteriaLs
FIRST-GENERATION CEPHALOSPORINS
J01DB01 CEFALEXIN
|3058 |Capsule 250mg |2.00 |GM |343,264 |2,970,667 |
|3094 |Granules for syrup 125mg per 5mL 100mL |2.00 |GM |128,202 |1,481,162 |
|3095 |Granules for syrup 250mg per 5mL 100mL |2.00 |GM |326,503 |4,499,557 |
|3119 |Capsule 500mg |2.00 |GM |3,064,075 |34,884,443 |
|3317 |Capsule 250mg |2.00 |GM |4,720 |39,730 |
|3318 |Capsule 500mg |2.00 |GM |18,204 |201,809 |
|3319 |Granules for syrup 125mg per 5mL 100mL |2.00 |GM |161 |1,831 |
|3320 |Granules for syrup 250mg per 5mL 100mL |2.00 |GM |214 |2,853 |
|J01DB03 |CEPHALOTHIN | | | | |
| |2964 Injection 1g (solvent required) |4.00 |GM |58,445 |2,397,654 |
|J01DB04 |CEPHAZOLIN | | | | |
| |1257 Injection 1g (solvent required) |3.00 |GM |16,747 |1,040,393 |
SECOND-GENERATION CEPHALOSPORINS
J01DC04 CEFACLOR
J01DC02
THIRD-GENERATION CEPHALOSPORINS
J01DD01 CEFOTAXIME
J01DD04
J
2006
atc code form and strength ddd units scripts cost($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
other Beta-Lactam antiBacteriaLs
FOUTH-GENERATION CEPHALOSPORINS
J01DE01 CEFEPIME
|8315 |Injection 1g (solvent required) |2.00 |GM |572 |145,145 |
|8316 |Injection 2g (solvent required) |2.00 |GM |731 |343,870 |
suLfonamides and trimethoprim
TRIMETHOPRIM AND DERIVATIVES
J01EA01 TRIMETHOPRIM
2922 Tablet 300mg 0.40 GM 719,107 5,725,696
COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVES
J01EE01 TRIMETHOPRIM with SULPHAMETHOXAZOLE
|2949 |Tablet 80mg-400mg |320.00 |MG |7,811 |79,495 |
|2951 |Tablet 160mg-800mg |320.00 |MG |310,543 |3,187,393 |
|3103 |Oral suspension 40mg-200mg per 5mL 100mL |320.00 |MG |113,151 |983,185 |
|3390 |Tablet 160mg-800mg |320.00 |MG |1,351 |11,986 |
macroLides, Lincosamides and streptogramins
MACROLIDES
J01FA10 AZITHROMYCIN
J01FA09
J01FA01
J01FA06
| J | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
macroLides, Lincosamides and streptogramins
LINCOSAMIDES
J01FF01 CLINDAMYCIN
J01FF02
aminogLYcoside antiBacteriaLs
OTHER AMINOGLYCOSIDES
J01GB03 GENTAMICIN SULPHATE
J01GB01
QuinoLone antiBacteriaLs
FLUOROQUINOLONES
J01MA02 CIPROFLOXACIN
J01MA14
J01MA06
other antiBacteriaLs
GLYCOPEPTIDE ANTIBACTERIALS
J01XA01 VANCOMYCIN
|3130 |Injection 500mg(500,000iu) (solvent required) |2.00 |GM |824 |86,103 |
|3131 |Injection 500mg(500,000iu) (solvent required) |2.00 |GM |28,269 |5,227,473 |
STEROID ANTIBACTERIALS
J01XC01 FUSIDIC ACID
2312 Tablet (sodium salt) 250mg (enteric coated) 1.50 GM 21,115 3,152,015
IMIDAZOLE DERIVATIVES
J01XD01 METRONIDAZOLE
1638 I.V. infusion 500mg in 100mL 1.50 GM 35,725 1,529,649
NITROFURAN DERIVATIVES
J01XE01 NITROFURANTOIN
|1692 |Capsule 50mg |0.20 |GM |68,847 |1,021,571 |
|1693 |Capsule 100mg |0.20 |GM |80,828 |1,820,975 |
OTHER ANTIBACTERIALS
J01XX05 METHENAMINE
3124 Tablet 1g 2.00 GM 69,690 2,250,307
J
2006
atc code form and strength ddd units scripts cost($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIMYCOTICS FOR SYSTEMIC USE
antimYcotics for sYstemic use
ANTIBIOTICS
J02AA01 AMPHOTERICIN
1047 Injection 50mg (solvent required) 35.00 MG 333 27,098
IMIDAZOLE DERIVATIVES
J02AB02 KETOCONAZOLE
|1572 |Tablet 200mg |0.20 |GM |22,580 |884,301 |
|1573 |Tablet 200mg |0.20 |GM |30,565 |578,085 |
TRIAZOLE DERIVATIVES
J02AC01 FLUCONAZOLE
J02AC02
| J | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIMYCOBACTERIALS
drugs for treatment of tuBercuLosis
ANTIBIOTICS
J04AB02 RIFAMPICIN
|1981 |Capsule 150mg |0.60 |GM |1,486 |15,025 |
|1982 |Capsule 150mg |0.60 |GM |1,293 |43,060 |
|1983 |Capsule 300mg |0.60 |GM |2,664 |163,050 |
|1984 |Capsule 300mg |0.60 |GM |6,406 |92,884 |
|8025 |Syrup 100mg per 5mL 60mL |0.60 |GM |556 |19,653 |
|11783 |Capsule 300mg 100 |0.60 |GM |192 |– |
HYDRAZIDES
J04AC01 ISONIAZID
1554 Tablet 100mg 0.30 GM 1,087 10,248
OTHER DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AK02 ETHAMBUTOL HYDROCHLORIDE
16028 Tablet 400mg 100 1.20 GM 592 –
drugs for treatment of Lepra
DRUGS FOR TREATMENT OF LEPRA
J04BA02 DAPSONE
|1272 |Tablet 100mg |50.00 |MG |2,532 |273,825 |
|8801 |Tablet 25mg |50.00 |MG |896 |90,036 |
J
2006
atc code form and strength ddd units scripts cost($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIVIRALS FOR SYSTEMIC USE
direct acting antiViraLs
NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS
J05AB01 ACICLOVIR
J05AB12 CIDOFOVIR
6247 Solution for I.V. infusion 375mg in 5 mL vial 25.00 MG 118 –
J05AB09 FAMCICLOVIR
J05AB11
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AF08 ADEFOVIR DIPIVOXIL
J05AF05
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AG03 EFAVIRENZ
J05AG01
NEURAMINIDASE INHIBITORS
J05AH02 OSELTAMIVIR
J05AH01
ANTIVIRALS FOR TREATMENT OF HIV INFECTION
J05AR01 ZIDOVUDINE and LAMIVUDINE
6234 Tablet 150mg - 300mg – – 209 128,522
| J | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
VACCINES
BacteriaL Vaccines
CHOLERA VACCINES
J07AE02 CHOLERA, LIVE ATTENUATED
18382 Oral granules Cholera, inactivated 14 – – 20,048 –
HEMOPHILUS INFLUENZA B VACCINES
J07AG01 HAEMOPHILUS INFLUENZA B CONJUGATE VACCINE
16731 Injection 0.5mL 1 – – 151 –
J07AG01 HAEMOPHILUS INFLUENZA B CONJUGATE and HEPATITIS B VACCINES
19684 Injection 0.5mL, 1 – – 215 –
J07AG01 HAEMOPHILUS INFLUENZA B VACCINE
14180 Injection 0.5mL 1 – – 252 –
MENINGOCOCCAL VACCINES
J07AH04 MENINGOCOCCAL
J07AH07
PERTUSSIS VACCINES
J07AJ52 DIPHTERIA WITH TETANUS WITH PERTUSSIS PURIFIED ANTIGEN
17092 Injection 0.5mL 1 – – 19,953 –
PNEUMOCOCCAL VACCINES
J07AL01 PNEUMOCOCCAL
|1903 |Injection 0.5mL (23 valent) |– |– |52,389 |2,124,006 |
|17156 |Injection 0.5mL (7 valent) |– |– |697 |– |
|19154 |Vaccine conjugate 7 valent 1 |– |– |208 |– |
TETANUS VACCINES
J07AM51 DIPHTHERIA and TETANUS VACCINE, ADSORBED, DILUTED FOR ADULT USE
18902 Injection 0.5mL – – 1,241 –
J07AM01 TETANUS
3492 Injection 0.5mL in pre-filled syringe 5 – – 2,959 74,417
8813 Injection 0.5mL in pre-filled syringe 3 – – 748 9,086 19597 Injection 0.5mL in pre-filled syringe 3 – – 564 –
J07AM51 TETANUS TOXOID, COMBINATIONS with DIPTHERIA
3463 Injection 0.5mL in pre-filled syringe – – 31,896 3,243,539
8783 Injection 0.5mL in pre-filled syringe – – 8,294 160,083
TYPHOID,VACCINES
J07AP01 SALMONELLA-TYPHI
J07AP03
OTHER BACTERIAL VACCINES
J07AX Q FEVER
15417 Vaccine 0.5mL – – 349 –
J
2006
atc code form and strength ddd units scripts cost($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
VACCINES
ViraL Vaccines
ENCEPHALITIS VACCINES
J07BA02 JAPANESE ENCEPHALITIS VACCINE
16423 Vaccine 1mL vial 3 – – 1,376 –
INFLUENZA VACCINES
J07BB02 INFLUENZA VACCINE
2852 Injection (trivalent) 0.5mL – – 815,913 14,681,392
HEPATITIS VACCINES
J07BC02 HEPATITIS A
J07BC20
J07BC01
J07BC20 SALMONELLA and HEPATITIS A
17818 Prefilled syringe 25ug and 160 Elisa units – – 41,052 –
MEASLES VACCINES
J07BD52 MEASLES with MUMPS with RUBELLA UBELLA)
|13288 |Injection 0.5mL 1 |– |– |188 |– |
|18509 |Injection 0.5mL 1 |– |– |1,948 |– |
POLIOMYELITIS VACCINES
J07BF03 POLIOMYELITIS
16235 Injection 0.5mL – – 13,043 –
RABIES VACCINES
J07BG01 RABIES INACTIVATED
14107 Injection 1mL 1 – – 3,899 –
19166 Injection 2.5ug 1 – – 618 –
ROTA VIRUS DIARRHEA VACCINES
J07BH01 ROTAVIRUS VACCINE,LIVE
|19674 |Oral liquid 2mL 1 |– |– |668 |– |
|19688 |Oral liquid 2mL 1 |– |– |3,392 |– |
RUBELLA VACCINES
J07BJ01 RUBELLA
11227 Injection 0.5mL – – 1,062 –
VARICELLA VACCINES
J07BK01 VARICELLA LIVE ATTENUATED
|16723 |Vaccine 0.5mL |– |– |33,196 |– |
|17821 |Vaccine 0.5mL |– |– |2,718 |– |
J
2006
atc code form and strength ddd units scripts cost($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
VACCINES
BacteriaL and ViraL Vaccines, comBined
BACTERIAL AND VIRAL VACCINES, COMBINED
J07CA02 DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS
19175 Injection 0.5mL, 1 – – 8,122 –
L
2006
atc code form and strength ddd units scripts cost($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
aLKYLating agents
NITROGEN MUSTARD ANALOGUES
L01AA02 CHLORAMBUCIL
1163 Tablet 2mg – – 5,017 372,896
L01AA01 CYCLOPHOSPHAMIDE
L01AA06
L01AA03 MELPHALAN
2547 Tablet 2mg – – 3,078 83,511
ALKYL SULPHONATES
L01AB01 BUSULPHAN
1128 Tablet 2mg – – 437 19,562
NITROSOUREAS
L01AD05 FOTEMUSTINE
5900 Powder for injection 208mg with solvent – – 250 222,750 8786 Powder for injection 208mg with solvent – – 584 836,196
OTHER ALKYLATING AGENTS
L01AX03 TEMOZOLOMIDE
|5982 |Capsule 100mg 5 |– |– |212 |412,563 |
|5983 |Capsule 250mg 5 |– |– |121 |218,686 |
|8378 |Capsule 5mg |– |– |186 |45,035 |
|8379 |Capsule 20mg 5 |– |– |944 |653,865 |
|8380 |Capsule 100mg 5 |– |– |3,167 |7,373,406 |
|8381 |Capsule 250mg 5 |– |– |1,526 |3,101,654 |
|8819 |Capsule 5mg 15 |– |– |169 |61,449 |
|8820 |Capsule 20mg 15 |– |– |651 |617,082 |
|8821 |Capsule 100mg 15 |– |– |907 |2,477,062 |
antimetaBoLites
FOLIC ACID ANALOGUES
L01BA01 METHOTREXATE
|1622 |Tablet 2.5mg |– |– |91,220 |1,100,512 |
|1623 |Tablet 10mg |– |– |79,063 |3,668,560 |
|2395 |Injection 50mg in 2mL |– |– |16,382 |609,724 |
|2396 |Injection 5mg in 2mL |– |– |1,208 |72,404 |
|5962 |Injection 5mg in 2mL |– |– |242 |3,860 |
|5963 |Injection 50mg in 2mL |– |– |475 |4,668 |
|8851 |Solution concentrate I.V. infusion 1000mg in 10mL |– |– |287 |120,707 |
|19606 |Tablet 2.5mg |– |– |744 |– |
| L | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
antimetaBoLites
FOLIC ACID ANALOGUES
L01BA04 PEMETREXED
L01BA03
PURINE ANALOGUES
L01BB02 MERCAPTOPURINE
L01BB03
PYRIMIDINE ANALOGUES
L01BC06 CAPECITABINE
L01BC01
L01BC02
L01BC05
pLant aLKaLoids and other naturaL products
VINCA ALKALOIDS AND ANALOGUES
L01CA01 VINBLASTINE SULPHATE
L01CA02
L01CA04
L
2006
atc code form and strength ddd units scripts cost($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
pLant aLKaLoids and other naturaL products
PODOPHYLLOTOXIN DERIVATIVES
|L01CB01 ETOPOSIDE |
| |1389 |Capsule 100 mg |– |– |447 |193,715 |
| |1390 |Solution for I.V. infusion 100mg in 5mL |– |– |2,673 |493,269 |
| |1396 |Capsule 50mg |– |– |627 |300,229 |
| |5931 |Solution for I.V. infusion 100mg in 5mL |– |– |1,159 |111,331 |
| |5932 |Powder for I.V. infusion 113.6mg |– |– |1,569 |147,491 |
| |8120 |Powder for I.V. infusion 113.6mg |– |– |3,172 |586,477 |
| |8515 |Powder for I.V. infusion 1136mg |– |– |422 |148,643 |
|TAXANES | | | | | | |
|L01CD02 DOCETAXEL |
|5921 |Injection set containing I.V. infusion 20mg |– |– |1,457 |954,885 |
|5922 |Injection set containing I.V. infusion 80mg |– |– |1,407 |2,169,940 |
|8071 |Injection set containing I.V. infusion 20mg |– |– |4,968 |6,714,098 |
|8074 |Injection set containing I.V. infusion 80mg |– |– |5,006 |11,097,640 |
|L01CD01 PACLITAXEL |
|3017 |Solution for I.V. infusion 150mg in 25mL |– |– |2,216 |4,866,040 |
|3026 |Solution for I.V. infusion 30mg in 5mL |– |– |2,888 |2,929,920 |
|5973 |Solution for I.V. infusion 30mg in 5mL |– |– |1,345 |541,855 |
|5974 |Solution for I.V. infusion 100mg in 16.7mL |– |– |1,216 |1,089,777 |
|5975 |Solution for I.V. infusion 150mg in 25mL |– |– |795 |874,933 |
|5976 |Solution for I.V. infusion 300mg in 50mL |– |– |1,316 |2,359,072 |
|8018 |Solution for I.V. infusion 100mg in 16.7mL |– |– |3,675 |6,664,611 |
|8360 |Solution for I.V. infusion 300mg in 50mL |– |– |7,071 |15,257,428 |
cYtotoXic antiBiotics and reLated suBstances
ANTHRACYCLINES AND RELATED SUBSTANCES
L01DB01 DOXORUBICIN HYDROCHLORIDE
|1336 |Solution for I.V. or intravesical 10mg |– |– |816 |79,319 |
|1340 |Solution for I.V. or intravesical 20mg |– |– |1,302 |251,388 |
|1342 |Solution for I.V. or intravesical 50mg |– |– |14,107 |5,571,159 |
|5879 |Solution for I.V. or intravesical 100mg in 50mL |– |– |449 |111,734 |
|5891 |Solution for I.V. infusion 20mg in 10mL |– |– |311 |347,429 |
|5892 |Suspn for IV infusion 50mg in 25mL |– |– |237 |377,127 |
|5925 |Solution for I.V. or intravesical 10mg |– |– |805 |61,921 |
|5926 |Solution for I.V. or intravesical 20mg |– |– |1,054 |117,365 |
|5927 |Solution for I.V. or intravesical 50mg |– |– |5,321 |1,144,756 |
|8569 |Suspn for IV infusion 20mg in 10mL |– |– |1,260 |2,236,506 |
|8570 |Suspn for IV infusion 50mg in 25mL |– |– |1,398 |3,336,443 |
|8827 |Solution for I.V. or intravesical 100mg in 50mL |– |– |1,132 |354,394 |
|8828 |Solution for I.V. or intravesical 200mg in 100mL |– |– |181 |117,391 |
| L | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
cYtotoXic antiBiotics and reLated suBstances
ANTHRACYCLINES AND RELATED SUBSTANCES
L01DB03 EPIRUBICIN HYDROCHLORIDE
L01DB07
OTHER CYTOTOXIC ANTIBIOTICS
L01DC01 BLEOMYCIN
L01DC03
other antineopLastic agents
PLATINUM COMPOUNDS
L01XA02 CARBOPLATIN
L01XA01
L01XA03
L
2006
atc code form and strength ddd units scripts cost($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
other antineopLastic agents
MONOCLONAL ANTIBODIES
L01XC07 BEVACIZUMAB
L01XC02
L01XC03 TRASTUZUMAB
6497 Powder for IV infusion 150mg – – 3,055 10,865,130
PROTEIN KINASE INHIBITORS
L01XE02 GEFITINIB
L01XE01
OTHER ANTINEOPLASTIC AGENTS
L01XX05 HYDROXYUREA
3093 Capsule 500mg – – 30,656 2,350,498
L01XX19 IRINOTECAN
L01XX17 TOPOTECAN
8199 Powder for I.V. infusion 4mg (base) – – 204 451,751
| L | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
hormones and reLated agents
PROGESTOGENS
L02AB02 MEDROXYPROGESTERONE
L02AB01
GONADOTROPHIN RELEASING HORMONE ANALOGUES
L02AE03 GOSERELIN
L02AE02
hormone antagonists and reLated agents
ANTI-ESTROGENS
L02BA01 TAMOXIFEN
L02BA02
ANTI-ANDROGENS
|L02BB03 |BICALUTAMIDE | | | | |
| |8094 Tablet 50mg |50.00 |MG |33,374 |7,535,079 |
|L02BB01 |FLUTAMIDE | | | | |
| |1417 Tablet 250mg |750.00 |MG |3,857 |843,160 |
|L02BB02 |NILUTAMIDE | | | | |
| |8131 Tablet 150mg |30.00 |MG |4,075 |947,344 |
ENZYME INHIBITORS
|L02BG01 |AMINOGLUTETHIMIDE | | | | |
| |1036 Tablet 250mg |1000.00 |MG |518 |82,214 |
|L02BG03 |ANASTROZOLE | | | | |
| |8179 Tablet 1mg |1.00 |MG |125,989 |24,681,374 |
|L02BG06 |EXEMESTANE | | | | |
| |8506 Tablet 25mg 30 |25.00 |MG |10,524 |2,298,735 |
|L02BG04 |LETROZOLE | | | | |
| |8245 Tablet 2.5mg |2.50 |MG |47,149 |9,969,067 |
L
2006
atc code form and strength ddd units scripts cost($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSTIMULANTS
cYtoKines and immunomoduLators
COLONY STIMULATING FACTORS
L03AA02
L03AA13
INTERFERONS
L03AB07 INTERFERON BETA-1a
|8289 |Inj. set 1 vial powder dose 30ug(6000000 i.u.) |4.30 |UG |8,371 |8,996,173 |
|8403 |Inj. 44ug (12000000iu)in 0.5 mL single syringe |4.30 |UG |16,929 |18,152,966 |
|8805 |Inj. 30ug (6000000iu) in 0.5mL single syringe |4.30 |UG |8,953 |9,566,372 |
|L03AB08 |INTERFERON BETA-1b | | | | |
| |8101 Injection set 1 vial powder dose 8000000iu |4.00 |ME |34,086 |40,086,298 |
|L03AB04 |INTERFERON-ALFA-2a | | | | |
| |8180 Solution for injection 3000000iu in 0.5mL |2.00 |ME |1,768 |958,604 |
| |8181 Solution for injection 3000000iu in 0.5mL |2.00 |ME |176 |102,527 |
| |8551 Injection 45000000iu in 0.5mL syringe |2.00 |ME |142 |92,040 |
|L03AB05 |INTERFERON-ALFA-2b | | | | |
| |6246 Solution for injection 10,000,000iu in 1 mL single |2.00 | |146 |345,910 |
| |6255 Solution for injection 60000000iu in 1.2mL mult |2.00 |ME |131 |295,603 |
| |8348 Soln for inj.18000000iu in 1.2mL multi-dose pen |2.00 |ME |561 |343,488 |
|L03AB60 |PEGINTERFERON ALFA-2b COMBINATIONS | | | | |
| |6394 112 ribavirin tabs 200mg +4 syrngs PEG-IFN alfa-2b |– |– |532 |937,063 |
| |6395 140 ribavirin tabs 200mg +4 syrngs PEG-IFN alfa-2b |– |– |630 |1,179,101 |
| |6396 168 ribavirin tabs 200mg +4 syrngs PEG-IFN alfa-2b |– |– |742 |1,450,883 |
| |6405 112 ribavirin 200mg/4 single use injection pens |– |– |339 |599,774 |
| |6407 140 ribavirin 200mg/4 single use injection pens |– |– |318 |632,363 |
| |6410 168 ribavirin 200mg/4 single use injection pens |– |– |247 |572,495 |
OTHER CYTOKINES AND IMMUNOMODULATORS
L03AX03 BCG VACCINE
L03AX13
| L | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSIVE AGENTS
immunosuppressiVe agents
SELECTIVE IMMUNOSUPPRESSIVE AGENTS
L04AA17 ADALIMUMAB
L04AA14
L04AA01
L04AA21
L04AA11
L04AA12
L04AA13
L04AA06
L
2006
atc code form and strength ddd units scripts cost($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSIVE AGENTS
immunosuppressiVe agents
SELECTIVE IMMUNOSUPPRESSIVE AGENTS
L04AA10
L04AA05
OTHER IMMUNOSUPPRESSIVE AGENTS
L04AX01 AZATHIOPRINE
L04AX02
M
2006
atc code form and strength ddd units scripts cost($)
MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
antiinfLammatorY/antirheumatic prodducts,non-steroids
ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES M01AB05 DICLOFENAC
M
2006
atc code form and strength ddd units scripts cost($)
MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
antiinfLammatorY/antirheumatic prodducts,non-steroids
PROPIONIC ACID DERIVATIVES
M01AE01 IBUPROFEN
M01AE51
M01AE03
M01AE02
M01AE11 TIAPROFENIC ACID
2103 Tablet 300mg 600.00 MG 18,097 287,448
M
2006
atc code form and strength ddd units scripts cost($)
MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
antiinfLammatorY/antirheumatic prodducts,non-steroids
FENAMATES
|M01AG01 MEFENAMIC ACID |
| |1824 |Capsule 250mg |1.00 |GM |39,772 |651,221 |
| |11611 |Capsule 250mg 20 |1.00 |GM |822 |– |
|COXIBS | | | | | | |
|M01AH01 CELECOXIB |
|8439 |Capsule 100mg 60 |0.20 |GM |224,840 |6,776,187 |
|8440 |Capsule 200mg 60 |0.20 |GM |1,535,353 |47,545,211 |
|17093 |Capsule 200mg 10 |0.20 |GM |2,432 |– |
|M01AH06 LUMIRACOXIB |
|9032 |Tablet 200mg,30 |– |– |163,014 |4,872,538 |
|18735 |Tablet 200mg 30 |– |– |296 |– |
|18736 |Tablet 400mg 5 |– |– |11,559 |– |
OTHER ANTIINFL./ANTIRHEUMATIC AGENTS, NON-STEROIDS
M01AX12 PENTOSAN-POLY SULFATE SODIUM
14955 Capsule 100mg 100 – – 728 –
specific antirheumatic agents
GOLD PREPARATIONS
M01CB03 AURANOFIN
M01CB01
PENICILLAMINE
M01CC01 PENICILLAMINE
|2721 |Tablet 125mg |0.50 |GM |609 |22,498 |
|2838 |Tablet 250mg |0.50 |GM |4,816 |222,634 |
| | | M |
| |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
MUSCULO-SKELETAL SYSTEM
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
topicaL products for Joint and muscuLar pain
ANTIINFL. PREP., NON-STEROIDS FOR TOPICAL USE
M02AA15 DICLOFENAC
M02AA10
M02AA07
CAPSICUM PREPARATIONS
M02AB CAPSAICIN
15579 Cream 0.025% 45g – – 169 –
PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
|M02AC |METHYL |SALICYLATE | | | | |
| |4022 |Compound Cream APF 100gm |– |– |3,156 |39,335 |
| |4023 |Ointment BP 100gm |– |– |1,986 |21,004 |
| |4025 |Compound ointment APF 1934 100gm |– |– |701 |6,497 |
| |4026 |Liniment APF 100gm |– |– |2,939 |24,875 |
| |4027 |Compound liniment APF 100gm |– |– |274 |2,768 |
| |10653 |Cream 50g 1 |– |– |140 |– |
| |12931 |Cream 100g 1 |– |– |8,797 |– |
| |15805 |Liniment APF 100mL |– |– |173 |– |
|M02AC METHYL SALICYLATE with MENTHOL with EUCALYPTUS OIL |
|11224 |Cream 125g 1 |– |– |3,707 |– |
|12943 |Cream 50g 1 |– |– |772 |– |
| M | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
MUSCULO-SKELETAL SYSTEM
MUSCLE RELAXANTS
muscLe reLaXants, centraLLY acting agents
ETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES
M03BC01 ORPHENADRINE CITRATE
M03BC51
OTHER CENTRALLY ACTING AGENTS
M03BX01 BACLOFEN
|2729 |Tablet 10mg |50.00 |MG |84,508 |3,446,950 |
|2730 |Tablet 25mg |50.00 |MG |46,087 |3,788,788 |
|6284 |Intrathecal injection 10mg in 5mL |55.00 |MG |290 |154,014 |
muscLe reLaXants, directLY acting agents
DANTROLENE AND DERIVATIVES
M03CA01 DANTROLENE SODIUM
|1779 |Capsule 25mg |0.10 |GM |4,161 |228,000 |
|1780 |Capsule 50mg |0.10 |GM |2,538 |164,257 |
M
2006
atc code form and strength ddd units scripts cost($)
MUSCULO-SKELETAL SYSTEM
ANTIGOUT PREPARATIONS
antigout preparations
PREPARATIONS INHIBITING URIC ACID PRODUCTION
M04AA01 ALLOPURINOL
|2600 |Tablet 100mg |0.40 |GM |247,890 |3,368,286 |
|2604 |Tablet 300mg |0.40 |GM |933,733 |9,524,856 |
|19182 |Capsule 300mg |0.40 |GM |203 |– |
PREPARATIONS INCREASING URIC ACID EXCRETION
M04AB01 PROBENECID
1940 Tablet 500mg 1.00 GM 18,287 1,266,217
PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM
M04AC01 COLCHICINE
1227 Tablet 500ug 1.00 MG 250,637 2,333,488
M
2006
atc code form and strength ddd units scripts cost($)
MUSCULO-SKELETAL SYSTEM
DRUGS FOR TREATMENT OF BONE DISEASES
drugs affecting Bone structure and mineraLiZation
BISPHOSPHONATES
M05BA04 ALENDRONIC ACID
M05BA02
M05BA01 DISODIUM ETIDRONATE
2920 Tablet 200mg 0.40 GM 471 73,162
M05BA03 DISODIUM PAMIDRONATE
|6223 |Vial pdr for IV infuse 90mg amp solvent 10mL |60.00 |MG |2,705 |1,192,993 |
|6279 |2 vials pdr for IV infuse 30mg 2 amp solvent 10mL |60.00 |MG |203 |63,503 |
|6289 |Concentrated injection 90mg in 10mL |60.00 |MG |304 |119,399 |
|8209 |2 vials pdr for IV infuse 30mg 2 amp solvent 10mL |60.00 |MG |823 |257,994 |
|8463 |Concentrated injection 60mg in 10mL |60.00 |MG |193 |52,782 |
|M05BA07 RISEDRONIC ACID |
|4443 |Tablet 5mg 28 |5.00 |MG |1,318 |70,162 |
|4444 |Tablet 35mg 4 |5.00 |MG |46,368 |2,469,048 |
|8481 |Tablet 5mg 28 |5.00 |MG |22,187 |1,182,191 |
|8482 |Tablet 30mg 28 |5.00 |MG |4,328 |1,330,790 |
|8621 |Tablet 35mg |5.00 |MG |706,301 |37,606,935 |
|M05BA05 |TILUDRONIC ACID | | | | |
| |8267 Tablet 200mg |0.40 |MG |936 |288,164 |
|M05BA08 |ZOLEDRONIC ACID | | | | |
| |6371 Injection concentrate I.V. infusion 4mg in 5mL |4.00 |MG |20,833 |9,928,229 |
BISPHOSPHONATES AND CALCIUM
|M05BB03 |ALENDRONIC ACID AND COLECALCIFEROL | | | | |
| |9012 Tablet equiv to 70mg alendronic with 70ug Colecal |– |– |93,769 |4,896,869 |
|M05BB01 |ETIDRONIC ACID AND CALCIUM | | | | |
| |8056 28 tabs 200mg and 76 tabs calcium (equiv 500mg) |– |– |18,272 |1,285,823 |
|M05BB02 |RISEDRONIC SODIUM with CALCIUM CARBONATE | | | | |
| |8899 Pack containing 4 tablets 35mg and 24 tabs 1.25g |– |– |208,989 |10,971,583 |
BISPHOSPHONATES AND CALCIUM
M05BX03 STRONTIUM RANELATE
19523 Granules for oral suspension 2g, 28 Sachets 2.00 GM 622 –
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANAESTHETICS
anaesthetics, generaL
OPIOID ANAESTHETICS
N01AH01 FENTANYL
|11946 |Ampoule 100ug/2mL 10 |– |– |353 |– |
|15874 |Ampoule 100ug/2mL 10 |– |– |244 |– |
OTHER GENERAL ANAESTHETICS
N01AX03 KETAMINE HYDROCHLORIDE
11084 Ampoule 200mg/2m 5 – – 118 –
anaesthetics, LocaL
AMIDES
N01BB01 BUPIVACAINE
|11219 |Vial 0.5% 20mL 5 |– |– |210 |– |
|13777 |Ampoule 0.5% 10mL 5 |– |– |243 |– |
|N01BB02 LIGNOCAINE HYDROCHLORIDE |
|13643 |Ampoule 2% 5mL 10 |– |– |382 |– |
|15897 |Ampoule 1% 5mL 50 |– |– |174 |– |
|15901 |Ampoule 2% 5mL 50 |– |– |121 |– |
|17544 |Ampoule 1% 5mL 50 |– |– |316 |– |
|N01BB52 LIGNOCAINE with ADRENALINE |
|15905 |Vial 2% 20mL 5 |– |– |830 |– |
|16268 |Ampoule 1% 5mL 50 |– |– |296 |– |
|N01BB52 |PRILOCAINE with LIGNOCAINE | | | | |
| |14984 Patch 1 g |– |– |580 |– |
|N01BB09 |ROPIVACAINE | | | | |
| |15643 Inj 10mL 7.5mg/mL 5 |– |– |115 |– |
| |15645 Injection 10mL 10mg/mL 5 |– |– |1,061 |– |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANALGESICS
opioids
NATURAL OPIUM ALKALOIDS
N02AA59 CODEINE with PARACETAMOL
N02AA08
N02AA03
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANALGESICS
opioids
NATURAL OPIUM ALKALOIDS
N02AA01 MORPHINE
|1607 |Injection 120mg in 1.5mL |30.00 |MG |5,081 |430,979 |
|1644 |Injection 10mg in 1mL |30.00 |MG |44,002 |707,086 |
|1645 |Injection 15mg in 1mL |30.00 |MG |17,769 |370,763 |
|1646 |Tablet 30mg |100.00 |MG |14,371 |273,980 |
|1647 |Injection 30mg in 1mL |30.00 |MG |29,287 |875,451 |
|1653 |Tablet 10mg (controlled release) |100.00 |MG |104,265 |2,513,642 |
|1654 |Tablet 30mg (controlled release) |100.00 |MG |99,647 |4,671,712 |
|1655 |Tablet 60mg (controlled release) |100.00 |MG |73,486 |5,586,289 |
|1656 |Tablet 100mg (controlled release) |100.00 |MG |67,698 |7,726,720 |
|2122 |Oral solution 2mg per mL 200mL |100.00 |MG |21,297 |373,446 |
|2123 |Oral solution 5mg per mL 200mL |100.00 |MG |36,050 |746,679 |
|2124 |Oral solution 10mg per mL 200mL |100.00 |MG |37,779 |1,120,975 |
|2839 |Capsule 20mg (sustained release) |100.00 |MG |69,510 |2,487,232 |
|2840 |Capsule 50mg (sustained release) |100.00 |MG |52,528 |3,142,428 |
|2841 |Capsule 100mg (sustained release) |100.00 |MG |40,133 |4,943,211 |
|3479 |Injection 15mg in 1mL |30.00 |MG |11,581 |145,908 |
|3480 |Injection 30mg in 1mL |30.00 |MG |5,363 |75,870 |
|8035 |Tablet 5mg (controlled release) |100.00 |MG |40,144 |692,841 |
|8146 |Sachet 30mg (controlled release) |100.00 |MG |1,483 |57,563 |
|8305 |Sachet 60mg granules for oral suspension |100.00 |MG |828 |61,461 |
|8306 |Sachet 100mg granules for oral suspension |100.00 |MG |465 |54,668 |
|8349 |Capsule 10mg (sustained release) 20 |100.00 |MG |31,204 |641,171 |
|8453 |Tablet 200mg (controlled release) |100.00 |MG |1,071 |438,204 |
|8489 |Tablet 15mg (controlled release) 20 |100.00 |MG |42,964 |1,164,598 |
|8490 |Sachet 20mg granules for oral suspension 20 |100.00 |MG |2,916 |80,224 |
|8491 |Capsule 30mg (controlled release) 10 |100.00 |MG |2,148 |60,178 |
|8492 |Capsule 60mg (controlled release) 10 |100.00 |MG |4,173 |165,553 |
|8493 |Capsule 90mg (controlled release) 10 |100.00 |MG |2,432 |147,695 |
|8494 |Capsule 120mg (controlled release) 10 |100.00 |MG |4,788 |432,670 |
|8669 |Tablet 10mg 20 |100.00 |MG |1,188 |15,296 |
|8670 |Tablet 20mg 20 |100.00 |MG |1,323 |20,747 |
|14259 |Tablet 30mg (controlled release) 60 |100.00 |MG |167 |– |
|14933 |Capsule 50mg (sustained release) |100.00 |MG |157 |– |
|15415 |Mixture 200mL 1mg per mL |100.00 |MG |753 |– |
|19608 |Injection 10mg in 1mL |30.00 |MG |821 |– |
|19620 |Injection 15mg in 1mL |30.00 |MG |328 |– |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANALGESICS
opioids
NATURAL OPIUM ALKALOIDS
N02AA05 OXYCODONE
|2481 |Suppository 30mg |30.00 |MG |13,055 |664,969 |
|2622 |Tablet 5mg |75.00 |MG |551,631 |7,086,679 |
|5195 |Tablet 5mg |75.00 |MG |486 |5,204 |
|8385 |Tablet 10mg (controlled release) 20 |75.00 |MG |249,228 |6,670,549 |
|8386 |Tablet 20mg (controlled release) 20 |75.00 |MG |245,814 |10,923,087 |
|8387 |Tablet 40mg (controlled release) 20 |75.00 |MG |153,590 |10,866,980 |
|8388 |Tablet 80mg (controlled release) 20 |75.00 |MG |84,459 |10,854,624 |
|8464 |Capsule 5mg 20 |75.00 |MG |33,399 |405,023 |
|8501 |Capsule 10mg 20 |75.00 |MG |51,242 |919,061 |
|8502 |Capsule 20mg 20 |75.00 |MG |40,819 |1,316,874 |
|8644 |Oral solution 5mg per 5mL 250mL |75.00 |MG |5,864 |106,591 |
|8681 |Tablet 5mg (controlled release) 20 |75.00 |MG |87,603 |1,689,792 |
|16418 |Tablet 40mg (controlled release) 60 |75.00 |MG |146 |– |
PHENYLPIPERIDINE DERIVATIVES
N02AB03 FENTANYL
N02AB02
DIPHENYLPROPYLAMINE DERIVATIVES
N02AC04 DEXTROPROPOXYPHENE NAPSYLATE
N02AC54
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANALGESICS
opioids
ORIPAVINE DERIVATIVES
N02AE01 BUPRENORPHINE
|8865 |Transdermal patch 5mg (releasing ~5ug/hour) 2 |1.20 |MG |80,144 |2,162,686 |
|8866 |Transdermal patch 10mg (releasing ~10ug/hour) |1.20 |MG |67,217 |2,686,700 |
|8867 |Transdermal patch 20mg (releasing ~20ug/hour) |1.20 |MG |36,929 |2,516,058 |
|15207 |Tablets 2 mg (slow release) |1.20 |MG |690 |– |
OTHER OPIOIDS
N02AX02 TRAMADOL
|2527 |Tablet 50mg (sustained release) 20 |0.30 |GM |471 |6,999 |
|3484 |Injection 100mg in 2mL 5 |0.30 |GM |17,218 |183,525 |
|5232 |Capsule 50mg 20 |0.30 |GM |1,071 |9,151 |
|5234 |Tablet 100mg (sustained release) 20 |0.30 |GM |445 |6,496 |
|8455 |Capsule 50mg 20 |0.30 |GM |227,249 |1,947,654 |
|8523 |Tablet 100mg (sustained release) 20 |0.30 |GM |453,520 |10,146,550 |
|8524 |Tablet 150mg (sustained release) 20 |0.30 |GM |219,377 |6,569,390 |
|8525 |Tablet 200mg (sustained release) 20 |0.30 |GM |352,113 |12,854,297 |
|8582 |Injection 100mg in 2mL 5 |0.30 |GM |15,521 |166,675 |
|8611 |Capsule 50mg 20 |0.30 |GM |889,019 |7,657,480 |
|8843 |Oral drops 100mg per mL 10mL |0.30 |GM |1,525 |16,848 |
|17988 |Capsule 50mg 50 |0.30 |GM |115 |– |
other anaLgesics and antipYretics
SALICYLIC ACID DERIVATIVES
|N02BA01 |ASPIRIN | | | | | |
| |1010 |Tablet 300mg (dispersible) |3.00 |GM |231,852 |1,677,287 |
| |10669 |Tablet soluble 24 |3.00 |GM |135 |– |
|N02BA51 CODEINE with ASPIRIN |
|4061 |Tablet soluble 8mg-300mg |– |– |8,600 |102,836 |
|10090 |Tablet soluble 20 |– |– |705 |– |
|10091 |Tablet soluble 100 |– |– |20,736 |– |
|10465 |Tablet soluble 50 |– |– |778 |– |
|12168 |Tablet 50 |– |– |491 |– |
|12169 |Tablet 100 |– |– |3,315 |– |
|N02BA11 DIFLUNISAL |
|1319 |Tablet 250mg |750.00 |MG |1,092 |16,275 |
|1320 |Tablet 500mg |750.00 |MG |4,751 |72,297 |
|5080 |Tablet 250mg |750.00 |MG |492 |5,443 |
|19581 |Tablet 250mg |750.00 |MG |416 |– |
|19583 |Tablet 500mg |750.00 |MG |1,790 |– |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANALGESICS
other anaLgesics and antipYretics
ANILIDES
N02BE51
N02BE51
N02BE51 METOCLOPRAMIDE with PARACETAMOL
19575 Capsule 5mg/500mg 10 – – 7,813 –
N02BE01 PARACETAMOL
|1746 |Tablet 500mg |3.00 |GM |2,178,111 |16,612,183 |
|1747 |Mixture 120mg per 5mL 100mL |3.00 |GM |29,779 |236,285 |
|1770 |Elixir 240mg per 5mL 200mL |3.00 |GM |158,476 |1,598,879 |
|5196 |Tablet 500mg |3.00 |GM |267 |1,984 |
|5319 |Suppositories 500mg 24 |3.00 |GM |2,056 |82,853 |
|5320 |Suppositories 500mg 24 |3.00 |GM |376 |19,087 |
|5343 |Tablet 665mg (modified release) 9 6 |3.00 |GM |1,171 |11,134 |
|5344 |Tablet 665mg (modified release) 9 6 |3.00 |GM |338 |2,637 |
|8784 |Tablet 500mg 300 |3.00 |GM |1,137,177 |14,444,905 |
|8814 |Tablet 665mg (modified release) 1 92 |3.00 |GM |495,606 |5,756,075 |
|11511 |Elixir 120mg/5 1 |3.00 |GM |479 |– |
|11512 |Elixir 200mL 1 |3.00 |GM |546 |– |
|11515 |Tablet 500mg 50 |3.00 |GM |2,236 |– |
|11516 |Tablet 500mg 100 |3.00 |GM |2,796 |– |
|11517 |Tab-sol 500mg 24 |3.00 |GM |1,520 |– |
|11519 |Drop 20mL 1 |3.00 |GM |1,359 |– |
|13759 |Tablet 500mg 100 |3.00 |GM |111 |– |
|18117 |Mixture 120mg per 5mL 100mL |3.00 |GM |219 |– |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANALGESICS
other anaLgesics and antipYretics
ANILIDES
N02BE51
N02BE51
antimigraine preparations
ERGOT ALKALOIDS
N02CA01 DIHYDROERGOTAMINE
|1323 |Injection 1mg in 1mL |4.00 |MG |1,308 |28,154 |
|3460 |Injection 1mg in 1mL |4.00 |MG |7,090 |109,125 |
|N02CA52 |ERGOTAMINE TARTRATE with CAFFEINE | | | | |
| |18569 Suppositories 2mg-100 mg 5 |– |– |22,557 |– |
|N02CA52 |ERGOTAMINE with CAFFEINE | | | | |
| |13550 Tablet 20 |– |– |59,075 |– |
|N02CA04 |METHYSERGIDE | | | | |
| |2826 Tablet 1mg |4.00 |MG |8,952 |399,116 |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANALGESICS
antimigraine preparations
SELECTIVE 5HT RECEPTOR AGONISTS
N02CC02
N02CC01
N02CC03 ZOLMITRIPTAN
8266 Tablet 2.5mg 4 (2 upto Feb06) 2.50 MG 123,260 3,242,874
OTHER ANTIMIGRAINE PREPARATIONS
N02CX01 PIZOTIFEN MALATE
3074 Tablet 500ug (base) 1.50 MG 124,387 2,568,880
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANTIEPILEPTICS
antiepiLeptics
BARBITURATES AND DERIVATIVES
N03AA02 PHENOBARBITONE
N03AA03
HYDANTOIN DERIVATIVES
N03AB02 PHENYTOIN
|1249 |Tablet 50mg |0.30 |GM |7,567 |213,150 |
|1873 |Capsule 30mg |0.30 |GM |20,449 |552,321 |
|1874 |Capsule 100mg |0.30 |GM |175,125 |4,892,357 |
|2692 |Paediatric oral suspension 30mg per 5mL 500mL |0.30 |GM |9,825 |247,003 |
SUCCINIMIDE DERIVATIVES
N03AD01 ETHOSUXIMIDE
|1413 |Capsule 250mg |1.25 |GM |2,458 |131,046 |
|1414 |Paediatric syrup 250mg per 5mL 250mL |1.25 |GM |3,452 |107,745 |
BENZODIAZEPINE DERIVATIVES
N03AE01 CLONAZEPAM
|1805 |Tablet 500ug |8.00 |MG |41,526 |939,109 |
|1806 |Tablet 2mg |8.00 |MG |24,585 |934,068 |
|1807 |Injection 1mg in 2mL (set containing solution) |8.00 |MG |2,664 |65,730 |
|1808 |Paediatric oral drops 2.5mg in 1mL 10mL |8.00 |MG |3,747 |57,787 |
|5337 |Tablet 500ug |8.00 |MG |22,155 |434,172 |
|5338 |Tablet 2mg |8.00 |MG |9,424 |333,683 |
|5339 |Oral liquid 2.5mg per mL 10mL |8.00 |MG |2,853 |41,265 |
|5340 |Tablet 500ug |8.00 |MG |8,967 |193,237 |
|5341 |Tablet 2mg |8.00 |MG |6,133 |201,962 |
|5342 |Oral liquid 2.5mg per mL 10mL |8.00 |MG |244 |4,337 |
CARBOXAMIDE DERIVATIVES
N03AF01 CARBAMAZEPINE
N03AF02
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANTIEPILEPTICS
antiepiLeptics
FATTY ACID DERIVATIVES
|N03AG01 |SODIUM |VALPROATE | | | | |
| |2289 |Tablet 200mg (enteric coated) 20 0 |1.50 |GM |256,314 |9,141,840 |
| |2290 |Tablet 500mg (enteric coated) 20 0 |1.50 |GM |284,292 |18,479,612 |
| |2293 |Oral liquid 200mg per 5mL 300 mL |1.50 |GM |51,894 |1,874,514 |
| |2294 |Crushable tablet 100mg |1.50 |GM |51,754 |1,583,904 |
| |2295 |Syrup 200mg per 5mL 300mL |1.50 |GM |17,937 |648,453 |
|N03AG06 TIAGABINE |
|8221 |Tablet 5mg (base) |30.00 |MG |1,011 |96,410 |
|8222 |Tablet 10mg (base) |30.00 |MG |1,003 |170,065 |
|8223 |Tablet 15mg (base) |30.00 |MG |437 |92,383 |
|N03AG04 VIGABATRIN |
|2667 |Tablet 500mg 120 |2.00 |GM |9,489 |1,292,526 |
|2668 |Oral powder sachet 500mg |2.00 |GM |2,081 |193,925 |
OTHER ANTIEPILEPTICS
N03AX12 GABAPENTIN
N03AX09
N03AX14
N03AX16
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANTIEPILEPTICS
antiepiLeptics
ANTIEPILEPTICS
N03AX03
N03AX11
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANTI-PARKINSON DRUGS
antichoLinergic agents
TERTIARY AMINES WITH CARBON CHAIN
N04AA01 BENZHEXOL HYDROCHLORIDE
N04AA02
ETHERS OF TROPINE OR TROPINE DERIVATIVES
N04AC01 BENZTROPINE MESYLATE
|2362 |Tablet 2mg 60 |2.00 |MG |60,888 |676,817 |
|3038 |Injection 2mg in 2mL |2.00 |MG |1,030 |25,120 |
|3457 |Injection 2mg in 2mL |2.00 |MG |12,606 |264,885 |
dopaminergic agents
DOPA AND DOPA DERIVATIVES
N04BA02 LEVODOPA with BENSERAZIDE
N04BA02
N04BA03
ADAMANTANE DERIVATIVES
N04BB01 AMANTADINE HYDROCHLORIDE
3016 Capsule 100mg 0.20 GM 14,783 626,142
DOPAMINE AGONISTS
N04BC01 BROMOCRIPTINE MESYLATE
N04BC06
N04BC02
N04BC04
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
ANTI-PARKINSON DRUGS
dopaminergic agents
MONOAMINE OXIDASE TYPE B INHIBITORS
N04BD01 SELEGILINE HYDROCHLORIDE
1973 Tablet 5mg 100 5.00 MG 7,368 412,337
OTHER DOPAMINERGIC AGENTS
N04BX02 ENTACAPONE
8367 Tablet 200mg 1.00 GM 17,883 5,146,324
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOLEPTICS
antipsYchotics
PHENOTHIAZINE WITH DIMETHYLAMINOPROPYL GROUP
N05AA01 CHLORPROMAZINE HYDROCHLORIDE
|1195 |Injection 50mg in 2 mL |0.10 |GM |878 |12,680 |
|1196 |Tablet 10mg |0.30 |GM |10,542 |85,449 |
|1197 |Tablet 25mg |0.30 |GM |46,328 |445,097 |
|1199 |Tablet 100mg |0.30 |GM |28,728 |385,666 |
|1201 |Mixture 25mg per 5mL 100mL |0.30 |GM |4,677 |71,163 |
|3455 |Injection 50mg in 2mL |0.10 |GM |4,394 |61,758 |
PHENOTHIAZINE WITH PIPERAZINE STRUCTURE
N05AB02 FLUPHENAZINE DECANOATE
N05AB04
N05AB06
PHENOTHIAZINE WITH PIPERIDINE STRUCTURE
N05AC01 PERICYAZINE
N05AC02
BUTYROPHENONE DERIVATIVES
N05AD01 HALOPERIDOL
|2761 |Tablet 500ug 100 |8.00 |MG |52,153 |446,920 |
|2763 |Oral liquid 2mg per mL 100 mL |8.00 |MG |1,854 |27,464 |
|2765 |I.M. injection equivalent to 50mg haloperidol |3.30 |MG |2,264 |55,658 |
|2766 |I.M. injection equivalent to 150mg haloperidol |3.30 |MG |2,001 |87,349 |
|2767 |Tablet 1.5mg |8.00 |MG |16,591 |149,685 |
|2768 |Injection 5mg in 1mL |8.00 |MG |7,710 |134,470 |
|2770 |Tablet 5mg |8.00 |MG |22,721 |221,597 |
|3456 |Injection 5mg in 1mL |8.00 |MG |4,621 |74,600 |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOLEPTICS
antipsYchotics
THIOXANTHENE DERIVATIVES
N05AF01 FLUPENTHIXOL
N05AF05
DIPHENYLBUTYLPIPERIDINE DERIVATIVES
N05AG02 PIMOZIDE
11421 Tablet 2mg 50 4.00 MG 3,539 –
DIAZEPINES, OXAZEPINES AND THIAZEPINES
N05AH02 CLOZAPINE
N05AH03
N05AH04
NEUROLEPTICS, IN TARDIVE DYSKINESIA
N05AK01 TETRABENAZINE
1330 Tablet 25mg 0.10 GM 4,770 1,707,941
BENZAMIDES
N05AL05 AMISULPRIDE
|8594 |Tablet 100mg 30 |0.40 |GM |19,534 |1,047,013 |
|8595 |Tablet 200mg 60 |0.40 |GM |28,779 |4,805,859 |
|8596 |Tablet 400mg 60 |0.40 |GM |33,857 |9,965,060 |
|8736 |Oral solution 100mg per mL 60mL 2 |0.40 |GM |284 |47,522 |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOLEPTICS
antipsYchotics
LITHIUM
N05AN01 LITHIUM CARBONATE
|3059 |Tablet 250mg 200 |889.00 |MG |101,101 |1,353,555 |
|8290 |Tablet 450mg (slow release) 200 |889.00 |MG |29,020 |725,298 |
OTHER ANTIPSYCHOTICS
N05AX12 ARIPIPRAZOLE
N05AX08
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOLEPTICS
anXioLYtics
BENZODIAZEPINE DERIVATIVES
N05BA12 ALPRAZOLAM
N05BA08
N05BA09 CLOBAZAM
10898 Tablet 10mg 50 20.00 MG 21,804 –
N05BA01 DIAZEPAM
N05BA06
N05BA04
AZASPIRODECANEDIONE DERIVATIVES
N05BE01 BUSPIRONE HYDROCHLORIDE
|4144 |Tablet 5mg 50 |30.00 |MG |2,470 |112,129 |
|4145 |Tablet 10mg 50 |30.00 |MG |2,454 |186,739 |
N
2004
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOLEPTICS
hYpnotics and sedatiVes
ALDEHYDES AND DERIVATIVES
N05CC01 CHLORAL HYDRATE
18744 Syrup 1g/10mL 200mL 1.00 GM 763 –
BENZODIAZEPINE DERIVATIVES
N05CD03 FLUNITRAZEPAM
4216 Tablet 1mg 30 1.00 MG 52,517 873,877
N05CD08 MIDAZOLAM
N05CD02
N05CD07
N05CD05 TRIAZOLAM
13374 Tablet 0.125mg 50 0.25 MG 3,842 –
BENZODIAZEPINE RELATED DRUGS
N05CF02 ZOLPIDEM
N05CF01
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOANALEPTICS
antidepressants
NON SELECTIVE MONOAMINE REUPTAKE INHIBITORS
N06AA09 AMITRIPTYLINE HYDROCHLORIDE
|2417 |Tablet 10mg 50 |75.00 |MG |325,905 |2,263,563 |
|2418 |Tablet 25mg 50 |75.00 |MG |536,361 |3,818,400 |
|2429 |Tablet 50mg 50 |75.00 |MG |365,522 |2,917,462 |
|19735 |Tablet 25mg |75.00 |MG |6,744 |– |
|N06AA04 |CLOMIPRAMINE HYDROCHLORIDE | | | | |
| |1561 Tablet 25mg 50 |100.00 |MG |66,318 |2,391,267 |
|N06AA16 |DOTHIEPIN HYDROCHLORIDE | | | | |
| |1357 Capsule 25mg 50 |150.00 |MG |280,558 |2,176,306 |
| |1358 Tablet 75mg 50 |150.00 |MG |367,784 |3,291,519 |
|N06AA12 |DOXEPIN HYDROCHLORIDE | | | | |
| |1011 Capsule 10mg (base)50 |100.00 |MG |72,209 |527,494 |
| |1012 Tablet 50mg (base) 50 |100.00 |MG |149,115 |1,330,847 |
| |1013 Capsule 25mg (base)50 |100.00 |MG |186,344 |1,485,684 |
|N06AA02 |IMIPRAMINE HYDROCHLORIDE | | | | |
| |2420 Tablet 10mg 50 |100.00 |MG |50,499 |364,599 |
| |2421 Tablet 25mg 50 |100.00 |MG |139,801 |1,135,751 |
|N06AA10 |NORTRIPTYLINE HYDROCHLORIDE | | | | |
| |2522 Tablet 10mg (base) 50 |75.00 |MG |18,991 |223,708 |
| |2523 Tablet 25mg (base) 50 |75.00 |MG |56,474 |957,578 |
|N06AA06 |TRIMIPRAMINE MALEATE | | | | |
| |14531 Tablet 25mg (base) |150.00 |MG |2,145 |– |
| |16468 Capsule 50mg 50 |150.00 |MG |12,541 |– |
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
N06AB04 CITALOPRAM
N06AB10
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOANALEPTICS
antidepressants
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
N06AB03 FLUOXETINE HYDROCHLORIDE
N06AB08
N06AB05 PAROXETINE
2242 Tablet 20mg (base) 30 20.00 MG 1,147,510 41,818,245
N06AB06 SERTRALINE
|2236 |Tablet 50mg (base) 30 |50.00 |MG |1,224,549 |38,000,942 |
|2237 |Tablet 100mg (base) 30 |50.00 |MG |1,134,697 |39,942,424 |
|8836 |Tablet 50mg (base) 30 |50.00 |MG |227,398 |7,007,975 |
|8837 |Tablet 100mg (base) 30 |50.00 |MG |186,991 |6,085,764 |
MONOAMINE OXIDASE INHIBITORS, NON-SELECTIVE
N06AF03 PHENELZINE SULPHATE
N06AF04
MONOAMINE OXIDASE TYPE A INHIBITORS
N06AG02 MOCLOBEMIDE
|1900 |Tablet 150mg 60 |0.30 |GM |52,282 |1,262,215 |
|8003 |Tablet 300mg 60 |0.30 |GM |143,045 |6,485,905 |
OTHER ANTIDEPRESSANTS
N06AX03 MIANSERIN HYDROCHLORIDE
N06AX11
N06AX18 REBOXETINE
8583 Tablet 4mg (base) 60 8.00 MG 99,228 3,843,753
N06AX16 VENLAFAXINE
|8068 |Tablet 37.5mg (base) 56 |100.00 |MG |18,019 |790,359 |
|8069 |Tablet 75mg (base) 56 |100.00 |MG |11,377 |639,000 |
|8301 |Capsule 75mg (base) modified release 28 |100.00 |MG |989,364 |46,469,842 |
|8302 |Capsule 150mg (base) modified release 28 |100.00 |MG |1,104,213 |70,508,509 |
|8868 |Tablet 37.5mg (base) (modified release) 28 |100.00 |MG |85,394 |2,155,804 |
|19599 |Tablet 37.5mg (base) |100.00 |MG |2,115 |– |
|19600 |Tablet 75mg (base) |100.00 |MG |738 |– |
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
PSYCHOANALEPTICS
psYchostimuLants and nootropics
CENTRALLY ACTING SYMPATHOMIMETICS
N06BA09 ATOMOXETINE
N06BA02 DEXAMPHETAMINE SULPHATE
1165 Tablet 5mg 15.00 MG 268,803 5,833,187
N06BA04 METHYLPHENIDATE
N06BA07
anti-dementia drugs ANTICHOLINESTERASES N06DA02 DONEPEZIL
N06DA04
N06DA03
OTHER ANTI-DEMENTIA DRUGS
N06DX01 MEMANTINE HYDROCHLORIDE
18031 Tablet 10mg 56 – – 11,569 –
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
OTHER NERVOUS SYSTEM DRUGS
parasYmpathomimetics
ANTICHOLINESTERASES
N07AA02 PYRIDOSTIGMINE BROMIDE
|1959 |Tablet 60mg |180.00 |MG |10,411 |612,237 |
|2608 |Tablet 180mg (sustained release) |180.00 |MG |1,903 |220,776 |
|2724 |Tablet 10mg |180.00 |MG |2,815 |73,069 |
| | | | | | |
|CHOLINE ESTERS | | | | | |
|N07AB02 BETHA |NECHOL CHLORIDE | | | | |
|1062 |Tablet 10mg |45.00 |MG |7,804 |144,773 |
drugs used in addictiVe disorders
DRUGS USED IN NICOTINE DEPENDENCE
N07BA02 BUPROPION
N07BA01
DRUGS USED IN ALCOHOL DEPENDENCE
|N07BB03 |ACAMPROSATE | | | | |
| |8357 Tablet 333mg (enteric coated) |2.00 |GM |24,288 |4,063,040 |
|N07BB01 |DISULFIRAM | | | | |
| |16345 Effervescent Tablet 200mg 30 |– |– |2,932 |– |
|N07BB04 |NALTREXONE | | | | |
| |8370 Tablet 50mg 30 |50.00 |MG |16,921 |2,782,214 |
DRUGS USED IN OPIOID DEPENDENCE
N07BC01 BUPRENORPHINE
N07BC51
N07BC02
N
2006
atc code form and strength ddd units scripts cost($)
NERVOUS SYSTEM
OTHER NERVOUS SYSTEM DRUGS
antiVertigo preparations
ANTIVERTIGO PREPARATIONS
ANTIVERTIGO PREPARATIONS
N07CA01 BETAHISTINE
|16064 |Tablet 16mg 25 |24.00 |MG |143,304 |– |
|18064 |Tablet 16mg 10 |24.00 |MG |136 |– |
other nerVous sYstem drugs
OTHER NERVOUS SYSTEM DRUGS
N07XX02 RILUZOLE
8664 Tablet 50mg 56 0.10 MG 5,574 3,792,009
P
2006
atc code form and strength ddd units scripts cost($)
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTS
ANTIPROTOZOALS
agents against amoeBiasis and other protoZoaL diseases
NITROIMIDAZOLE DERIVATIVES
P01AB01 METRONIDAZOLE
|1621 |Tablet 400mg |2.00 |GM |307,563 |2,996,819 |
|1626 |Tablet 400mg |2.00 |GM |1,601 |12,192 |
|1630 |Oral suspension 320mg per 5mL |2.00 |GM |30,608 |451,660 |
|1636 |Tablet 200mg |2.00 |GM |123,181 |869,607 |
|1642 |Suppositories 500mg 10 |2.00 |GM |1,272 |28,931 |
|3339 |Tablet 200mg |2.00 |GM |56,809 |399,195 |
|3341 |Oral suspension 320mg per 5mL |2.00 |GM |318 |4,594 |
|5155 |Tablet 400mg |2.00 |GM |41,563 |401,817 |
|5159 |Tablet 400mg |2.00 |GM |243 |1,688 |
|P01AB02 TINIDAZOLE |
|1465 |Tablet 500mg |2.00 |GM |118,869 |952,748 |
|antimaLariaLs | | | | | |
|QUINOLINE DERIVATIVES |
|P01BA01 |CHLOROQUINE | | | | |
| |15137 Tablet equivalent to 150mg (approx.) |0.50 |GM |3,741 |– |
|P01BA02 |HYDROXYCHLOROQUINE SULPHATE | | | | |
| |1512 Tablet 200mg |0.52 |GM |134,050 |4,728,038 |
|P01BA03 |PRIMAQUINE PHOSPHATE | | | | |
| |17824 Tablet 7.5mg 60 |15.00 |MG |159 |– |
|BIGUANIDES | | | | | |
|P01BB51 |ATOVAQUONE with PROGUANIL | | | | |
| |16050 Tablet 12 |– |– |9,452 |– |
| |18864 Tablet 12 |– |– |966 |– |
|P01BB01 |PROGUANIL | | | | |
| |15224 Tablet 100mg |0.20 |GM |805 |– |
METHANOLQUINOLINES
P01BC02 MEFLOQUINE
P01BC01
DIAMINOPYRIMIDINES
P01BD01 PYRIMETHAMINE
1966 Tablet 25mg – – 269 3,391
ARTEMISININ AND DERIVATIVES
P01BE52 ARTEMETHER with LUMEFANTRINE
17720 Tablet 20mg/120mg 24 – – 150 –
| | | P |
| |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTS
ANTHELMINTICS
antitrematodaLs
QUINOLINE DERIVATIVES
P02BA01 PRAZIQUANTEL
13814 Tablet 600mg 8 3.00 GM 324 –
antinematodaL agents
BENZIMIDAZOLE DERIVATIVES
P02CA03 ALBENDAZOLE
P02CA01
TETRAHYDROPYRIMIDINE DERIVATIVES
P02CC01 PYRANTEL EMBONATE
|3047 |Tablet 125mg (base) |0.75 |GM |792 |5,245 |
|3048 |Tablet 250mg (base) |0.75 |GM |3,152 |25,299 |
| | | | | | |
|AVERMECTINES | | | | | |
|P02CF01 IVERM |ECTIN | | | | |
|8359 |Tablet 3mg 4 |12.00 |MG |4,279 |153,746 |
P
2006
atc code form and strength ddd units scripts cost($)
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTS
ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLANTS
ectoparasiticides, incL. scaBicides
CHLORINE CONTAINING PRODUCTS
P03AB02 LINDANE
11763 Ltn 100mL 1 – – 429 –
PYRETHRINES, INCL. SYNTHETIC COMPOUNDS
P03AC04 PERMETHRIN
3054 Cream 50mg per g (5%) 30g – – 49,014 742,869
OTHER ECTOPARASITICIDES, INCL. SCABICIDES
P03AX01 BENZYL BENZOATE
|1114 |Application 50g in 200mL (25%) |– |– |2,969 |22,150 |
|13227 |Lotion 25% 200mL 1 |– |– |500 |– |
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
NASAL PREPARATIONS
decongestants and other nasaL preparations for topicaL use
SYMPATHOMIMETICS, PLAIN
R01AA05
R01AA07
ANTIALLERGIC AGENTS,EXCL.CORTICOSTEROIDS
R01AC02 LEVOCABASTINE
4311 Nasal spray 500ug per mL (0.05) 10mL 0.60 MG 3,592 59,033
R01AC01 SODIUM CROMOGLYCATE
4468 Nasal spray metered dose pump 20mg per mL (2%) 40.00 MG 1,425 26,210
CORTICOSTEROIDS
R01AD01 BECLOMETHASONE DIPROPIONATE
17056 Aqueous nasal spray 50ug per dose 200 dose 0.40 MG 5,983 –
R01AD05 BUDESONIDE
|4092 |Nasal spray aqueous(pump) 64ug per dose 120 doses |0.30 |MG |37,717 |982,886 |
|17200 |Nasal spray aqueous(pump) 32ug per dose 60 doses |0.30 |MG |2,757 |– |
|17201 |Nasal spray aqueous(pump) 32ug per dose 120 doses |0.30 |MG |1,578 |– |
|17850 |Nasal spray aqueous(pump) 64ug per dose 240 doses |0.30 |MG |86,571 |– |
|17952 |Nasal spray aqueous(pump) 64ug per dose 120 doses |0.30 |MG |140,272 |– |
|18069 |Nasal spray aqueous(pump) 64ug per dose 50 doses |0.30 |MG |115 |– |
|R01AD08 |FLUTICASONE | | | | |
| |17840 Aqueous Nasal unit dose instillation 400ug 28 |0.20 |MG |110 |– |
|R01AD09 |MOMETASONE FUROATE | | | | |
| |16441 Aqueous Nasal spray 50ug per dose |0.20 |MG |376,198 |– |
| |18043 Aqueous Nasal spray 50ug per dose 65 doses |0.20 |MG |28,952 |– |
OTHER NASAL PREPARATIONS
R01AX03 IPRATROPIUM BROMIDE
R01AX10
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
NASAL PREPARATIONS
nasaL decongestants for sYstemic use
SYMPATHOMIMETICS
R01BA52 BROMHEXINE with PSEUDOEPHEDRINE
19651 Liquid 200mL 1 – – 6,707 –
|R01BA52 |BROMHEXINE with GUAIPHENESIN with PSEUDOEPHEDRINE | | |
| |19678 Liquid 100mL 1 – – |2,426 |– |
|R01BA52 |BROMHEXINE with PSEUDOEPHEDRINE | | |
| |19485 Liquid 200mL – – |1,501 |– |
|R01BA52 |CHLORPHENIRAMINE with DEXTROMETHORPHAN with PSEUDOEPHEDRINE | |
| |19681 Mixture 100mL 1 – – 116 |– |
|R01BA52 |CHLORPHENIRAMINE with PSEUDOEPHEDRINE with PARACETEMOL | |
| |19538 Tablet 24 – – 6,262 |– |
|R01BA52 |CODEINE with PARRACETAMOL with PSEUDOEPHEDRINE with TRIPROLIDINE | |
| |19481 Tablet 24 – – 158,000 |– |
|R01BA52 |CODEINE with PSEUDOEPHEDRINE | |
| |19680 Mixture 100mL 1 – – 420 |– |
|R01BA52 |DEXTROMETHORPHAN with DOXYLAMINE with PARACETAMOL with PSEUDOEPHEDRINE | |
| |19483 Capsule 24 – – 63,880 | |
| | |– |
| |19484 Capsule 20 – – 5,231 |– |
|R01BA52 |DEXTROMETHORPHAN with PARACETAMOL with PSEUDOEPHEDRINE | |
| |19482 Capsule 24 – – 6,869 |– |
| |19488 Tablet 24 – – 128 |– |
| |19499 Tablet 24 – – 1,497 |– |
| |19500 Tablet 48 – – 163 |– |
| |19503 Tablet 24 – – 5,267 |– |
|R01BA52 |DEXTROMETHORPHAN with PARACETAMOLE with PSEUDOEPHEDRINE | |
| |19541 Tablet 24 – – 4,017 |– |
|R01BA52 |DEXTROMETHORPHAN with PSEUDOEPHEDRINE | |
| |19511 Syrup 100mL – – 1,536 |– |
| |19512 Syrup 200mL – – 512 |– |
| |19533 Tablet 6 – – 69,402 |– |
|R01BA52 |GUAIPHENESIN with PSEUDOEPHEDRINE | |
| |19510 Syrup 200mL – – 570 |– |
|R01BA52 |IBUPROFEN WITH PSEUDOEPHEDRINE | |
| |19663 Tablets 20 – – 871 |– |
|R01BA52 |IBUPROFEN with PSEUDOEPHEDRINE | |
| |19513 Tablet 24 – – 10,816 |– |
|R01BA52 |IBUPROFEN with PSEUDOEPHEDRINE with PSEUDOEPHEDRINE | |
| |19492 Tablet 24 – – 30,076 |– |
| |19493 Tablet 48 – – 1,178 |– |
|R01BA52 |LORATADINE with PSEUDOEPHEDRINE | |
| |19534 Tablet 6 – – 26,414 |– |
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
NASAL PREPARATIONS
nasaL decongestants for sYstemic use
SYMPATHOMIMETICS
|R01BA52 PARACETAMOL with PSEUDOEPHEDRINE |
|11894 |Tablet 10 |– |– |2,135 |– |
|11895 |Tablet 30 |– |– |696 |– |
|11896 |Tablet 50 |– |– |328 |– |
|19049 |Sachet, 10 |– |– |3,641 |– |
|19478 |Tablet 24 |– |– |9,801 |– |
|19504 |Tablet 24 |– |– |31,595 |– |
|19505 |Tablet 48 |– |– |689 |_ |
|19515 |Tablet 24 |– |– |26,001 |– |
|19520 |Tablet 24 |– |– |233 |– |
|R01BA52 PARACETAMOL with PSEUDOEPHEDRINE with CHLORPHENIRAMINE |
|11897 |Tablet 10 |– |– |19,416 |– |
|11898 |Tablet 30 |– |– |9,150 |– |
|11899 |Tablet 50 |– |– |2,500 |– |
|R01BA52 PARACETAMOL with PSEUDOEPHEDRINE with TRIPROLIDINE |
|19514 |Tablet 24 |– |– |31,379 |– |
|19516 |Tablet 20 |– |– |12,994 |– |
|R01BA52 |PHOLCODEINE ith PSEUDOEPHEDRINE | | | | |
| |19653 Liquid 100mL 1 |– |– |194 |– |
|R01BA52 |PSEUDEPHEDRINE with CETIRIZINE | | | | |
| |19060 Tablet 10 |– |– |3,924 |– |
|R01BA52 |PSEUDEPHEDRINE with FEXOFENADINE | | | | |
| |19052 Tablet 120mg-60mg 10 |– |– |12,769 |– |
| |19644 Tablet 120mg-60mg 6 |– |– |14,493 |– |
|R01BA02 |PSEUDOEPHEDRINE | | | | |
| |4420 Tablet 60mg |0.24 |GM |38,259 |555,798 |
| |10746 Tablet repetabs 18 |0.24 |GM |294 |– |
| |11948 Elixir 30mg/5mL 1 |0.24 |GM |7,649 |– |
| |12614 Capsule 120mg 10 |0.24 |GM |1,149 |– |
| |17458 Tablet 60mg 60 |0.24 |GM |4,370 |– |
| |18518 Tablet 60mg 30 |0.24 |GM |5,655 |– |
| |19051 Tablet 60mg 24 |0.24 |GM |181 |– |
| |19683 Tablets 60mg 12 |– |– |8,988 |– |
|R01BA52 TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDE |
|10013 |Tablet 30 |– |– |8,392 |– |
|19458 |Tablet 15 |– |– |1,981 |– |
| R | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
RESPIRATORY SYSTEM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
adrenergics, inhaLants
SELECTIVE BETA-2-ADRENOCEPTOR AGONISTS
R03AC13 EFORMOTEROL
R03AC02
R03AC12
R03AC03
ADRENERGICS AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03AK07 EFORMOTEROL with BUDESONIDE
R03AK04 SALBUTAMOL with IPRATROPIUM BROMIDE
4283 Oral press inhal 20ug (anhydrous)-100 ug per dose 0.80 MG 2,384 111,773
R03AK06 SALMETEROL and FLUTICASONE
|8430 |Pdr oral inhal in breath actu dev 50ug/100ug |– |– |96,807 |4,418,197 |
|8431 |Pdr oral inhal in breath actu dev 50ug/250ug |– |– |719,779 |42,395,074 |
|8432 |Pdr oral inhal in breath actu dev 50ug/500ug |– |– |707,562 |56,376,284 |
|8517 |Oral Press inhal 25ug-50ug |– |– |91,257 |4,158,757 |
|8518 |Oral Press inhal 25ug-125ug |– |– |265,884 |15,614,886 |
|8519 |Oral Press inhal 25ug-250ug |– |– |912,581 |71,754,480 |
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
other drugs for oBstructiVe airWaY diseases,inhaLants
GLUCOCORTICOIDS
R03BA01 BECLOMETHASONE DIPROPIONATE
R03BA02
R03BA08
R03BA05
ANTICHOLINERGICS
R03BB01 IPRATROPIUM BROMIDE
R03BB04
ANTIALLERGIC AGENTS, EXCL. CORTICOSTEROIDS
R03BC03 NEDOCROMIL
R03BC01
adrenergics for sYstemic use
SELECTIVE BETA-2-ADRENOCEPTOR AGONISTS
R03CC02 SALBUTAMOL
R03CC03
| R | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
RESPIRATORY SYSTEM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
other sYstemic drugs for oBstructiVe airWaY diseases
XANTHINES
|R03DA02 |CHOLINE THEOPHYLLINATE | | | | |
| |16083 Elixir 50mg per 5mL 500mL |0.60 |GM |7,477 |– |
|R03DA54 |CHOLINE THEOPHYLLINATE with GUAIPHENESIN | | | | |
| |10362 Expectorant 500mL 1 |– |– |15,203 |– |
|R03DA04 |THEOPHYLLINE | | | | |
|1143 |Tablet 125mg |0.40 |GM |518 |4,523 |
|2614 |Syrup 80mg per 15mL 500mL |0.40 |GM |15,025 |140,492 |
|2634 |Tablet 250mg (sustained release) |0.40 |GM |23,040 |269,787 |
|8230 |Tablet 200mg (sustained release) |0.20 |GM |15,995 |168,754 |
|8231 |Tablet 300mg (sustained release) |0.40 |GM |18,023 |235,456 |
|19598 |Tablet 125mg |0.40 |GM |534 |– |
LEUKOTRIENERECEPTOR ANTAGONISTS
R03DC03 MONTELUKAST
R03DC01
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
COUGH AND COLD PREPARATIONS
eXpectorants,eXcL comBinations With antitussiVes
EXPECTORANTS
R05CA CAMPHOR COMPOUND
15831 Linctus 100mL – – 327 –
R05CA10 GUAIPHENESIN with PSEUDOEPHEDRINE
| |13545 |Syrup sf100m |– |– |3,513 |– |
| |19459 |Capsules 12 |– |– |490 |– |
| |19461 |Syrup 100m 1 |– |– |11,164 |– |
| |19462 |Syrup 200m 1 |– |– |1,048 |– |
|R05CA10 |SENEGA |and AMMONIA | | | | |
| |4074 |Mixture 200mL |– |– |15,194 |116,789 |
| |19447 |Mixture 200mL |– |– |5,075 |– |
MUCOLYTICS
R05CB02 BROMHEXINE HYDROCHLORIDE with GUAIPHENESIN with PSEUDOEPHEDRINE
19467 Syrup 200mL – – 1,263 –
R05CB02 BROMHEXINE HYDROCHLORIDE with PSEUDOEPHEDRINE
19466 Syrup 250mL – – 2,535 –
cough suppressants, Binations With eXpectorants
OPIUM ALKALOIDS AND DERIVATIVES
R05DA04 CODEINE
R05DA20 CODEINE WITH PSEUDOEPHEDRINE with PHENYLEPHRINE
19650 Mixture 100mL 1 – – 4,640 –
R05DA20 CODEINE with PARACETAMOL with PSEUDOEPHEDRINE
R05DA20
R05DA20
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
COUGH AND COLD PREPARATIONS
cough suppressants, Binations With eXpectorants
OPIUM ALKALOIDS AND DERIVATIVES
R05DA20 DEXTROMETHORPHAN with PSEUDOEPHEDRINE
19460 Capsules 12 – – 504 –
R05DA08 PHOLCODINE
R05DA20 PHOLCODINE with PSEUDOEPHEDRINE
13367 Mixture 200mL 1 50.00 MG 3,868 –
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
ANTIHISTAMINES FOR SYSTEMIC USE
antihistamines for sYstemic use
AMINOALKYL ETHERS
R06AA02 DIMENHYDRINATE
|10683 |Tablet 50mg 10 |300.00 |MG |454 |– |
|10684 |Syrup 2.5mg/mL 50mL |300.00 |MG |1,500 |– |
|R06AA02 |DIPHENHYDRAMINE | | | | |
| |15912 Capsule 50mg 8 |200.00 |MG |8,264 |– |
|R06AA52 |DIPHENHYDRAMINE with AMMONIUM CHLORIDE | | | | |
| |10194 Mixture 100mL 1 |– |– |5,291 |– |
| |10196 Mixture 500mL 1 |– |– |842 |– |
| |13099 Mixture 200mL 1 |– |– |5,793 |– |
|R06AA52 |DIPHENHYDRAMINE with PHENYLEPH | | | | |
| |11694 200mL 1 |– |– |2,441 |– |
|R06AA09 |DOXYLAMINE | | | | |
| |13003 Tablet 25mg 20 |– |– |40,784 |– |
| |14123 Capsule 25mg 20 |– |– |25,350 |– |
SUBSTITUTED ALKYLAMINES
R06AB01 BROMPHENIRAMINE
16130 Drops 50mL 1 – – 18,905 –
R06AB51 BROMPHENIRAMINE COMBINATIONS
R06AB54 CHLORPHENIRAMINE with CODEINE with PARACETAMOL with PSEUDOEPHRINE
19679 Tablets 24 – – 88,206 –
R06AB54 CHLORPHENIRAMINE with CODINE with PARACETAMOL WITH PSEUDOEPHEDRINE
19479 Tablet 24 – – 11,108 –
19480 Capsule 24 – – 49,315 –
R06AB54 CHLORPHENIRAMINE with CODINE with PARACETAMOLwith PSEUDOEPHEDRINE
19468 Tablet 30 – – 28,494 –
19470 Tablet 60 – – 4,054 –
R06AB54 CHLORPHENIRAMINE with DEXTROMETHORPHAN WITH PARACETAMOL WITH PSEUDOEPHEDRINE
19486 Sachets 10 – – 3,265 –
19489 Tablets 24 – – 5,572 –
R06AB54 CHLORPHENIRAMINE with DEXTROMETHORPHAN with PARACETAMOL with PSEUDOEPHRINE
19547 Capsules 24 – – 4,616 –
R06AB54 CHLORPHENIRAMINE with DEXTROMETHORPHAN with PSEUDOEPHEDRINE
19473 Mixture 200 mL – – 152 –
19476 Liquid 100mL – – 154 –
R06AB54 CHLORPHENIRAMINE with PARACETAMOL
18516 Tablets 2mg/500mg 24 – – 3,237 –
R06AB54 CHLORPHENIRAMINE with PARACETAMOL with PSEUDOEPHEDRINE
19475 Tablet 24 – – 17,487 –
19502 Tablets 24 – – 4,062 –
19506 Tablets 24 – – 6,280 –
19517 Tablets 24 – – 262 –
| R | |
| | | | | |2006 | |
|atc |code |form and strength |ddd |units |scripts |cost($) |
RESPIRATORY SYSTEM
ANTIHISTAMINES FOR SYSTEMIC USE
antihistamines for sYstemic use
SUBSTITUTED ALKYLAMINES
R06AB54 CHLORPHENIRAMINE with PHENYLEPHRINE
R06AB54
R06AB54
R06AB54 CHLORPHENIRAMINE with PSEUDOEPHREDINE with PARACETAMOL
14784 Tablet 14 – – 1,540 –
R06AB54 CHLORPHENIRAMINE with PSEUDOEPHRINE
19532 Tablets 12 – – 63,893 –
R06AB02 DEXCHLORPHENIRAMINE
R06AB52 DEXCHLORPHENIRAMINE with PHENYLEPHRINE
10608 Tablet 18 – – 9,495 –
|R06AB52 |DEXCHLORPHENIRAMINE with PSEUDOEPHEDRINE with GUA | | |
| |19050 Tablet 12 – – |3,134 |– |
|R06AB05 |PHENIRAMINE | | |
| |10066 Tablet 50mg 10 75.00 MG |1,177 |– |
| |13917 Tablet 50mg 75.00 MG |4,878 |– |
PHENOTHIAZINE DERIVATIVES
R06AD04 METHDILAZINE HYDROCHLORIDE
R06AD02
R
2006
atc code form and strength ddd units scripts cost($)
RESPIRATORY SYSTEM
ANTIHISTAMINES FOR SYSTEMIC USE
antihistamines for sYstemic use
PHENOTHIAZINE DERIVATIVES
R06AD52 PROMETHAZINE with PHOLCODINE
R06AD01
R06AE07
OTHER ANTIHISTAMINES FOR SYSTEMIC USE
R06AX09 AZATADINE MALEATE
|12579 |Tablet 1mg 20 |2.00 |MG |1,096 |– |
|12814 |Tablet 1mg 50 |2.00 |MG |1,598 |– |
|R06AX02 |CYPROHEPTADINE HYDROCHLORIDE | | | | |
| |1798 Tablet 4mg |12.00 |MG |88,844 |1,042,079 |
|R06AX27 |DESLORATADINE | | | | |
| |18720 Tablet 5mg 28 |5.00 |MG |466 |– |
| |18721 Tablet 5mg 7 |5.00 |MG |640 |– |
|R06AX26 |FEXOFENADINE | | | | |
|4237 |Capsule 60mg |0.12 |GM |6,342 |286,889 |
|4238 |Tablet 120mg |0.12 |GM |14,427 |558,545 |
|16141 |Tablet 120mg 10 |0.12 |GM |752 |– |
|16142 |Tablet 180mg 10 |0.12 |GM |3,911 |– |
|16266 |Tablet 180mg 30 |0.12 |GM |1,229 |– |
|18893 |Tablet 120mg 10 |0.12 |GM |157 |– |
|18895 |Tablet 180mg 30 |0.12 |GM |183 |– |
|R06AX13 LORATADINE |
|4313 |Tablet 10mg |10.00 |MG |43,074 |1,827,126 |
|13978 |Tablet 10mg |10.00 |MG |7,549 |– |
|14513 |Syrup 100mL |10.00 |MG |2,002 |– |
|16908 |Syrup 1mg/mL 200mL |10.00 |MG |145 |– |
|18283 |Tablet 10mg 50 |10.00 |MG |240 |– |
|19685 |Tablet 10mg |10.00 |MG |377 |– |
|R06AX13 LORATADINE with PSEUDOEPHEDRINE |
|15405 |Tablet 10 |10.00 |MG |4,991 |– |
|16281 |Tablet 10 |10.00 |MG |2,400 |– |
S
2006
atc code form and strength ddd units scripts cost($)
SENSORY ORGANS
OPHTHALMOLOGICALS
antiinfectiVes
ANTIBIOTICS
S01AA01 CHLORAMPHENICOL
S01AA11 GENTAMICIN SULPHATE
1441 Eye drops 3mg (base) per mL (0.3%) 5mL – – 10,681 181,217
S01AB04 SULPHACETAMIDE
2063 Eye drops 100mg per mL (10%) 15mL – – 33,456 375,016
ANTIVIRALS
S01AD03 ACICLOVIR
1002 Eye ointment 30mg per g (3%) 4.5g – – 41,739 963,210
OTHER ANTIINFECTIVES
S01AX13 CIPROFLOXACIN
S01AX11
antiinfLammatorY agents
CORTICOSTEROIDS, PLAIN
|S01BA01 |DEXAMETHASONE | | | | |
| |1288 Eye drops 1mg per mL (0.1%) 5mL |– |– |173,518 |1,513,904 |
|S01BA07 |FLUOROMETHOLONE | | | | |
| |1204 Eye drops 1mg per mL (0.1%) 5mL |– |– |242,197 |2,113,751 |
| |1438 Eye drops 1mg per mL (0.1%) 5mL |– |– |49,554 |432,145 |
|S01BA02 |HYDROCORTISONE | | | | |
| |1492 Eye drops 10mg per mL (1%) 10mL |– |– |146 |1,590 |
| |1497 Eye ointment 5mg per g (0.5%) 5g |– |– |19,062 |197,938 |
| |2441 Eye ointment 10mg per g (1%) 5g |– |– |39,563 |418,692 |
|S01BA04 |PREDNISOLONE | | | | |
| |14678 Minims 0.5% 20 |– |– |2,165 |– |
CORTICOSTEROIDS AND SYMPATHOMIMETICS IN COMB
S01BB02 PREDNISOLONE ACETATE with PHENYLEPHRINE HYDROCHLORIDE
3112 Eye drops 10mg-1.2mg per mL (1%-0.12%) 10mL – – 255,506 5,122,354
S
2006
atc code form and strength ddd units scripts cost($)
SENSORY ORGANS
OPHTHALMOLOGICALS
antiinfLammatorY agents
ANTIINFLAMMATORY AGENTS, NON-STEROIDS
S01BC03 DICLOFENAC
|8329 |Eye drops 0.1% 5mL |– |– |26,348 |330,468 |
|15226 |Eye drops 0.1% |– |– |720 |– |
|19829 |Eye drops 5mg/5mL (0.1%) 1 .3mL, 5 |– |– |1,415 |– |
|S01BC04 |FLURBIPROFEN | | | | |
| |8699 Eye drops 300ug per mL(0.03%) single dose 0.4mL 5 |– |– |2,201 |29,308 |
|S01BC05 |KETOROLAC TROMETAMOL | | | | |
| |16800 Eye drops 0.5% 5mL |– |– |18,852 |– |
antigLaucoma preparations and miotics
SYMPATHOMIMETICS IN GLAUCOMA THERAPY
|S01EA03 |APRACLONIDINE | | | | |
| |8083 Eye drops 5mg (base) per mL (0.5%) 10mL |1.50 |MG |7,005 |253,747 |
|S01EA05 |BRIMONIDINE | | | | |
| |8351 Eye drops 2mg per mL (0.2%) 5mL |0.40 |MG |205,546 |3,973,199 |
|S01EA02 |DIPIVEFRINE | | | | |
| |1351 Eye drops 1mg per mL (0.1%) 10mL |0.20 |MG |10,124 |212,791 |
PARASYMPATHOMIMETICS
S01EB02 CARBACHOL
S01EB01
CARBONIC ANHYDRASE INHIBITORS
|S01EC01 |ACETAZOLAMIDE | | | | |
| |1004 Tablet 250mg |0.75 |GM |33,967 |657,489 |
|S01EC04 |BRINZOLAMIDE | | | | |
| |8483 Eye drops 10mg per mL (1%) 5mL |2.00 |MG |123,091 |2,383,276 |
|S01EC03 |DORZOLAMIDE | | | | |
| |8488 Eye drops 20mg per mL (2%) 5mL |6.00 |MG |56,798 |1,100,907 |
S
2006
atc code form and strength ddd units scripts cost($)
SENSORY ORGANS
OPHTHALMOLOGICALS
antigLaucoma preparations and miotics
BETA BLOCKING AGENTS
S01ED02 BETAXOLOL HYDROCHLORIDE
|2811 |Eye drops 2.5mg (base) per mL(0.25%) 5mL |0.50 |MG |118,600 |1,550,668 |
|2825 |Eye drops 5mg (base) per mL (0.5%) 5mL |1.00 |MG |53,022 |693,934 |
|S01ED51 |BRIMONIDINE TARTRATE with TIMOLOL MALEATE | | | | |
| |8826 Eye drops 2mg-5mg (base) per mL (0.2-0.5%) 5mL |– |– |70,609 |1,929,455 |
|S01ED51 |LATANOPROST with TIMOLOL MALEATE | | | | |
| |4300 Eye drops 50ug 5mg per mL (0.005%-0.5%) 2.5mL |– |– |4,128 |185,710 |
| |8895 Eye drops 50ug 5mg per mL (0.005%-0.5%), 2.5 mL |– |– |108,324 |4,695,009 |
|S01ED03 |LEVOBUNOLOL | | | | |
| |1819 Eye drops 2.5mg per mL (0.25%) 5mL |0.50 |MG |29,232 |350,844 |
|S01ED01 |TIMOLOL MALEATE | | | | |
| |1278 Eye drops 2.5mg (base) per mL (0.25%) 5mL |0.50 |MG |63,666 |762,799 |
| |1279 Eye drops 5mg (base) per mL (0.5% ) 5mL |1.00 |MG |383,989 |5,013,563 |
| |1925 Eye drops (gellan gum solution) 2.5mg (base) |0.50 |MG |32,124 |385,950 |
| |1926 Eye drops (gellan gum solution) 5mg (base) |1.00 |MG |193,404 |2,530,467 |
| |8803 Eye gel 1mg (base) per g (0.1%) 5g |– |– |60,385 |724,502 |
|S01ED51 |TIMOLOL MALEATE with PILOCARPINE HYDROCHLORIDE | | | |
| |8567 Eye drops 5mg-20mg per mL (0.5%- 2%) 5mL – |– |277,144 |7,598,239 |
|S01ED51 |TRAVAPROST WITH TIMOLOL | | | |
| |9057 Eye drops 0.04-5mg (base)per mL(0.004-0.5%)2.5mL – |– |886 |38,253 |
PROSTAGLANDIN ANALOGUES
S01EE03 BIMATOPROST
S01EE01
OTHER ANTIGLAUCOMA PREPARATIONS
S01EX04 TRAVOPROST
8597 Eye drops 0.040mg per mL (0.004%) – – 146,496 5,288,482
mYdriatics and cYcLopLegics
ANTICHOLINERGICS
S01FA01 ATROPINE SULPHATE
|1093 |Eye drops 10mg per mL (1%) 15mL |– |– |18,797 |181,339 |
|18561 |Eye drops 5mg per mL (0.5%) 15mL |– |– |518 |– |
|S01FA04 |CYCLOPENTOLATE | | | | |
| |10596 Eye drops 1%15mL 1 |– |– |128 |– |
|S01FA05 |HOMATROPINE HYDROBROMIDE | | | | |
| |2541 Eye drops 20mg per mL (2%) 15mL |– |– |12,707 |193,043 |
| |2542 Eye drops 50mg per mL (5%) 15mL |– |– |564 |10,431 |
| |19627 Eye drops 50mg per mL (5%) 15mL |– |– |549 |– |
|S01FA06 |TROPICAMIDE | | | | |
| |11192 Eye drops 0.5% 1 |– |– |123 |– |
SYMPATHOMIMETICS EXCL. ANTIGLAUCOMA PREPARATIONS
S01FB01 PHENYLEPHRINE
|13252 |Eye drops 0.12% 1 |– |– |162 |– |
|16103 |Eye drops 1 |– |– |224 |– |
S
2006
atc code form and strength ddd units scripts cost($)
SENSORY ORGANS
OPHTHALMOLOGICALS
decongestants and antiaLLergics
SYMPATHOMIMETICS USED AS DECONGESTANTS
S01GA51 ANTAZOLINE with NAPHAZOLINE
|4031 |Eye drops 5mg (sulphate)-250ug (nitrate) |– |– |6,681 |81,340 |
|4032 |Eye drops 5mg (phosphate)-500ug |– |– |186 |2,245 |
|S01GA01 |NAPHAZOLINE | | | | |
| |4035 Eye drops 1mg per mL (0.1%) 15mL |– |– |1,775 |21,323 |
|S01GA51 |NAPHAZOLINE COMBINATIONS | | | | |
| |4355 Eye drops 250ug-3mgper mL (0.025%-0.3%) 15mL |– |– |3,302 |41,057 |
|S01GA55 |PHENYLEPHRINE HYDROCHLORIDE with ZINC SULPHATE | | | |
| |4034 Eye drops 2.5mg-1.2mg per mL (0.25%-0.12%) 15mL – |– |1,291 |14,787 |
|S01GA02 |TETRAHYDROZOLINE | | | |
| |12179 Eye drops 0.05% 15mL 1 – |– |250 |– |
| |12197 Eye drops plus 15mL 1 – |– |514 |– |
OTHER ANTIALLERGICS
S01GX08 KETOTIFEN
|18722 |Eye drops 250mg (base) per mL 2.5mL |– |– |2,695 |– |
|18723 |Eye drops 250mg (base) per mL 5mL |– |– |9,588 |– |
|19791 |Eye drops 250mg (base) per mL 2.5mL |– |– |1,758 |– |
|19792 |Eye drops 250mg (base) per mL 2.5mL |– |– |280 |– |
|S01GX02 |LEVOCABASTINE | | | | |
| |4310 Eye drops 500ug per mL (0.05%) 4mL |– |– |5,454 |89,625 |
|S01GX05 |LODOXAMIDE | | | | |
| |8268 Eye drops 0.1% 10mL |– |– |3,101 |45,335 |
| |19726 Eye drops 0.1% 10mL |– |– |583 |– |
|S01GX01 |SODIUM CROMOGLYCATE | | | | |
| |1127 Eye drops 20mg per mL (2%) 10mL |– |– |24,426 |341,745 |
S
2006
atc code form and strength ddd units scripts cost($)
SENSORY ORGANS
OPHTHALMOLOGICALS
other ophthaLmoLogicaLs OTHER OPHTHALMOLOGICALS S01XA20 ARTIFICIAL TEARS
8548 Eye drops 5mg per mL (0.5%) 15mL – – 420,594 3,826,824
|S01XA20 |ARTIFICIAL TEARS and OTHER INDEFFERENT PREPARATIONS | | |
| |8564 Ocular lubricating gel 2mg-3mg per g (0.2%-0.3%) – – |96,725 |883,622 |
|S01XA20 |ARTIFICIAL TEARS and OTHER INDIFFERS | | |
| |8676 Eye drops 4mg-3mg per mL (0.4%-0.3%) 15mL – – |310,357 |2,821,572 |
|S01XA20 |CARBOMER 940 | | |
| |8384 Ocular lubricating gel 2mg per g (0.2%) 10g – – |186,019 |1,711,434 |
| |8514 Ocular lubricating gel 3mg per g (0.3%) 30 – – |18,792 |653,358 |
|S01XA20 |CARBOMER 980 | | |
| |8578 Eye drops 2mg per g (0.2%) single dose units – – |4,620 |162,608 |
|S01XA20 |CARMELLOSE SODIUM | | |
| |2324 Eye drops 10mg per mL (1%) single dose units – – |15,448 |550,698 |
| |2338 Eye drops 5mg per mL (0.5%) single dose units – – |80,349 |2,838,772 |
| |8593 Eye drops 10mg per mL (1%) 15mL – – |121,163 |1,102,606 |
| |8823 Eye drops 2.5mg per mL (0.25%) single dose 0.6mL – – |3,541 |129,353 |
| |8824 Ocular lub gel 10mg per mL (1%) single unit 0.6mL – – |1,478 |48,326 |
|S01XA20 |HYPROMELLOSE | | |
| |1509 Eye drops 3mg-1mg per mL (0.3%-0.1%) 15mL – – |619,911 |5,651,953 |
| |2956 Eye drops 5mg per mL (0.5%) 15mL – – |29,579 |268,983 |
| |8287 Eye drops 3mg-1mg per mL (0.3%) 15mL – – |131,117 |1,192,218 |
|S01XA20 |HYPROMELLOSE with DEXTRAN | | |
| |8299 Eye drops (0.3%-0.1%) single dose 0.4mL 28 – – |48,640 |1,617,101 |
|S01XA20 |PARAFFIN | | |
| |1750 Compound eye ointment 7g – – |149,674 |2,901,935 |
| |1754 Compound eye ointment 3.5g – – |20,068 |371,544 |
| |10757 Eye ointment 3.5g 1 – – |415 |– |
|S01XA20 |POLYVINYL ALCOHOL | | |
| |2681 Eye drops 30mg per mL (3%) 15mL – – |30,412 |277,058 |
| |2682 Eye drops 14mg per mL (1.4%) 15mL – – |134,130 |1,222,474 |
| |8831 Eye drops 14mg per mL (1.4%) 15mL – – |1,186 |10,733 |
| |8832 Eye drops 30mg per mL (3%) 15mL – – |724 |6,611 |
S
2006
atc code form and strength ddd units scripts cost($)
SENSORY ORGANS
OTOLOGICALS
antiinfectiVes
ANTIINFECTIVES
|S02AA10 |ACETIC ACID | | | | |
| |10103 Ear drops 35mL 1 |– |– |238 |– |
|S02AA01 |CHLORAMPHENICOL | | | | |
| |1172 Ear drops (aqueous) 5mg per mL (0.5%) 5mL |– |– |17,208 |164,545 |
|S02AA15 |CIPROFLOXACIN | | | | |
| |19900 Eye drops 3mg per mL (0.3%) 5mL 1 |– |– |143 |– |
|S02AA30 |NEOMYCIN UNDECENOATE with BACITRACIN ZINC | | | | |
| |2296 Ear ointment 12mg (3.5mg base)-400 units per g |– |– |113,143 |816,747 |
corticosteroids and antiinfectiVes in comBination
CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
|S02CA06 |DEXAMETHASONE with FRAMYCETIN SULPHATE and GRAMICIDIN | |
| |2781 Ear drops 500ug-5mg-50ug per mL – – 524,896 |3,861,939|
|S02CA02 |FLUMETHASONE PIVALATE with CLIOQUINOL | |
| |15097 Ear drops 200ug-10mg per mL (0.02%-1%) – – 50,447 |– |
|S02CA03 |HYDROCORTISONE with CIPROFLOXACIN | |
| |4528 Ear drops 2mg/10mg per mL(0.2-1%) 10mL – – 99,849 |2,738,251|
|S02CA04 |TRIAMCINOLONE ACETONIDE with NEOMYCIN SULPHATE GRAMICIDIN and NYSTATIN | |
| |2971 Ear drops 1mg-2.5mg (base)-250ug-per mL – – 145,189 | |
| | |1,070,047|
| |2974 Ear ointment 1mg-2.5mg (base)-250ug- per mL – – 405,418 |2,795,861|
other otoLogicaLs
ANALGESICS AND ANESTHETICS
S02DA PHENAZONE with BENZOCAINE
10094 Ear drops 10mL 1 – – 787 –
INDIFFERENT PREPARATIONS
|S02DC |CARBAMIDE PEROXIDE | | | |
| |4176 Ear drops 65mg per mL (6.5%) 10mL – |– |4,892 |62,097 |
|S02DC |DICHLOROBENZENE CHLORBUTOL and TURPENTINE OIL | | | |
| |4180 Ear drops 20mg-50mg-0.1mL per mL (2%-5%-10%) 11mL – |– |7,404 |91,668 |
|S02DC |DOCUSATE SODIUM | | | |
| |4199 Ear drops 50mg per mL (5%) 10mL – |– |13,679 |174,261 |
SENSORY ORGANS
OPTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
antiinfectiVes
ANTIINFECTIVES
S03AA FRAMYCETIN SULPHATE
1440 Eye and ear drops 5mg per mL (0.5%) 8 mL – – 70,169 553,168
V
2006
atc code form and strength ddd units scripts cost($)
VARIOUS
ALLERGENS ALLERGENS ALLERGEN EXTRACTS
V01AA07 INSECT ALLERGEN EXTRACT -HONEY BEE VENOM
2886 Injection set containing 550ug – – 2,607 533,117
V01AA07 INSECT ALLERGEN EXTRACT -PAPER WASP VENOM
2918 Injection set containing 550ug – – 412 84,434
V
2006
atc code form and strength ddd units scripts cost($)
VARIOUS
ALL OTHER THERAPEUTIC PRODUCTS
aLL other therapeutic products
ANTIDOTES
V03AB15 NALOXONE HYDROCHLORIDE
|3481 |Injection 800ug in 2mL |– |– |2,643 |231,754 |
|3482 |Injection 2mg in 5mL |– |– |11,942 |693,187 |
IRON CHELATING AGENTS
V03AC02 DEFERIPONE
V03AC01
DRUGS FOR TREATMENT OF HYPERKALEMIA
V03AE01 SODIUM POLYSTYRENE SULPHONATE
|4470 |Oral powder 454g |– |– |3,891 |253,098 |
|17376 |Oral powder 300g |– |– |1,022 |– |
DETOXIFYING AGENTS FOR CYTOSTATIC TREATMENT
V03AF03 CALCIUM FOLINATE
| |2308 |Tablet 15mg |60.00 |MG |5,887 |633,222 |
| |5886 |Injection equiv to 100mg folinic acid in 10mL |60.00 |MG |1,954 |310,999 |
| |5890 |Injection equiv to 50mg folinic acid in 5mL |60.00 |MG |6,380 |654,383 |
| |8740 |Injection equiv to 50mg folinic acid in 5mL |60.00 |MG |13,717 |2,524,357 |
| |8812 |Injection equiv to 100mg folinic acid in 10mL |60.00 |MG |4,920 |1,400,438 |
|V03AF01 |MESNA | | | | | |
| |5961 |Solution for I.V. injection 1g in 10mL |– |– |139 |7,390 |
| |8078 |Solution for I.V. injection 400mg in 4mL |– |– |158 |9,783 |
| |8079 |Solution for I.V. injection 1g in 10mL |– |– |1,231 |185,656 |
DRUGS FOR TREATMENT OF HYPERCALCEMIA
V03AG SODIUM ACID PHOSPHATE
2946 Tablet containing 500mgP-469mgNa-123mgK – – 2,964 268,607
-----------------------
|1121 |Mouth and throat rinse 22.5mg per 15mL 500mL |– |– |6,266 |112,084 |
|13467 |Gel 3% 30g 1 |– |– |267 |– |
|13757 |Gel 3% 75g 1 |– |– |367 |– |
|14683 |Solution 0.15% 200mL |– |– |303 |– |
|BENZYDAMINE with CHLORHEXIDINE |
|14358 |Solution 100mL |– |– |226 |– |
|14359 |Solution 200mL |– |– |349 |– |
|1156 |Effervescent tablet 800mg (as hydrochloride) |0.80 |GM |1,116 |30,705 |
|1157 |Tablet 200mg |0.80 |GM |3,095 |79,218 |
|1158 |Tablet 400mg |0.80 |GM |33,260 |866,036 |
|1159 |Tablet 800mg |0.80 |GM |4,125 |112,157 |
|8901 |Effervescent tablet 800mg (as hydrochloride) |0.80 |GM |113 |5,510 |
|FAMOTIDINE |
|2487 |Tablet 20mg |40.00 |MG |90,564 |1,857,485 |
|2488 |Tablet 40mg |40.00 |MG |81,894 |1,789,201 |
|19219 |Tablet 20mg |40.00 |MG |119 |– |
|19220 |Tablet 40mg |40.00 |MG |163 |– |
|NIZATIDINE |
|1504 |Capsules 300mg 30 |0.30 |GM |31,854 |809,370 |
|1505 |Capsules 150mg 30 |0.30 |GM |77,505 |1,873,494 |
|RANITIDINE HYDROCHLORIDE |
|1937 |Effervescent tablet 150mg (base) |0.30 |GM |51,468 |1,099,594 |
|1977 |Tablet 300mg (base) |0.30 |GM |282,697 |6,167,377 |
|1978 |Tablet 150mg (base) |0.30 |GM |930,048 |19,575,867 |
|4978 |Effervescent tablet 150mg (base) |0.30 |GM |437 |11,049 |
|4980 |Syrup 150mg (base) per 10mL 300mL |0.30 |GM |636 |14,935 |
|8162 |Syrup 150mg (base) per 10mL 300mL |0.30 |GM |20,865 |394,727 |
|8903 |Effervescent tablet 150mg (base) |0.30 |GM |1,511 |38,829 |
|8905 |Syrup 150mg (base) per 10mL 300mL |0.30 |GM |291 |7,130 |
|12268 |Ampoule 50mg/2mL 5 |0.30 |GM |362 |– |
|17164 |Tablet 150mg 14 |0.30 |GM |299 |– |
|8600 |Tablet 20mg (enteric coated) 30 |30.00 |MG |2,371,487 |97,671,425 |
|8601 |Tablet 40mg (enteric coated) 30 |30.00 |MG |1,627,844 |108,071,082 |
|8886 |Tablet 20mg (enteric coated) 30 |30.00 |MG |68,266 |2,693,722 |
|LANSOPRAZOLE |
|2240 |Capsule 30mg |30.00 |MG |33,034 |1,355,183 |
|2241 |Capsule 30mg |30.00 |MG |790,048 |35,119,449 |
|8198 |Capsule 15mg |30.00 |MG |18,248 |488,364 |
|8528 |Sachet for oral suspension 30mg |30.00 |MG |2,801 |109,971 |
|8529 |Sachet for oral suspension 30mg |30.00 |MG |14,698 |620,004 |
|9731 |Sachet for oral suspension 30mg 28 |30.00 |MG |356 |20,536 |
|9732 |Sachet for oral suspension 30mg 28 |30.00 |MG |388 |16,759 |
|9733 |Sachet for oral suspension 30mg 28 |30.00 |MG |3,495 |148,739 |
|OMEPRAZOLE |
|1326 |Capsule 20mg |20.00 |MG |21,830 |697,901 |
|1327 |Capsule 20mg |20.00 |MG |207,391 |8,396,041 |
|8331 |Tablet 20mg (as magnesium salt) 30 |20.00 |MG |124,357 |4,433,858 |
|8332 |Tablet 10mg (as magnesium salt) 30 |20.00 |MG |61,172 |1,700,081 |
|8333 |Tablet 20mg (as magnesium salt) 30 |20.00 |MG |3,582,131 |143,888,289 |
|PANTOPRAZOLE |
|8007 |Tablet (enteric coated) equivalent to 40mg |40.00 |MG |278,170 |11,474,102 |
|8008 |Tablet (enteric coated) equivalent to 40mg |40.00 |MG |2,340,162 |102,788,376 |
|8399 |Tablet (enteric coated) equivalent to 20mg |40.00 |MG |246,863 |6,165,843 |
|16667 |Tablet (enteric coated) equivalent to 40mg |40.00 |MG |702 |– |
|RABEPRAZOLE |
|8507 |Tablet 10mg 30 |20.00 |MG |40,354 |1,095,454 |
|8508 |Tablet 20mg 30 |20.00 |MG |1,391,936 |62,698,907 |
|8509 |Tablet 20mg 30 |20.00 |MG |207,179 |8,725,279 |
|8738 |Pack 14 tabs(ent coated)equiv 20mg esomeprazole |– |– |66,484 |6,422,522 |
|OMEPRAZOLE and CLARITHROMYCIN and AMOXYCILLIN |
|8272 |Pack 14 caps 20mg,14 tabs 500mg,28 caps 500mg |– |– |14,385 |1,390,102 |
|2014 |Oral liquid 1gm-320mg in 20mL 500mL |– |– |130,156 |1,694,035 |
|SUCRALFATE |
|2055 |Tablet 1g |4.00 |GM |12,952 |295,121 |
|4279 |Injection 20mg in 1mL |60.00 |MG |4,526 |126,309 |
|5317 |Injection 20mg in 1mL |60.00 |MG |1,796 |108,290 |
|5318 |Injection 20mg in 1mL |60.00 |MG |289 |14,360 |
|12939 |Tablet 10mg 100 |60.00 |MG |14,796 |– |
|15287 |Tablet 10mg |60.00 |MG |23,340 |– |
|1347 |Tablet 10mg |30.00 |MG |235,007 |2,531,773 |
|11309 |Tablet 10mg 100 |30.00 |MG |13,961 |– |
|5923 |Tablet 200mg |0.20 |GM |3,816 |149,412 |
|5924 |I.V. injection 100mg in 5mL |0.10 |GM |3,883 |76,179 |
|8191 |Tablet 200mg |0.20 |GM |20,125 |1,174,139 |
|8192 |I.V. injection 100mg in 5mL |0.10 |GM |9,768 |350,499 |
|GRANISETRON |
|5898 |Tablet 2mg (base) 2 |2.00 |MG |907 |42,766 |
|5899 |Concentrated injection 3mg (base) in 3mL |3.00 |MG |1,126 |29,192 |
|8728 |Tablet 2mg (base) 2 |2.00 |MG |15,555 |1,158,352 |
|8729 |Concentrated injection 3mg (base) in 3mL |3.00 |MG |19,355 |917,972 |
|8730 |Concentrated injection 3mg (base) in 3mL |3.00 |MG |276 |23,422 |
|8873 |Tablet 2mg (base) 5 |2.00 |MG |178 |39,965 |
|ONDANSETRON |
|1594 |Tablet 4mg |16.00 |MG |1,674 |230,686 |
|1595 |Tablet 8mg |16.00 |MG |2,835 |541,276 |
|1597 |I.V.injection 8mg in 4mL |16.00 |MG |470 |93,761 |
|5967 |Tablet 4mg |16.00 |MG |258 |9,898 |
|5968 |Tablet 8mg |16.00 |MG |8,612 |499,169 |
|5970 |Wafer 8mg 4 |16.00 |MG |1,075 |61,275 |
|5972 |I.V. injection 8mg in 4mL |16.00 |MG |7,327 |199,555 |
|8224 |Tablet 4mg |16.00 |MG |9,361 |509,242 |
|8225 |Tablet 8mg |16.00 |MG |42,791 |3,171,535 |
|8226 |I.V. injection 4mg in 2mL |16.00 |MG |2,212 |69,879 |
|8227 |I.V. injection 8mg in 4mL |16.00 |MG |33,023 |1,664,428 |
|8410 |Wafer 4mg 4 |16.00 |MG |9,723 |458,480 |
|8411 |Wafer 8mg 4 |16.00 |MG |11,852 |959,706 |
|8412 |Wafer 4mg 10 |16.00 |MG |1,735 |206,648 |
|8413 |Wafer 8mg 10 |16.00 |MG |2,364 |501,671 |
|TROPISETRON |
|2745 |Capsule 5mg (base) |5.00 |MG |31,719 |2,042,932 |
|2746 |I.V. injection 5mg/5mL |5.00 |MG |22,149 |866,582 |
|5986 |Capsule 5mg (base) |5.00 |MG |7,297 |300,828 |
|5987 |I.V. injection 5mg/5mL |5.00 |MG |9,159 |190,085 |
|4200 |Tablet 50mg |0.15 |GM |10,605 |117,448 |
|16099 |Tablet 120mg 100 |0.15 |GM |14,370 |– |
|4285 |Sachets 3.5g 30 |7.00 |GM |3,900 |58,827 |
|4419 |Oral powder(orange-flavour sugar free)315g |7.00 |GM |28,954 |579,102 |
|4422 |Oral powder (non-flavoured) 375g |7.00 |GM |26,887 |537,614 |
|11156 |Powder 500g 1 |7.00 |GM |1,777 |– |
|11273 |Powder 500g 1 |7.00 |GM |879 |– |
|STERCULIA with FRANGULA BARK |
|1104 |Granules 620mg-80mg per g (62%-8) 500g |– |– |90,283 |2,088,931 |
|3275 |Granules 620mg-80mg per g (62%-8) 500g |– |– |757 |25,696 |
|4558 |Granules 620mg-80mg per g (62%-8) 500g |– |– |12,517 |290,315 |
|13098 |Granules 200g 1 |– |– |287 |– |
|STERCULIA, COMBINATIONS |
|3064 |Mixture 3.34g per 5mL 500mL |6.70 |GM |383,378 |5,835,972 |
|5387 |Mixture 3.34g per 5mL 500mL 1 |6.70 |GM |2,711 |58,853 |
|5388 |Mixture 3.34g per 5mL 500mL 1 |6.70 |GM |640 |17,229 |
|2325 |Tablet 500mg |5.00 |GM |850 |19,165 |
|NYSTATIN |
|1696 |Tablet 500,000 units |1500.00 |TE |20,585 |382,980 |
|1699 |Capsule 500,000 units |1500.00 |TE |28,018 |580,558 |
|2501 |Tablet 2.5mg-25ug |15.00 |MG |275,579 |2,229,804 |
|11123 |Tablet 2.5mg-25ug |15.00 |MG |1,147 |– |
|16260 |Tablet 2.5mg-25ug |15.00 |MG |14,217 |– |
|LOPERAMIDE HYDROCHLORIDE |
|1571 |Capsule 2mg |10.00 |MG |279,507 |3,404,918 |
|16133 |Tablet 2mg 8 |10.00 |MG |1,771 |– |
|1502 |Rectal foam 125mg per applicator (10%) aerosol |– |– |14,419 |518,703 |
|PREDNISOLONE SODIUM PHOSPHATE |
|1920 |Retention enema equivalent to 20mg prednisolone |– |– |6,929 |850,484 |
|2554 |Suppositories equivalent to 5mg prednisolone 10 |– |– |7,871 |232,497 |
|1611 |Tablet 250mg |1.50 |GM |80,404 |11,098,609 |
|8598 |Oral granules 500mg per sachet 100 |1.50 |GM |3,132 |498,769 |
|8599 |Oral granules 1 mg per sachet 100 |1.50 |GM |19,292 |5,289,434 |
|8616 |Enemas 2g in 60mL 7 |1.50 |GM |1,952 |656,077 |
|8617 |Enemas 4g in 60mL 7 |1.50 |GM |5,768 |2,612,023 |
|8731 |Tablet 500mg (enteric coated) |1.50 |GM |27,853 |6,126,712 |
|8752 |Suppositories 1gm 28 |1.50 |GM |4,346 |556,289 |
|8753 |Enemas 1g in 100mL 7 |1.50 |GM |495 |162,456 |
|8768 |Rectal foam 1g per app, 14 apps aerosol 80g 4 |1.50 |GM |930 |307,908 |
|OLSALAZINE SODIUM |
|1728 |Capsule 250mg |1.00 |GM |7,687 |671,786 |
|8086 |Capsule 500mg |1.00 |GM |16,890 |2,306,742 |
|12053 |Tablet 25mg 50 |75.00 |MG |2,464 |– |
|12054 |Tablet 75mg 30 |75.00 |MG |20,905 |– |
|12055 |Tablet 75mg 100 |75.00 |MG |3,307 |– |
|PHENTERMINE |
|10636 |Capsule 15mg 30 |15.00 |MG |11,200 |– |
|10637 |Capsule 30mg 30 |15.00 |MG |57,943 |– |
|10638 |Capsule 40mg 30 |15.00 |MG |74,927 |– |
|SIBUTRAMINE |
|17447 |Capsule 10mg 30 |10.00 |MG |52,975 |– |
|17448 |Capsule 15mg 30 |10.00 |MG |61,805 |– |
|1711 |Injection 100 units per mL 10mL |40.00 |IE |1,213 |163,672 |
|INSULIN (HUMAN) |
|1533 |Injection 100 units per mL 10mL |40.00 |IE |42,650 |5,681,987 |
|1761 |Injection 100 units per mL 3mL 5 |40.00 |IE |107,808 |23,977,959 |
|9040 |Injection 100 units per mL 3mL 5 |40.00 |IE |6,703 |2,780,328 |
|19162 |Injection 100 units per mL 3mL 5 |40.00 |IE |2,142 |– |
|INSULIN GLARGINE |
|9039 |Injection 100 units per mL 3mL 5 |40.00 |IE |28,350 |11,225,986 |
|18352 |Injection 100 units per mL 3mL 5 |40.00 |IE |19,208 |– |
|18353 |Injection 100 units per mL 10mL |40.00 |IE |12,009 |– |
|8694 |Tablet 15mg (base) 28 |30.00 |MG |39,656 |2,474,457 |
|8695 |Tablet 30mg (base) 28 |30.00 |MG |92,240 |8,493,062 |
|8696 |Tablet 30mg (base) 28 |30.00 |MG |47,265 |5,540,135 |
|ROSIGLITAZONE |
|8689 |Tablet 4mg (base) 28 |6.00 |MG |228,151 |14,428,820 |
|8690 |Tablet 8mg (base) 28 |6.00 |MG |179,230 |16,429,531 |
|VITAMINS |
|11955 |Dispersible tablet 10 |– |– |187 |– |
|11956 |Dispersible tablet 20 |– |– |114 |– |
|16530 |Tablet 60 |– |– |271 |– |
|VITAMINS with IRON |
|11030 |Syrup 100m 1 |– |– |843 |– |
|11031 |Syrup 200m 1 |– |– |260 |– |
|2502 |Capsule 0.25ug |1.00 |UG |167,167 |9,157,987 |
|ERGOCALCIFEROL |
|16060 |Capsule 25ug 60 |– |– |56,862 |– |
58
A
|2593 |Injection 100mg (iron) in 2mL |0.10 |GM |38,181 |2,134,118 |
|SACCHARATED IRON OXIDE |
|8807 |Concent for soln for infus 2.7g =100mg iron in 5mL |0.10 |GM |150 |21,219 |
|9011 |Tablet 310mg-350ug |– |– |16,339 |172,841 |
|FERROUS SULPHATE DRIED with FOLIC ACID |
|14528 |Capsule 270mg-300ug (delayed release) |– |– |4,062 |– |
|18904 |Tablet 270mg-300ug (sustained release) |– |– |77,050 |– |
|12782 |Ampoule 1000ug/ 5 |20.00 |UG |765 |– |
|HYDROXOCOBALAMIN |
|1508 |Injection 1mg in 1mL |20.00 |UG |388,599 |4,694,645 |
|6320 |Injection 10ug in 0.4mL syringe 4 |4.50 |UG |277 |56,157 |
|6321 |Injection 20ug in 0.5mL syringe 4 |4.50 |UG |2,894 |1,157,335 |
|6322 |Injection 30ug in 0.3mL syringe 4 |4.50 |UG |2,853 |1,534,247 |
|6323 |Injection 40ug in 0.4mL syringe 4 |4.50 |UG |9,332 |6,614,750 |
|6324 |Injection 50ug in 0.5mL syringe 4 |4.50 |UG |1,302 |1,071,036 |
|6325 |Injection 60ug in 0.3mL syringe 4 |4.50 |UG |3,604 |3,723,282 |
|6326 |Injection 100ug in 0.5mL syringe |4.50 |UG |2,330 |4,193,475 |
|6365 |Injection 150ug in 0.3mL syringe |4.50 |UG |624 |1,492,437 |
|6438 |Injection 80ug in 0.4mL syringe 4 |4.50 |UG |1,337 |1,744,777 |
|6489 |Injection 40ug in 0.4mL prefilled injection pen 1 |4.50 |UG |198 |129,027 |
|ERYTHROPOIETIN |
|6205 |Injection 3,000 units in 0.3mL syringe |1.00 |TE |230 |148,394 |
|6206 |Injection 4,000 units in 0.4mL syringe |1.00 |TE |1,095 |762,507 |
|6207 |Injection 10,000 units in 1mL syringe |1.00 |TE |1,169 |1,800,916 |
|6302 |Injection 5,000 units in 0.5mL syringe |1.00 |TE |263 |252,894 |
|6303 |Injection 6,000 units in 0.6mL syringe |1.00 |TE |944 |923,690 |
|6305 |Injection 8,000 units in 0.8mL syringe |1.00 |TE |1,016 |1,260,656 |
|6339 |Injection 40,000 units in 1mL syringe |1.00 |TE |224 |609,974 |
60
62
|1322 |Tablet 250ug |0.25 |MG |191,247 |1,724,296 |
|2605 |Tablet 62.5ug |0.25 |MG |294,057 |2,565,330 |
|3164 |Oral solution for children 50ug per mL, |0.25 |MG |779 |18,852 |
|2923 |Capsule 100mg |0.40 |GM |8,263 |211,859 |
|2924 |Capsule 150mg |0.40 |GM |4,019 |137,657 |
|QUINIDINE |
|2623 |Tablet 250mg (sustained release) |1.20 |GM |7,902 |260,124 |
|19846 |Tablet 250mg (sustained release) 100 |1.20 |GM |213 |– |
|2875 |Injection 100mg in 5mL |3.00 |GM |325 |13,253 |
|2876 |Infusion 500mg in 5mL |3.00 |GM |358 |15,756 |
|3474 |Injection 100mg in 5mL |3.00 |GM |8,494 |292,364 |
|MEXILETINE HYDROCHLORIDE |
|1682 |Capsule 50mg |0.80 |GM |4,707 |150,165 |
|1683 |Capsule 200mg |0.80 |GM |3,670 |210,811 |
|GLYCERYL TRINITRATE |
|1459 |Tablets 600ug 100 |2.50 |MG |90,196 |778,109 |
|1515 |Td pad releasing approx. 5mg per 24 hours |5.00 |MG |243,761 |6,579,384 |
|1516 |Td pad releasing approx. 10mg per 24 hours |5.00 |MG |152,579 |5,175,240 |
|3475 |Buccal/sublingual spray (pump pack) 400ug per dose |2.50 |MG |21,652 |398,044 |
|8010 |Td patch releasing approx. 5mg per 24 hours |5.00 |MG |93,070 |2,508,601 |
|8011 |Td patch releasing approx. 10mg per 24 hours |5.00 |MG |54,611 |1,847,296 |
|8026 |Td patch releasing approx. 1mg per 24 hours |5.00 |MG |19,914 |676,087 |
|8027 |Td patch releasing approx. 5mg per 24 hours |5.00 |MG |11,786 |319,064 |
|8028 |Td patch releasing approx. 10mg per 24 hours |5.00 |MG |9,298 |315,906 |
|8119 |Td patch releasing approx. 15mg per 24 hours |5.00 |MG |5,502 |188,187 |
|8171 |Buccal/sublingual spray (pump pack) 400ug per dose |2.50 |MG |304,200 |5,569,771 |
|ISOSORBIDE DINITRATE |
|2587 |Tablet 10mg |60.00 |MG |23,154 |282,226 |
|2588 |Sublingual tablet 5mg |20.00 |MG |11,081 |145,452 |
|19186 |Tablet 20mg 100 |60.00 |MG |206 |– |
|ISOSORBIDE MONONITRATE |
|1558 |Tablets sustained release 60mg 30 |40.00 |MG |812,868 |11,003,495 |
|8273 |Tablets sustained release 120mg 30 |40.00 |MG |304,057 |7,618,275 |
64
|3141 |Tablet 150ug |0.45 |MG |32,125 |1,146,012 |
|3145 |Tablet 100ug |0.45 |MG |99,422 |2,668,459 |
|12786 |Ampoule 150ug/mL 5 |0.45 |MG |473 |– |
|MOXONIDINE |
|9019 |Tablet 200mg 30 |0.30 |MG |1,137 |20,321 |
|9020 |Tablet 400mg 30 |0.30 |MG |430 |11,719 |
|19449 |Tablet 0.2mg 30 |0.30 |MG |165 |– |
|1585 |Tablet 25mg |25.00 |MG |41,305 |495,989 |
|INDAPAMIDE |
|2436 |Tablet 2.5mg 90 |2.50 |MG |256,668 |4,968,520 |
|8532 |Tablet 1.5mg (sustained release) 90 |2.50 |MG |421,224 |8,332,084 |
|16435 |Tablet 1.5mg 30 |2.50 |MG |248 |– |
|17855 |Tablet 1mg |1.00 |MG |8,743 |– |
|FRUSEMIDE |
|2411 |Oral solution 10mg per mL 30mL |40.00 |MG |2,961 |46,123 |
|2412 |Tablet 40mg |40.00 |MG |1,242,775 |10,103,557 |
|2413 |Injection 20mg in 2mL |40.00 |MG |6,375 |81,113 |
|2414 |Tablet 20mg |40.00 |MG |196,458 |1,646,462 |
|2415 |Tablet 500mg |40.00 |MG |15,071 |313,497 |
|3466 |Injection 20mg in 2mL |40.00 |MG |9,699 |100,019 |
|8880 |Tablet 50mg 30 |50.00 |MG |237 |28,478 |
|SPIRONOLACTONE |
|2339 |Tablet 25mg |75.00 |MG |269,095 |3,447,991 |
|2340 |Tablet 100mg |75.00 |MG |63,062 |2,258,963 |
|1486 |Tablet 50mg-5mg |– |– |178,248 |2,010,220 |
|HYDROCHLOROTHIAZIDE with TRIAMTERENE |
|1280 |Tablet 25mg-50mg 100 |– |– |49,371 |559,155 |
66
|C05AA01 |HYDROCORTISONE with CINCHOCAINE HYDROCHLORIDE | | | |
| |4036 Ointment 5mg-5mg per g (0.5%-).5%),30g – |– |36,819 |669,433 |
|C05AA01 |HYDROCORTISONE, CINCHOCAINE HYDROCHLORIDE | | | |
| |4038 Suppositories 5mg-5mg 12 – |– |22,005 |393,486 |
| |14345 Ointment 5mg-5mg-10mg per g (0.5%-0.5%-1%) – |– |22,554 |– |
|12829 |Cream 0.3%40g 1 |– |– |654 |– |
|13774 |Cream 0.3% 20g 1 |– |– |1,396 |– |
|HEPARINOID with HYALURONIDASE |
|12830 |Ointment 14g 1 |– |– |596 |– |
|12831 |Ointment 40g 1 |– |– |303 |– |
|2942 |Tablet 20mg |0.16 |GM |2,494 |21,225 |
|2961 |Tablet 40mg |0.16 |GM |12,176 |128,169 |
|PINDOLOL |
|3062 |Tablet 5mg |15.00 |MG |28,916 |336,290 |
|3065 |Tablet 15mg |15.00 |MG |27,494 |404,452 |
|PROPRANOLOL HYDROCHLORIDE |
|2565 |Tablet 10mg |0.16 |GM |115,608 |922,485 |
|2566 |Tablet 40mg |0.16 |GM |302,957 |2,461,016 |
|2899 |Tablet 160mg |0.16 |GM |35,329 |322,785 |
|SOTALOL HYDROCHLORIDE |
|2043 |Tablet 160mg |0.16 |GM |136,351 |4,274,690 |
|8398 |Tablet 80mg 60 |0.16 |GM |291,793 |5,039,901 |
|8255 |Tablet 3.125mg 30 |37.50 |MG |46,036 |1,376,384 |
|8256 |Tablet 6.25mg |37.50 |MG |121,609 |9,059,939 |
|8257 |Tablet 12.5mg |37.50 |MG |143,671 |13,042,142 |
|8258 |Tablet 25mg |37.50 |MG |240,041 |27,204,427 |
|8742 |Pack 30 tab 3.125mg, 30 tab 6.25mg, 10 tab 12.5mg |37.50 |MG |840 |55,204 |
|16540 |Tablet 6.25mg 30 |37.50 |MG |188 |– |
|LABETALOL HYDROCHLORIDE |
|1566 |Tablet 100mg |0.60 |GM |17,244 |237,923 |
|1567 |Tablet 200mg |0.60 |GM |19,626 |418,391 |
|2751 |Tablet 5mg (base) besylate salt 3 0 |5.00 |MG |1,253,436 |25,836,715 |
|2752 |Tablet 10mg (base) besylate salt 30 |5.00 |MG |959,124 |31,036,240 |
|4985 |Tablet 5mg (base) besylate salt 3 0 |5.00 |MG |24,998 |672,825 |
|4986 |Tablet 10mg (base) besylate salt 30 |5.00 |MG |20,363 |811,366 |
|8923 |Tablet 5mg (base) besylate salt 3 0 |5.00 |MG |242,662 |6,568,697 |
|8924 |Tablet 10mg (base) besylate salt 30 |5.00 |MG |281,015 |11,310,783 |
|FELODIPINE |
|2361 |Tablet 2.5mg (extended release) |5.00 |MG |209,039 |3,258,800 |
|2366 |Tablet 5mg (extended release) |5.00 |MG |565,488 |11,122,308 |
|2367 |Tablet 10mg (extended release) |5.00 |MG |657,681 |21,309,031 |
|LERCANIPIDINE |
|4959 |Tablet 20mg 30 |10.00 |GM |4,881 |205,366 |
|4960 |Tablet 10mg 30 |10.00 |GM |7,348 |221,765 |
|8534 |Tablet 10mg 30 |10.00 |GM |743,548 |18,348,500 |
|8679 |Tablet 20mg 30 |10.00 |GM |443,889 |16,362,236 |
|8939 |Tablet 10mg 30 |10.00 |GM |69,597 |2,113,536 |
|8940 |Tablet 20mg 30 |10.00 |GM |52,401 |2,213,776 |
|NIFEDIPINE |
|1694 |Tablet 10mg 60 |30.00 |MG |35,462 |678,091 |
|1695 |Tablet 20mg 60 |30.00 |MG |48,611 |1,125,051 |
|1906 |Tablet 30mg (controlled release) 30 |30.00 |MG |443,961 |10,702,092 |
|1907 |Tablet 60mg (controlled release) 30 |30.00 |MG |367,349 |10,959,875 |
|4961 |Tablet 20mg (controlled release) 30 |30.00 |MG |890 |24,502 |
|8610 |Tablet 20mg (controlled release) 30 |30.00 |MG |107,786 |2,454,012 |
|8938 |Tablet 20mg (controlled release) 30 |30.00 |MG |7,090 |207,372 |
|1147 |Tablet 12.5mg |50.00 |MG |20,928 |406,419 |
|1148 |Tablet 25mg |50.00 |MG |45,029 |1,166,793 |
|1149 |Tablet 50mg |50.00 |MG |70,108 |3,291,195 |
|8760 |Oral solution 5mg per mL 95mL |50.00 |MG |516 |33,977 |
|ENALAPRIL MALEATE |
|1368 |Tablet 10mg |10.00 |MG |259,984 |5,625,241 |
|1369 |Tablet 20mg |10.00 |MG |481,034 |14,258,933 |
|1370 |Tablet 5mg |10.00 |MG |123,378 |1,826,510 |
|19864 |Tablet 5mg 30 |10.00 |MG |177 |– |
|FOSINOPRIL |
|1182 |Tablet 10mg 30 |15.00 |MG |186,446 |3,485,751 |
|1183 |Tablet 20mg |15.00 |MG |288,460 |7,999,370 |
|LISINOPRIL |
|2456 |Tablet 5mg 30 |10.00 |MG |160,450 |2,563,717 |
|2457 |Tablet 10mg 30 |10.00 |MG |290,213 |6,286,881 |
|2458 |Tablet 20mg 30 |10.00 |MG |484,134 |13,473,814 |
|PERINDOPRIL |
|3050 |Tablet 2mg 30 |4.00 |MG |815,708 |15,110,439 |
|3051 |Tablet 4mg 30 |4.00 |MG |1,422,118 |35,128,097 |
|8704 |Tablet 8mg 30 |4.00 |MG |689,579 |27,680,776 |
|9006 |Tablet 2.5mg 30 |4.00 |MG |309,925 |4,502,435 |
|9007 |Tablet 5mg 30 |4.00 |MG |585,926 |13,023,983 |
|9008 |Tablet 10mg 30 |4.00 |MG |339,469 |10,461,850 |
|19889 |Tablet 2mg 30 |4.00 |MG |1,175 |– |
|19890 |Tablet 4mg 30 |4.00 |MG |1,520 |– |
|QUINAPRIL |
|1968 |Tablet 5mg 30 |15.00 |MG |60,483 |1,012,603 |
|1969 |Tablet 10mg 30 |15.00 |MG |169,511 |3,691,267 |
|1970 |Tablet 20mg 30 |15.00 |MG |300,491 |8,537,242 |
|19873 |Tablet 5mg 30 |15.00 |MG |383 |– |
|19874 |Tablet 10mg 30 |15.00 |MG |601 |– |
|19875 |Tablet 20mg 30 |15.00 |MG |1,684 |– |
|RAMIPRIL |
|1944 |Capsule 1.25mg 28 |2.50 |MG |167,140 |2,188,098 |
|1945 |Capsule 2.5mg 28 |2.50 |MG |561,332 |9,418,499 |
|1946 |Capsule 5.0mg 28 |2.50 |MG |1,180,164 |24,229,473 |
|4951 |Tablet 1.25mg 30 |2.50 |MG |137 |2,218 |
|4952 |Tablet 5mg 30 |2.50 |MG |299 |5,625 |
|4953 |Tablet 2.5mg 30 |2.50 |MG |926 |25,139 |
|4962 |Capsule 10mg 30 |2.50 |MG |16,273 |552,977 |
|8470 |Capsule 10mg 30 |2.50 |MG |1,386,516 |42,641,799 |
|8668 |Pack 7 Tabs 2.5mg 21 tabs 5mg and 10 caps 10mg |2.50 |MG |4,465 |121,255 |
|8937 |Capsule 10mg 30 |2.50 |MG |161,760 |5,511,806 |
|8945 |Tablet 1.25mg 30 |2.50 |MG |567 |7,968 |
|8946 |Tablet 2.5mg 30 |2.50 |MG |2,035 |36,783 |
|8947 |Tablet 5mg 30 |2.50 |MG |6,438 |166,009 |
|8213 |Tablet 10mg |10.00 |MG |1,990,037 |82,812,084 |
|8214 |Tablet 20mg |10.00 |MG |3,475,228 |205,142,399 |
|8215 |Tablet 40mg |10.00 |MG |2,975,373 |241,301,714 |
|8521 |Tablet 80mg |10.00 |MG |1,068,247 |121,410,758 |
|C10AA04 FLUVASTATIN |
|8023 |Capsule 20mg (base) |40.00 |MG |39,420 |1,017,937 |
|8024 |Capsule 40mg (base) |40.00 |MG |61,644 |1,995,105 |
|C10AA03 PRAVASTATIN |
|2833 |Tablet 10mg 30 |20.00 |MG |138,532 |4,116,851 |
|2834 |Tablet 20mg 30 |20.00 |MG |578,879 |25,625,239 |
|8197 |Tablet 40mg 30 |20.00 |MG |1,133,173 |75,200,053 |
|8829 |Tablet 80mg 30 |20.00 |MG |97,442 |9,584,052 |
|C10AA07 ROSUVASTATIN |
|9042 |Tablet 5mg 30 |10.00 |MG |2,088 |105,890 |
|9043 |Tablet 10mg 30 |10.00 |MG |16,157 |1,133,664 |
|9044 |Tablet 20mg 30 |10.00 |MG |3,129 |306,251 |
|9045 |Tablet 40mg 30 |10.00 |MG |1,062 |145,663 |
|C10AA01 SIMVASTATIN |
| |2011 |Tablet 10mg |15.00 |MG |757,800 |26,699,852 |
| |2012 |Tablet 20mg |15.00 |MG |2,222,805 |107,711,039 |
| |2013 |Tablet 5mg |15.00 |MG |40,073 |1,078,182 |
| |8173 |Tablet 40mg |15.00 |MG |2,573,010 |173,725,747 |
| |8313 |Tablet 80mg |15.00 |MG |674,856 |64,012,492 |
|FIBRATES | | | | | | |
|C10AB05 FENOFIBRATE |
|8721 |Capsule 67mg 60 |0.20 |GM |12,106 |338,095 |
|8722 |Tablet 160mg 30 |0.20 |GM |116,139 |4,583,230 |
|9022 |Tablet 48mg 60 |0.20 |GM |1,937 |53,572 |
|9023 |Tablet 145mg 30 |0.20 |GM |34,149 |1,331,067 |
|19830 |Capsule 67mg 60 |0.20 |GM |522 |– |
|19831 |Tablet 160mg 30 |0.20 |GM |382 |– |
|4003 |Cream 10mg per g (1%) 15g |– |– |6,062 |93,533 |
|8066 |Cream 10mg per g (1%) 15g 2 |– |– |589 |16,949 |
|CLOTRIMAZOLE |
|1027 |Lotion 10mg per mL (1%) 20mL 2 |– |– |267 |4,260 |
|4004 |Cream 10mg per g (1%) 20g |– |– |19,385 |146,387 |
|4005 |Lotion 10mg per mL (1%) 20mL |– |– |2,944 |31,661 |
|15576 |Cream 10mg per g (1%) 50g |– |– |2,909 |– |
|15786 |Cream 10mg per g (1%) 50g |– |– |26,950 |– |
|16585 |Cream 10mg per g (1%) 20g |– |– |4,392 |– |
|17061 |Cream (vaginal) 100 mg per g (10%) |– |– |6,370 |– |
|1574 |Shampoo 20mg per mL (2%) 60mL |– |– |378 |6,329 |
|4007 |Shampoo 20mg per mL (2%) 100mL |– |– |413 |7,360 |
|4008 |Shampoo 20mg per mL (2%) 60mL |– |– |4,422 |76,811 |
|9024 |Shampoo 20mg per g (2%) 30g 1 |– |– |1,265 |34,004 |
|9025 |Shampoo 10mg per g (1%) 100mL |– |– |491 |7,956 |
|13472 |Cream 2% 30g 1 |– |– |1,918 |– |
|MICONAZOLE |
|4341 |Tincture 20mg per mL (2%), 20mL |– |– |2,401 |44,730 |
|9026 |Tincture 20mg per mL (2%), 15mL 2 |– |– |273 |3,780 |
|9027 |Cream 20mg per g (2%) 30g 1 |– |– |544 |8,127 |
|9028 |Cream 20mg per g (2%) 70g 1 |– |– |366 |7,072 |
|9030 |Lotion 20mg per mL (2%) 30g 1 1 |– |– |130 |1,954 |
|9031 |Tincture 20mg per mL (2%) 30mL 1 |– |– |295 |5,653 |
|14846 |Ointment 15g |– |– |395 |– |
|17964 |Cream 10mg per g (1%) 40g |– |– |4,179 |– |
|MICONAZOLE NITRATE |
|4009 |Cream 20mg per g (2%) 20g |– |– |136 |1,295 |
|4454 |Cream 20mg per g (2%) 30g |– |– |775 |10,230 |
|14052 |Cream 30mg per g (2%) 30g |– |– |1,428 |– |
|14053 |Lotion 30mg per mL (2%) 30g |– |– |275 |– |
|MICONAZOLE and HYDROCORTISONE |
|1460 |Tablet 125mg |0.50 |GM |3,266 |60,851 |
|2982 |Tablet 500mg |0.50 |GM |89,171 |1,720,024 |
|TERBINAFINE |
|2804 |Tablet 250mg (base) |0.25 |GM |93,034 |12,626,031 |
|4011 |Tablet 250mg (base) |0.25 |GM |3,403 |467,056 |
|4551 |Cream 150mg-20mg per g (15%-2%) 600g |– |– |234 |4,871 |
|4556 |Cream 150mg-20mg per g (15%-2%) 75g |– |– |195 |1,921 |
|SILICONE |
|10740 |Cream pump 1 |– |– |501 |– |
|LIGNOCAINE |
|12226 |Ointment 10%15g 1 |– |– |119 |– |
|12234 |Gel 2% 15mL 1 |– |– |1,823 |– |
|12239 |Ointment 5%15g 1 |– |– |1,038 |– |
|12240 |Ointment 5% 35g 1 |– |– |595 |– |
|LIGNOCAINE HYDROCHLORIDE and CARBOXYMETHYLCELLULOSE |
|4308 |Mucilage 20 mg-25 mg per mL (2%-2.5%), 200 mL |– |– |2,731 |210,733 |
|8291 |Ointment 0.005%, 30gm |– |– |92,339 |4,549,027 |
|14883 |Ointment 100gm |– |– |772 |– |
|15867 |Cream 30g |– |– |3,476 |– |
|15868 |Cream 100g |– |– |1,310 |– |
|16979 |Scalp Solution 30mL 50ug/mL |– |– |3,315 |– |
|TAZAROTENE |
|19647 |Cream 0.05% 30g 1 |– |– |750 |– |
|19648 |Cream 0.1% 30g 1 |– |– |1,453 |– |
|D06AX |FRAMYCETIN SULPHATE with GRAMICIDIN | | | | |
| |12003 Ointment 1.5%15g 1 |– |– |221 |– |
|D06AX01 |FUSIDIC ACID | | | | |
| |13926 Ointment 2% 15mg 1 |– |– |13,859 |– |
|D06AX09 |MUPIROCIN | | | | |
| |4348 Cream 20mg (as calcium) per g (2%), 15g |– |– |162,201 |2,370,290 |
| |4350 Ointment 20mg per g(2%), 15g |– |– |147,574 |2,181,179 |
| |13705 Ointment nasal 3g 1 |– |– |32,248 |– |
|D06AX |NEOMYCIN with BACITRACIN | | | | |
| |10457 Powder 15g 1 |– |– |827 |– |
| |1996 |Cream 10mg-2mg per g (1%-0.2%) 50g |– |– |26,769 |428,072 |
| |1997 |Cream 10mg-2mg per g (1%-0.2%) 100g |– |– |43,328 |909,139 |
| |13610 |Cream 1%500g 1 |– |– |345 |– |
| | | | | | | |
|ANTIVIRALS | | | | | | |
|2546 |Cream 50mg per g (5%), 250mg Sachet 12 |– |– |1,358 |222,014 |
|4559 |Cream sachets 50mg per g (5%), 250mg 12 |– |– |21,165 |3,424,849 |
|16216 |Cream 5% sachets 12 |– |– |9,672 |– |
|17990 |Cream 5% sachets 6 |– |– |38,420 |– |
|PODOPHYLLOTOXIN |
|4566 |Paint 5mg per mL (0.5%), 3.5mL (with 30 swabs) |– |– |6,800 |225,840 |
|17402 |Paint 5mg per mL (0.5%) 3mL (with applicators) |– |– |1,895 |– |
|17933 |Cream 1.5mg per g (0.15%) 5g |– |– |2,377 |– |
|1115 |Cream 500ug per g (0.05%) 15g |– |– |335,997 |3,200,417 |
|1119 |Ointment 500ug per g (0.05%) 15g |– |– |204,150 |2,245,264 |
|2812 |Cream 200ug per g (0.02%) 100g |– |– |412,107 |5,630,994 |
|2813 |Cream 500ug per g (0.05%) 15g |– |– |97,948 |739,848 |
|2815 |Ointment 500ug per g (0.05%) 15g |– |– |40,011 |312,365 |
|2820 |Ointment 200ug per g (0.02%) 100g |– |– |76,032 |1,049,657 |
|4131 |Cream 1mg per g (0.1%) 30g |– |– |14,195 |334,448 |
|4132 |Ointment 1mg per g (0.1%) 30g |– |– |8,038 |210,485 |
|4511 |Cream 500ug per g (0.05%) 30g |– |– |510 |5,676 |
|10627 |Ointment 30g 1 |– |– |30,555 |– |
|12881 |Cream 30g 1 |– |– |24,669 |– |
|15271 |Cream 500ug per g (0.05%) 50g |– |– |15,967 |– |
|15272 |Ointment 500ug per g (0.05%) 50g |– |– |9,078 |– |
|17216 |Scalp lotion 500ug per mL (0.05%) 30mL |– |– |2,164 |– |
|17217 |Scalp lotion 500ug per mL (0.05%) 30mL |– |– |21,150 |– |
|19628 |Cream 500ug per g (0.05%) 30g |– |– |879 |– |
|METHYLPREDNISOLONE ACEPONATE |
|8054 |Cream 1mg per g (0.1%) 15g |– |– |192,432 |2,853,032 |
|8055 |Ointment 1mg per g (0.1%) 15g |– |– |108,769 |1,830,906 |
|8128 |Ointment 1mg per g (0.1%) 15g |– |– |130,002 |2,257,489 |
|8618 |Lotion 1mg per g (0.1%) 20g |– |– |9,308 |153,714 |
|15990 |Cream 0.1% 30gm 1 |– |– |2,390 |– |
|15991 |ointment 0.1% 30gm 1 |– |– |857 |– |
|MOMETASONE |
|1913 |Cream 1mg per g (0.1%) 15g |– |– |500,699 |7,252,103 |
|1915 |Ointment 1mg per g (0.1%) 15g |– |– |266,067 |4,857,784 |
|4342 |Cream 1mg per g (0.1%) 45g |– |– |30,802 |924,755 |
|4343 |Ointment 1mg per g (0.1%) 45g |– |– |18,332 |601,849 |
|8043 |Lotion 1mg per g (0.1% w/w) 30mL |– |– |242,638 |5,044,026 |
82
|15680 |Gel 0.1% 30G 1 |– |– |46,005 |– |
|16348 |Cream 0.1% 30g 1 |– |– |36,921 |– |
| |11780 |Cream 0.05%20g 1 |– |– |12,891 |– |
| |14354 |Cream .025% 25g 1 |– |– |5,804 |– |
| |14355 |Cream 0.05% 25g 1 |– |– |4,669 |– |
| |14356 |Cream 0.1% 25g 1 |– |– |2,548 |– |
| |14512 |Cream 0.05% 50g 1 |– |– |12,724 |– |
| |17039 |Gel 0.01%30g 1 |– |– |4,478 |– |
| | | | | | | |
|PEROXIDES | | | | | | |
|13816 |Topical solution 1% 100mL 1 |– |– |18,060 |– |
|16422 |Topical solution 1% 50mL 1 |– |– |14,282 |– |
|16520 |Lotion 10mg per mL 60mL |– |– |2,414 |– |
|19646 |Gel 1% 30g 1 |– |– |1,171 |– |
|ERYTHROMYCIN |
|15129 |Gel 2% 30g 1 |– |– |76,672 |– |
|10734 |Roll-on 20%50mL 1 |– |– |163 |– |
|AZELAIC ACID |
|14704 |Cream 20 % 30mg |– |– |129 |– |
|4014 |Pessaries 100mg 6 |0.10 |GM |11,667 |175,262 |
|4015 |Pessary 500mg |0.10 |GM |15,930 |257,625 |
|4016 |Vaginal cream 50mg per 5g (1%) 35g |0.10 |GM |51,588 |766,059 |
|4017 |Vaginal cream 100mg per 5g (2%)20g |0.10 |GM |43,375 |672,284 |
|15913 |Pessary 500mg |0.10 |GM |16,801 |– |
|19063 |Vaginal cream 50mg per 5g (1%) 35g |0.10 |GM |1,680 |– |
|19067 |Vaginal cream 50mg per 5g (1%) 35g |0.10 |GM |833 |– |
|ECONAZOLE NITRATE |
|12661 |Foam-sol 1%10g 3 |0.10 |GM |1,570 |– |
|15473 |Pessaries 150 mg, 3 |0.10 |GM |2,728 |– |
|MICONAZOLE NITRATE |
|4021 |Vaginal cream 100mg per 5g (2%) 40g |0.10 |GM |2,325 |30,457 |
|18370 |Vaginal ovule 1.2g/cream(2%) 9 g, 100mg per 5g |0.10 |GM |4,029 |– |
|18371 |Vaginal cream (4%) and applicators 25g, 200mg/5g |0.10 |GM |722 |– |
|G03AA09 |DESOGESTREL with ETHINYLOESTRADIOL | | | | |
| |14249 Tablet 28 1 150 ug/30ug |– |– |63,922 |– |
|G03AA12 |ETHINYLOESTRADIOL with DROSPIRENONE | | | | |
| |17645 Tablet 3mg - 30ug 21 + 7 inert |– |– |85,681 |– |
| |17646 Tablet 3mg - 30ug 21 + 7 inert,28*3 |– |– |302,467 |– |
|G03AA10 |ETHINYLOESTRADIOL with GESTODENE | | | | |
| |15082 Tablets 75ug/30ug, 21 + 7 |– |– |19,189 |– |
|G03AA07 |LEVONORGESTREL with ETHINYLOESTRADIOL | | | | |
| |1393 Tablets 150ug - 30ug 21 |– |– |15,099 |231,949 |
| |1394 Tablets 150ug - 30ug 21 + 7 iner t, 28 |– |– |1,338,991 |20,747,635 |
| |1456 Tablets 125ug - 50ug 21 + 7 iner t |– |– |93,441 |1,448,361 |
| |16212 Tablets 100ug - 50ug 28 |– |– |102,486 |– |
| |16217 Tablets 100ug - 20ug + 7 inert 28 |– |– |34,399 |– |
| |16970 Tablets 100ug - 20ug 21 + 7 iner t |– |– |132,315 |– |
| |17707 Tablets 100ug 20ug + 7 inert 28 |– |– |409 |– |
| |17708 Tablets 100ug 20ug + 7 inert 28X3 |– |– |2,021 |– |
|G03AA05 |NORETHISTERONE with ETHINYLOESTRADIOL | | | | |
| |2772 Tablets 500ug-35ug 21 |– |– |1,682 |26,075 |
| |2773 Tablets 1mg-35ug, 21 |– |– |1,555 |23,996 |
| |2774 Tablets 500ug-35ug 21 + 7 inert 28 |– |– |139,216 |2,158,131 |
| |2775 Pack containing 21 tablets 1mg-35ug |– |– |97,012 |1,504,030 |
|G03AA05 |NORETHISTERONE with MESTRANOL | | | | |
| |3176 Tablets 1mg-50ug 21 |– |– |2,519 |39,041 |
| |3179 Tablets 1mg-50ug 21 + 7 inert 28 |– |– |15,949 |247,401 |
|G03AA12 |OESTRADID with DROSPIRENONE | | | | |
| |19550 Tablet 1mg - 2mg 28 |– |– |5,682 |– |
| |
|PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS |
|G03AB06 ETHINYLOESTRADIOL WITH GESTODENE | | | | |
|18555 Tablet 30ug/75ug 28x3 |– |– |12,797 |– |
|G03AB03 LEVONORGESTREL with ETHINYLOESTRADIOL | | | | |
|1392 Pack containing 6 tablets 50ug |– |– |614,491 |9,527,538 |
|19188 Tablets 50/50ug 11, 125/50ug 10 + 7 |– |– |587 |– |
|19189 Tablets 50/30ug 6, 75/40ug 5, 125/30ug 10 |– |– |165 |– |
|G03AB04 NORETHISTERONE with ETHINYLOESTRADIOL | | | | |
|2776 Tablets 500/35ug 12,1000/35ug 9 + 7 inert |– |– |9,720 |150,816 |
|PROGESTOGENS | | | | |
|1061 |Injection 10mg in 1mL |1.00 |MG |1,484 |94,329 |
|1663 |Tablets 1mg 28 |2.00 |MG |45,503 |480,419 |
|1664 |Tablets 2mg 28 |2.00 |MG |65,782 |857,997 |
|4365 |Implant 50mg 1 |– |– |1,877 |57,352 |
|4366 |Implant 100mg 1 |– |– |4,684 |511,166 |
|8274 |Tablets 2mg 56 |2.00 |MG |4,522 |57,560 |
|19626 |Injection 10mg in 1mL |1.00 |MG |390 |– |
|G03CA04 OESTRIOL |
|1771 |Pessaries 500ug 15 |0.20 |MG |59,199 |1,150,517 |
|1776 |Tablets 1mg 30 |2.00 |MG |3,759 |41,178 |
|1781 |Vaginal cream 1mg per g (0.1%), 15g |0.20 |MG |288,776 |4,697,220 |
|19732 |Tablets 1mg 30 |2.00 |MG |835 |– |
|G03CA57 OESTROGENS CONJUGATED |
|1733 |Tablets 300ug 28 |0.63 |MG |219,998 |2,358,690 |
|1734 |Tablets 625ug 28 |0.63 |MG |353,996 |4,504,034 |
|15325 |Tablet 1.25mg 28 |0.63 |MG |983 |– |
|G03CA07 OESTRONE |
|1777 |Tablet 730ug |1.00 |MG |81,376 |861,848 |
|1778 |Tablet 1.46mg |1.00 |MG |73,724 |939,039 |
|11413 |Tablet 625ug 100 |1.00 |MG |1,025 |– |
|11414 |Tablet 1.25mg 100 |1.00 |MG |1,159 |– |
|progestogens | | | | | |
|2319 |Injection 50 mg in 1 mL |7.00 |MG |797 |8,846 |
|2321 |Tablet 10mg |5.00 |MG |39,250 |592,833 |
|2323 |Tablet 5mg 56 |5.00 |MG |142,461 |1,959,732 |
|2722 |Tablet 10mg |5.00 |MG |14,703 |450,422 |
|14247 |Tablet 2.5mg |5.00 |MG |2,248 |– |
|PROGESTERONE |
|6366 |Gel Vaginal (prolonged release) 90mg single dose |90.00 |MG |859 |– |
|15327 |Cream 1.6% 50g |– |– |112 |– |
|15328 |Cream 3.2% 50g |– |– |2,074 |– |
|16638 |Cream 10% 50g |– |– |797 |– |
|18750 |Pessaries 200mg 15 |90.00 |MG |128 |– |
|8168 |Tablet 625ug 2.5mg 28 |0.63 |MG |129,271 |2,094,457 |
|8169 |Tablet 625ug 5mg 28 |0.63 |MG |212,987 |3,458,477 |
|NORETHISTERONE AND ESTROGEN |
|8081 |Pack containing 28 tablets 2mg-1mg |2.00 |MG |131,537 |2,134,315 |
|8353 |Tablets 1mg-500ug, 28 |– |– |196,454 |3,180,261 |
|1285 |Capsule 100mg |0.60 |GM |580 |34,582 |
|1287 |Capsule 200mg |0.60 |GM |2,088 |186,779 |
|GESTRINONE |
|8015 |Capsule 2.5mg |0.70 |MG |390 |30,322 |
|8039 |Tablet 5mg |15.00 |MG |223,686 |3,533,955 |
|TOLTERODINE |
|18891 |Tablet 1mg 56 |4.00 |MG |3,345 |– |
|18892 |Tablet 2mg 56 |4.00 |MG |18,909 |– |
|4579 |Intracavernosal injection 10ug in single syringe |0.02 |MG |6,690 |538,854 |
|4580 |Intracavernosal injection 20 ug in single syringe|0.02 |MG |14,033 |1,438,982 |
|SILDENAFIL |
|4584 |Tablet 25mg 4 |50.00 |MG |3,592 |1,079,624 |
|4585 |Tablet 50mg 4 |50.00 |MG |63,397 |5,123,848 |
|4586 |Tablet 100mg 4 |50.00 |MG |249,799 |18,046,393 |
|TADALAFIL |
|4596 |Tablet 10mg 4 |10.00 |MG |15,044 |1,011,328 |
|4597 |Tablet 20mg 4 |10.00 |MG |190,600 |13,791,392 |
|18863 |Tablet 20mg 8 |– |– |23,156 |– |
|VARDENAFIL |
|17959 |Tablet 5mg 4 |– |– |178 |– |
|17960 |Tablet 10mg 2 |– |– |533 |– |
|17961 |Tablet 10mg 4 |– |– |9,759 |– |
|17962 |Tablet 20mg 2 |– |– |956 |– |
|17963 |Tablet 20mg 2 |– |– |33,419 |– |
|4464 |Capsule 400ug (modified release) |0.40 |MG |30,182 |1,761,894 |
|19574 |Capsule 400ug (modified release) |0.40 |MG |96,528 |– |
|19633 |Capsule 400ug (modified release) |0.40 |MG |2,341 |– |
|TERAZOSIN |
|4397 |Tablet 2mg |5.00 |MG |2,386 |105,194 |
|4398 |Tablet 5mg |5.00 |MG |4,578 |276,515 |
|4399 |Tablet 10mg |5.00 |MG |142 |12,506 |
|6423 |Injection 60mg (base) single dose syringe |3.00 |MG |181 |267,970 |
|6424 |Injection 90mg (base) single dose syringe |3.00 |MG |200 |384,811 |
|6425 |Injection 120mg (base) single dose syringe |3.00 |MG |199 |495,893 |
|OCTREOTIDE |
|6228 |Injection 100ug in 1mL ampoule 5 |0.70 |MG |210 |178,483 |
|6427 |Inj(mod release) 20mg(base) vial + diluent syringe |0.70 |MG |688 |1,619,126 |
|6428 |Inj(mod release) 30mg(base) vial + diluent syringe |0.70 |MG |914 |2,605,306 |
|LIOTHYRONINE |
|2318 |Tablet 20ug |60.00 |UG |11,046 |908,705 |
|THYROXINE SODIUM |
|2173 |Tablet equivalent to 200ug anhydrous |0.15 |MG |67,023 |1,722,836 |
|2174 |Tablet equivalent to 50ug anhydrous |0.15 |MG |518,080 |10,165,733 |
|2175 |Tablet equivalent to 100ug anhydrous |0.15 |MG |504,297 |10,423,351 |
|2702 |Tablet 100mg (HCl salt after 1 Oct 2007) 28 |0.10 |GM |70,326 |1,078,678 |
|2703 |Capsule 100mg (as HCl salt after 1 Oct 2007) |0.10 |GM |46,863 |731,142 |
|2707 |Capsule 50mg (as HCl salt after 1 Oct 2007) |0.10 |GM |219,669 |2,168,439 |
|2708 |Capsule 100mg (as HCl salt after 1 Oct 2007) |0.10 |GM |247,719 |1,940,212 |
|2709 |Tablet 100mg (as HCl salt after 1 Oct 2007) |0.10 |GM |354,802 |2,800,092 |
|2711 |Tablet 50mg (as HCl salt after 1 Oct 2007) 25 |0.10 |GM |408,012 |4,020,089 |
|2714 |Tablet 100mg (as HCl salt after 1 Oct 2007) 21 |0.10 |GM |62,177 |787,555 |
|2715 |Capsule 100mg (as HCl salt after 1 Oct 2007) |0.10 |GM |42,762 |551,927 |
|3321 |Tablet 100mg |0.10 |GM |3,360 |25,872 |
|3322 |Capsule 100mg |0.10 |GM |1,473 |11,330 |
|18808 |Capsule 100mg 21 |0.10 |GM |213 |– |
|18810 |Capsule 100mg 7 |0.10 |GM |638 |– |
|18811 |Capsule 50mg 25 |0.10 |GM |350 |– |
|MINOCYCLINE |
|1616 |Tablet 50mg |0.20 |GM |375,720 |6,296,594 |
|3037 |Capsule 100mg |0.20 |GM |3,782 |35,731 |
|TETRACYCLINE |
|19204 |Capsule 250mg |1.00 |GM |151 |– |
|19205 |Capsule 250mg |1.00 |GM |1,639 |– |
|19206 |Capsule 250mg |1.00 |GM |57,339 |– |
|1878 |Sachet containing oral powder 3g |1.00 |GM |16,737 |163,244 |
|1883 |Chewable tablet 250mg |1.00 |GM |81,771 |734,666 |
|1884 |Capsule 250mg |1.00 |GM |359,331 |2,903,098 |
|1886 |Powder for syrup 125mg per 5mL 100mL |1.00 |GM |446,753 |4,530,381 |
|1887 |Powder for syrup 250mg per 5mL 100mL |1.00 |GM |731,047 |8,289,047 |
|1889 |Capsule 500mg |1.00 |GM |2,213,624 |24,638,046 |
|3300 |Capsule 500mg |1.00 |GM |419,708 |4,555,821 |
|3301 |Capsule 250mg |1.00 |GM |80,859 |649,181 |
|3302 |Powder for syrup 125mg per 5mL 100 mL |1.00 |GM |11,063 |112,326 |
|3303 |Chewable tablet 250mg |1.00 |GM |1,823 |16,315 |
|3309 |Sachet containing oral powder 3g |1.00 |GM |37,216 |328,473 |
|3310 |Powder for paediatric oral drops 100mg per mL |1.00 |GM |170 |2,071 |
|3393 |Powder for syrup 250mg per 5mL 100mL |1.00 |GM |7,583 |85,747 |
|5225 |Powder for oral suspension 500mg per 5mL 100mL |1.00 |GM |151 |2,188 |
|8581 |Tablet 1g 14 |1.00 |GM |299,969 |3,348,028 |
|8705 |Powder for oral suspension 500mg per 5mL 100mL |1.00 |GM |42,387 |606,634 |
|10116 |Vial 1g 5 |1.00 |GM |161 |– |
|19739 |Powder for syrup 250mg per 5mL 100mL |1.00 |GM |2,211 |– |
|AMPICILLIN |
|1048 |Capsule 250mg |2.00 |GM |568 |5,339 |
|2390 |Injection 500mg (solvent required) |2.00 |GM |284 |3,746 |
|2671 |Capsule 500mg |2.00 |GM |4,988 |66,084 |
|2977 |Injection 1g (solvent required) |2.00 |GM |8,881 |173,519 |
|AMOXYCILLIN |
|1888 |Powder paediatric oral drops 100mg per mL 20mL A |1.00 |GM |148,147 |1,791,444 |
|9715 |Powder paediatric oral drops 100mg per mL 20mL A |1.00 |GM |8,244 |67,452 |
|8167 |Injection 900mg in 2mL cartridge-needle unit |3.60 |GM |1,335 |48,640 |
|8743 |Injection 900mg in 2mL cartridge-needle unit |3.60 |GM |1,267 |63,925 |
|9002 |Powder for injection 900mg(1.2MU)1-needle unit |3.60 |GM |359 |18,782 |
|9003 |Powder for injection 900mg(1.2MU)2-needle unit |3.60 |GM |345 |25,820 |
|BENZATHINE PHENOXYMETHYLPENICILLIN |
|2354 |Oral suspension 250mg per 5mL 100mL |2.00 |GM |100,888 |1,453,812 |
|2356 |Paediatric oral suspension 125mg per 5mL 100mL |2.00 |GM |35,457 |420,634 |
|3365 |Paediatric oral suspension 125mg per 5mL 100mL |2.00 |GM |392 |3,827 |
|3366 |Oral suspension 250mg per 5mL 100mL |2.00 |GM |192 |2,081 |
|BENZYLPENICILLIN |
|1775 |Injection 600mg (solvent required ) |3.60 |GM |4,223 |194,914 |
|2647 |Injection 3g (solvent required) |3.60 |GM |1,266 |88,307 |
|3398 |Injection 600 mg (solvent required) |3.60 |GM |113 |1,296 |
|3486 |Injection 600mg (with sterilised water) |3.60 |GM |4,410 |91,643 |
|3487 |Injection 3g (solvent supplied) |3.60 |GM |3,708 |41,909 |
|1703 |Tablet 250mg |2.00 |GM |12,365 |144,843 |
|1705 |Capsule 250mg |2.00 |GM |21,777 |250,360 |
|1787 |Tablet 250mg |2.00 |GM |22,017 |248,119 |
|1789 |Capsule 250mg |2.00 |GM |38,441 |430,674 |
|2965 |Capsule 500mg |2.00 |GM |212,946 |3,136,818 |
|3028 |Tablet 500mg |2.00 |GM |104,540 |1,508,250 |
|3360 |Tablet 250mg |2.00 |GM |2,668 |23,124 |
|3361 |Tablet 500mg |2.00 |GM |5,118 |53,428 |
|3363 |Capsule 250mg |2.00 |GM |3,291 |32,032 |
|3364 |Capsule 500mg |2.00 |GM |10,203 |120,336 |
|PROCAINE PENICILLIN |
|1794 |Injection 1.5g |3.60 |GM |8,507 |443,392 |
|3485 |Injection 1.5g |3.60 |GM |22,128 |1,150,353 |
|8121 |Capsule 250mg |2.00 |GM |47,345 |558,531 |
|8122 |Capsule 500mg |2.00 |GM |309,408 |6,673,413 |
|8123 |Injection 500mg (solvent required) |2.00 |GM |224 |4,658 |
|8124 |Injection 1g (solvent required) |2.00 |GM |3,738 |151,064 |
|FLUCLOXACILLIN |
|1524 |Injection 500mg (solvent required ) |2.00 |GM |320 |6,738 |
|1525 |Injection 1g (solvent required) |2.00 |GM |14,804 |848,257 |
|1526 |Capsule 250mg |2.00 |GM |54,450 |650,546 |
|1527 |Capsule 500mg |2.00 |GM |301,598 |6,513,926 |
|1528 |Powder for syrup 125mg per 5mL 100mL |2.00 |GM |17,736 |238,310 |
|1529 |Powder for syrup 250mg per 5mL 100mL |2.00 |GM |52,809 |998,214 |
|5091 |Capsule 500mg |2.00 |GM |536 |9,774 |
|19742 |Powder for syrup 125mg per 5mL 100mL |2.00 |GM |2,060 |– |
|1891 |Tablet 500mg-125mg |1.00 |GM |392,580 |5,241,290 |
|1892 |Powder for syrup 125mg-31.25mg per 5mL 75mL |1.00 |GM |52,653 |655,853 |
|5006 |Tablet 875mg-125mg |1.00 |GM |36,200 |592,317 |
|5008 |Tablet 500mg-125mg |1.00 |GM |11,669 |151,689 |
|5009 |Powder for syrup 125mg-31.25mg per 5mL 75mL |1.00 |GM |223 |2,811 |
|5011 |Powder for syrup 400mg-57mg per 5mL 50mL |1.00 |GM |409 |5,899 |
|8254 |Tablet 875mg-125mg |1.00 |GM |2,181,449 |36,933,381 |
|8319 |Powder for syrup 400mg-57mg per 5mL 50mL |1.00 |GM |369,661 |5,476,948 |
|1169 |Tablet 375mg (sustained release) |1.00 |GM |665,270 |9,591,389 |
|2460 |Powder for oral susp 125mg per 5mL 100mL |1.00 |GM |130,954 |1,812,886 |
|2461 |Powder for oral susp 250mg per 5mL 75mL |1.00 |GM |285,955 |4,102,809 |
|5045 |Tablet 375mg (sustained release) |1.00 |GM |1,047 |14,787 |
|5047 |Powder for oral susp 250mg per 5mL 75mL |1.00 |GM |120 |1,744 |
|CEFUROXIME |
|5052 |Tablet 250mg 14 |0.50 |GM |217 |3,237 |
|8292 |Tablet 250mg 14 |0.50 |GM |109,486 |1,698,637 |
|1085 |Injection 1g (solvent required) |4.00 |GM |2,902 |133,480 |
|1086 |Injection 2g (solvent required) |4.00 |GM |486 |36,081 |
|CEFTRIAXONE |
|1782 |Injection 250mg (solvent required) |2.00 |GM |1,143 |12,647 |
|1783 |Injection 500mg (solvent required ) |2.00 |GM |342 |14,216 |
|1784 |Injection 1g (solvent required) |2.00 |GM |48,502 |2,995,802 |
|1785 |Injection 2g (solvent required) |2.00 |GM |6,705 |780,053 |
|1790 |Injection 250mg (solvent required) |2.00 |GM |129 |4,146 |
|18777 |Injection 1g (solvent required) |2.00 |GM |154 |– |
|19828 |Injection 250mg (solvent required ) |2.00 |GM |182 |– |
|4115 |Tablet 500mg |0.30 |GM |2,356 |112,593 |
|8200 |Tablet 500mg |0.30 |GM |51,859 |1,141,524 |
|8201 |Powder for oral suspension 200mg per 5mL 15mL |0.30 |GM |1,253 |27,003 |
|8336 |Tablet 500mg 2 |0.30 |GM |18,131 |397,199 |
|CLARITHROMYCIN |
|6151 |Tablet 250mg 100 |0.50 |GM |113 |8,596 |
|6152 |Tablet 500mg 100 |0.50 |GM |223 |30,912 |
|8318 |Tablet 250mg 14 |0.50 |GM |594,525 |9,042,145 |
|16432 |Liquid 250mg per 5mL 1 |0.50 |Gm |197 |– |
|ERYTHROMYCIN |
|1397 |I.V. infusion 1g (base) |1.00 |GM |769 |38,448 |
|1404 |Capsule 250mg |1.00 |GM |123,132 |1,161,373 |
|2424 |Granules for paediatric oral susp 200mg |1.00 |GM |133,471 |1,432,345 |
|2428 |Granules for oral susp 400mg (base) per 5mL 10 |1.00 |GM |148,127 |1,846,724 |
|2750 |Tablet 400mg (base) |1.00 |GM |360,065 |3,201,211 |
|3325 |Capsule 250mg |1.00 |GM |18,766 |167,448 |
|3334 |Granules for paediatric oral suspension 200mg |1.00 |GM |560 |5,984 |
|3336 |Tablet 400mg (base) |1.00 |GM |7,220 |62,077 |
|3337 |Granules for oral suspension 400mg(base) per 5mL |1.00 |GM |286 |3,518 |
|ROXITHROMYCIN |
|1760 |Tablet 150mg |0.30 |GM |772,428 |9,356,874 |
|8016 |Tablet 300mg |0.30 |GM |1,142,221 |13,998,828 |
|8129 |Tablet for oral suspension 50 mg |0.30 |GM |74,726 |800,481 |
|3138 |Capsule 150mg |1.20 |GM |80,170 |2,785,602 |
|5057 |Capsule 150mg |1.20 |GM |27,885 |487,233 |
|16644 |Capsule 150mg 100 |1.20 |GM |869 |– |
|LINCOMYCIN |
|2530 |Injection 600mg in 2mL |1.80 |GM |2,526 |104,897 |
|2824 |Injection 80mg (base) in 2mL |0.24 |GM |23,384 |463,759 |
|19183 |Injection 40mg (base) in 1mL |0.24 |GM |299 |– |
|TOBRAMYCIN |
|1356 |Injection 80mg (base) |0.24 |GM |2,468 |275,368 |
|8872 |Injection 80mg (base) in 2mL (without preserv) |0.24 |GM |590 |76,108 |
|1208 |Tablet 250mg |1.00 |GM |14,922 |657,144 |
|1209 |Tablet 500mg |1.00 |GM |113,344 |9,507,485 |
|1210 |Tablet 750mg |1.00 |GM |36,446 |5,242,278 |
|1311 |Tablet 250mg |1.00 |GM |4,878 |60,577 |
|MOXIFLOXACIN |
|4329 |Tablet 400mg 5 |0.40 |GM |1,892 |110,249 |
|8635 |Solution for I.V. infusion 400mg (base)in 250mL |0.40 |GM |158 |43,049 |
|8636 |Tablet 400mg (base) 5 |0.40 |GM |7,916 |438,245 |
|19908 |Tablet 400mg (base) 5 |0.40 |GM |261 |– |
|NORFLOXACIN |
|3010 |Tablet 400mg |0.80 |GM |184,484 |4,413,265 |
|13660 |Tablet 400mg 6 |0.80 |GM |34,493 |– |
|1471 |Capsule 50mg 28 |0.20 |GM |3,111 |554,209 |
|1472 |Capsule 100mg 28 |0.20 |GM |8,806 |2,985,814 |
|1474 |Solution for IV infusion 200mg in 100mL 7 |0.20 |GM |676 |363,562 |
|1475 |Capsule 200mg |0.20 |GM |7,874 |5,823,913 |
|14171 |Capsule 150mg 1 |0.20 |GM |74,882 |– |
|19776 |Capsule 150mg 1 |0.20 |GM |9,745 |– |
|19901 |Capsule 150mg 1 |0.20 |GM |1,187 |– |
|19902 |Capsule 150mg 1 |0.20 |GM |548 |– |
|ITRACONAZOLE |
|8196 |Capsule 100mg |0.20 |GM |5,484 |1,529,371 |
|14810 |Capsule 100mg |0.20 |GM |1,635 |– |
|16227 |Capsule 100mg 28 |0.20 |GM |1,711 |– |
|1003 |Tablet 200mg |4.00 |GM |4,351 |422,682 |
|1007 |Tablets 200mg 90 |4.00 |GM |32,279 |5,694,325 |
|1052 |Tablets 800mg 35 |4.00 |GM |8,156 |1,699,953 |
|8234 |Tablets 800mg 120 |4.00 |GM |283 |181,467 |
|8002 |Tablet 250mg |0.75 |GM |41,482 |6,500,755 |
|8092 |Tablet 125mg |0.75 |GM |9,717 |1,448,588 |
|8217 |Tablet 250mg |0.75 |GM |56,148 |22,099,477 |
|8896 |Tablet 500mg 56 |0.75 |GM |1,251 |461,098 |
|8897 |Tablet 500mg 30 |0.75 |GM |855 |179,227 |
|VALACICLOVIR |
|8064 |Tablet 500mg |3.00 |GM |33,007 |7,630,203 |
|8133 |Tablet 500mg |3.00 |GM |15,750 |1,808,643 |
|8134 |Tablet 500mg |3.00 |GM |256,267 |46,948,456 |
|6450 |Tablet 30mg 30 |10.00 |MG |2,849 |1,907,853 |
|LAMIVUDINE |
|6257 |Tablet 100mg |0.30 |GM |9,847 |1,324,439 |
|6356 |Tablet 600mg 30 |0.60 |GM |120 |35,347 |
|NEVIRAPINE |
|6215 |Tablet 200mg |0.40 |GM |185 |53,033 |
|18057 |Suspension 12mg per ml 1 |– |– |1,691 |– |
|ZANAMIVIR |
|16327 |Rotadisk 5mg 20 |20.00 |MG |220 |– |
|14507 |Vial 0.5mL 1 |– |– |5,373 |– |
|15130 |Vial 0.5mL 1 |– |– |487 |– |
|MENINGOCOCCAL C |
|17391 |Vial 0.5mL 1 |– |– |2,896 |– |
|17637 |Syringe 10ug per 0.5mL conjugated 1 |– |– |649 |– |
|19176 |Oral live attenuated capsule Typhoid |– |– |3,882 |– |
|TYPHOID PURIFIED POLYSACCHARIDE ANTIGEN |
|14718 |Syringe 0.5mL |– |– |59,869 |– |
|16719 |Injection 25ug |– |– |14,298 |– |
|15677 |Syringe 720u/0.5mL |– |– |9,868 |– |
|15687 |Syringe 144u 1 |– |– |58,304 |– |
|15770 |Syringe 25u 1 |– |– |218 |– |
|15771 |Syringe 50u 1 |– |– |803 |– |
|HEPATITIS A\HEPATITIS B |
|15760 |Syringe 1mL |– |– |115,011 |– |
|15917 |Syringe 0.5mL |– |– |3,067 |– |
|17055 |Syringe 0.5mL |– |– |982 |– |
|HEPATITIS B |
|12913 |Vial 1mL 1 |– |– |8,411 |– |
|12914 |Vial 0.5mL 1 |– |– |344 |– |
|13026 |Ampoule 20ug per mL 1 |– |– |48,584 |– |
|13473 |Ampoule 10ug per 0.5ml 1 |– |– |3,354 |– |
|15783 |Vial 40ug per mL 1 |– |– |861 |– |
|1031 |Injection 2g (solvent required) |– |– |10,814 |458,528 |
|1079 |Injection 500mg (solvent required) |– |– |2,040 |51,890 |
|1080 |Injection 1g (solvent required) |– |– |7,059 |198,877 |
|1266 |Tablet 50mg |– |– |9,948 |294,560 |
|5914 |Injection 500mg (solvent required) |– |– |2,319 |24,884 |
|5915 |Injection 1g (solvent required) |– |– |3,961 |66,357 |
|5916 |Injection 2g (solvent required) |– |– |1,726 |51,299 |
|IFOSFAMIDE |
|5944 |Powder for I.V. injection 2g |– |– |111 |34,757 |
|8076 |Powder for I.V. injection 1g |– |– |283 |73,239 |
|8077 |Powder for I.V. injection 2g |– |– |899 |453,144 |
|5801 |Powder for I.V. infusion 500mg (base), 2 |– |– |200 |634,790 |
|5887 |Powder for I.V. infusion 500mg (base), 2 |– |– |111 |301,447 |
|8809 |Powder for I.V. infusion 500mg (base), 2 |– |– |247 |794,375 |
|9713 |Powder for I.V. infusion 500mg (base), 2 |– |– |1,171 |4,181,330 |
|RALTITREXED |
|8284 |Powder for I.V. infusion 2 mg |– |– |120 |115,605 |
|1598 |Tablet 50mg |– |– |10,825 |1,066,743 |
|THIOGUANINE |
|1233 |Tablet 40mg |– |– |789 |90,316 |
|8361 |Tablet 150mg |– |– |2,006 |271,910 |
|8362 |Tablet 500mg 120 |– |– |17,482 |13,463,984 |
|CYTARABINE |
|2884 |Injection set containing 100mg and 5mL solvent |– |– |561 |103,488 |
|5918 |Injection set containing 100mg and 5mL solvent |– |– |283 |9,498 |
|5919 |Injection set containing 500mg and 5mL solvent |– |– |251 |16,094 |
|8034 |Injection set containing 500mg and 5mL solvent |– |– |449 |271,105 |
|FLUOROURACIL |
|2528 |Injection 500mg in 10mL |– |– |38,868 |2,423,171 |
|4222 |Cream 50mg per g (5%) 20g |– |– |74,260 |3,043,860 |
|5872 |Injection 1000mg in 20mL 5 |– |– |621 |19,537 |
|5935 |Injection 500mg in 10mL |– |– |12,366 |402,827 |
|9005 |Injection 100mg in 20mL 5 |– |– |230 |10,873 |
|GEMCITABINE |
|5936 |Powder for I.V. infusion 200mg (base) |– |– |2,650 |429,145 |
|5937 |Powder for I.V. infusion 1gm (base) |– |– |5,381 |2,252,527 |
|8049 |Powder for I.V. infusion 200mg (base) |– |– |6,278 |2,616,273 |
|8050 |Powder for I.V. infusion 1gm (base) |– |– |15,319 |12,742,684 |
|2199 |Injection set containing 10mg and 10mL solvent |– |– |1,012 |84,884 |
|5988 |Injection 10mg (solvent required) |– |– |178 |4,081 |
|5989 |Injection set containing 10mg and 10mL solvent |– |– |873 |26,190 |
|VINCRISTINE SULPHATE |
|2374 |Injection set containing 1mg and 1mL solvent |– |– |4,887 |584,434 |
|5991 |Injection set containing 1mg and 1mL solvent |– |– |2,582 |85,219 |
|VINORELBINE |
|5992 |Solution for I.V. infusion 10mg (base) in 1mL |– |– |280 |85,697 |
|5993 |Solution for I.V. infusion 50mg (base) in 5mL |– |– |561 |253,991 |
|8280 |Solution for I.V. infusion 10mg (base) in 1mL |– |– |894 |849,930 |
|8281 |Solution for I.V. infusion 50mg (base) in 5mL |– |– |1,939 |2,050,467 |
|1375 |Solution for I.V. injection 10mg in 5mL 4 |– |– |610 |91,124 |
|1376 |Solution for I.V. injection 20mg in 10mL 4 |– |– |967 |284,380 |
|1377 |Solution for I.V. injection 50mg in 25mL 3 |– |– |7,109 |5,500,678 |
|5885 |Solution for injection 100mg in 50mL 2 |– |– |932 |689,234 |
|5928 |Solution for I.V. injection 10mg in 5mL 4 |– |– |583 |51,634 |
|5929 |Solution for I.V. injection 20mg in 10mL 4 |– |– |631 |117,372 |
|5930 |Solution for I.V. injection 50mg in 25mL 3 |– |– |1,972 |1,028,673 |
|8817 |Solution for injection 100mg in 50mL 2 |– |– |1,669 |1,574,679 |
|8858 |Solution for injection 200mg in 100mL |– |– |1,559 |1,546,830 |
|9018 |Powder for injection 50mg 3 |– |– |257 |170,986 |
|MITOZANTRONE |
|1929 |Injection 20mg in 10mL |– |– |1,894 |614,598 |
|1930 |Injection 25mg in 12.5mL |– |– |918 |368,186 |
|1932 |Injection 10mg in 5mL |– |– |360 |63,899 |
|5965 |Injection 20mg in 10mL |– |– |515 |139,410 |
|5966 |Injection 25mg in 12.5mL |– |– |266 |90,563 |
|2315 |Injection 15,000 units (solvent required) |– |– |924 |307,553 |
|5903 |Injection 15,000 units (solvent required) |– |– |1,364 |130,214 |
|MITOMYCIN |
|13990 |Vial 2mg 10 |– |– |1,347 |– |
|1160 |Solution for I.V. injection 50mg in 5mL |– |– |1,389 |95,793 |
|1161 |Solution for I.V. injection 150mg in 15mL |– |– |8,591 |3,622,809 |
|1162 |Solution for I.V. injection 450mg in 45mL |– |– |7,780 |2,290,616 |
|5906 |Solution for I.V. injection 50mg in 5mL |– |– |1,523 |65,905 |
|5907 |Solution for I.V. injection 150mg in 15mL |– |– |3,880 |569,993 |
|5908 |Solution for I.V. injection 450mg in 45mL |– |– |3,946 |657,830 |
|CISPLATIN |
|2578 |I.V. injection 10mg in 10mL |– |– |288 |19,313 |
|2579 |I.V. injection 50mg in 50mL |– |– |4,335 |195,549 |
|2580 |I.V. injection 100mg in 100mL |– |– |7,451 |542,908 |
|5909 |I.V. injection 10mg in 10mL |– |– |138 |1,036 |
|5910 |I.V. injection 50mg in 50mL |– |– |1,087 |22,588 |
|5911 |I.V. injection 100mg in 100mL |– |– |2,585 |131,473 |
|OXALIPLATIN |
|5877 |Solution for I.V. infusion 50mg in 10mL |– |– |1,974 |890,101 |
|5878 |Solution for I.V. infusion 100mg in 20mL |– |– |3,923 |3,948,624 |
|5994 |Powder for I.V. infusion 50mg |– |– |400 |179,804 |
|5995 |Powder for I.V. infusion 100mg |– |– |733 |761,178 |
|8539 |Powder for I.V. infusion 50mg |– |– |1,330 |1,455,231 |
|8540 |Powder for I.V. infusion 100mg |– |– |2,804 |5,509,945 |
|8847 |Solution for I.V. infusion 50mg in 10mL |– |– |5,353 |5,522,539 |
|8848 |Solution for I.V. infusion 100mg in 20mL |– |– |11,506 |22,210,935 |
|19029 |Soln for IV infusion 100mg/4mL |– |– |132 |– |
|19030 |Soln for IV infusion 400mg/16mL |– |– |317 |– |
|RITUXIMAB |
|5896 |Solution for IV infusion 100mg\10mL |– |– |1,905 |1,534,707 |
|5897 |Solution for IV infusion 500mg\50mL |– |– |1,693 |3,870,705 |
|5978 |Solution for IV infusion 100mg\10mL |– |– |3,087 |2,634,353 |
|5979 |Solution for IV infusion 500mg\50mL |– |– |2,983 |6,826,927 |
|8293 |Solution for IV infusion 100mg\10mL |– |– |9,947 |12,006,335 |
|8294 |Solution for IV infusion 500mg\50mL |– |– |10,482 |26,589,326 |
|8665 |Solution for IV infusion 100mg\10mL |– |– |6,536 |7,624,891 |
|8666 |Solution for IV infusion 500mg\50mL |– |– |6,500 |15,892,488 |
|8769 |Tablet 250mg 30 |– |– |501 |2,029,285 |
|IMATINIB |
|6440 |Tablet 100mg (base) 60 |– |– |770 |2,840,879 |
|6441 |Tablet 400mg (base) 30 |– |– |1,685 |6,537,726 |
|6444 |Tablet 100mg (base) 60 |– |– |3,897 |15,496,735 |
|6445 |Tablet 400mg (base) 30 |– |– |6,629 |27,454,329 |
|6446 |Tablet 100mg (base) 60 |– |– |741 |3,348,767 |
|6447 |Tablet 400mg (base) 30 |– |– |830 |4,046,324 |
|5958 |I V injection 40mg in 2mL |– |– |903 |174,252 |
|5959 |I V injection 100mg in 5mL |– |– |2,006 |1,780,649 |
|8414 |I V injection 40mg in 2mL |– |– |2,024 |1,197,456 |
|8415 |I V injection 100mg in 5mL |– |– |7,144 |11,337,598 |
|2316 |Tablet 200mg |1000.00 |MG |1,568 |173,856 |
|2725 |Tablet 100mg |1000.00 |MG |2,198 |212,532 |
|2727 |Tablet 250mg |1000.00 |MG |280 |37,850 |
|2728 |Tablet 500mg |1000.00 |MG |1,019 |137,580 |
|MEGESTROL |
|2734 |Tablet 160mg |160.00 |MG |1,576 |114,359 |
|1454 |Subcutaneous implant 3.6mg |0.13 |MG |23,042 |7,764,541 |
|8093 |Subcutaneous implant 10.8mg (base) in prefilled |0.13 |MG |44,250 |49,815,612 |
|LEUPRORELIN ACETATE |
|1565 |Injection 7.5mg |0.13 |MG |3,450 |1,485,942 |
|8211 |Injection 7.5mg |0.13 |MG |6,830 |7,807,046 |
|8484 |I.M. injection (modified release) |0.13 |MG |4,911 |7,442,219 |
|8707 |Suspn subcutaneous inj(mod rel) 7.5mg inj set |0.13 |MG |856 |363,615 |
|8708 |Suspn subcutaneous inj(mod rel) 22.5mg inj set |0.13 |MG |1,741 |1,957,408 |
|8709 |Suspn subcutaneous inj(mod rel) 30mg inj set |0.13 |MG |1,598 |2,370,541 |
|8859 |Suspn subcutaneous inj(mod rel) 45mg inj set |0.13 |MG |1,058 |2,286,649 |
|14727 |Injection 5mg |0.13 |MG |284 |– |
|19724 |I.M. injection (modified release) |0.13 |MG |110 |– |
|2109 |Tablet 10mg (base) 60 |20.00 |MG |6,011 |281,142 |
|2110 |Tablet 20mg (base) 60 |20.00 |MG |151,901 |11,796,328 |
|TOREMIFENE |
|8216 Tablet 60mg (base) 60.00 |MG |4,638 |319,031 |
|FILGRASTIM |
|6126 |Injection 300ug in 1mL vial |0.35 |MG |122 |207,308 |
|6291 |Injection 300ug in 0.5mL syringe |0.35 |MG |1,756 |3,575,595 |
|6292 |Injection 480ug in 0.5mL syringe |0.35 |MG |848 |3,672,404 |
|PEGFILGRASTIM |
|6363 |Injection 6mg in 0.6mL single use syringe |0.30 |MG |10,100 |21,845,656 |
|1131 |Vial powder for intravesical admin. 5x108 CFU/mL |– |– |1,159 |617,998 |
|1140 |Injection set 1 vial Powder |– |– |1,030 |456,514 |
|5901 |Injection set 1 vial Powder |– |– |401 |79,920 |
|5902 |Ampoule containing powder 5x108 CFU/mL |– |– |122 |33,909 |
|GLATIRAMER ACETATE |
|8726 |Inj 20mg in 1mL single dose prefilled syringe |20.00 |MG |16,648 |18,143,016 |
|8737 |Injection 40mg in 0.8mL prefilled syringe |2.90 |MG |3,945 |7,141,280 |
|8741 |Injection 40mg in 0.8mL prefilled syringe |2.90 |MG |13,770 |24,871,738 |
|9033 |Injection 40mg in 0.8mL prefilled syringe |2.90 |MG |302 |527,084 |
|ANAKINRA |
|8773 |Injection 100mg in 0.67mL pre-filled syringe 28 |0.10 |GM |111 |156,313 |
|8774 |Injection 100mg in 0.67mL pre-filled syringe 28 |0.10 |GM |300 |417,398 |
|CYCLOSPORIN |
|6232 |Capsule 10mg (with microemulsion pre-concentrate) |0.25 |GM |193 |15,378 |
|6352 |Capsule 25mg 30 |0.25 |GM |1,570 |254,897 |
|6353 |Capsule 50mg 30 |0.25 |GM |1,532 |332,413 |
|6354 |Capsule 100mg 30 |0.25 |GM |3,299 |1,407,188 |
|8657 |Capsule 10mg 120 |0.25 |GM |673 |65,843 |
|8658 |Capsule 25mg 60 |0.25 |GM |5,942 |708,538 |
|8659 |Capsule 50mg 60 |0.25 |GM |7,374 |1,438,955 |
|8660 |Capsule 100mg 60 |0.25 |GM |8,370 |3,272,421 |
|8661 |Oral liquid 100mg per mL |0.25 |GM |206 |132,883 |
|EFALIZUMAB |
|9000 |Inj set 4 vials pdr 125 mg and 4 pre filled syring |10.00 |MG |1,586 |1,711,740 |
|9001 |Inj set 4 vials pdr 125 mg and 4 pre filled syring |10.00 |MG |1,392 |1,485,503 |
|ETANERCEPT |
|6367 |Injection set vial pdr 25mg and syringe solvent 4 |7.00 |MG |1,222 |2,039,619 |
|8637 |Injection set vial pdr 25mg and syringe solvent 4 |7.00 |MG |1,453 |2,688,797 |
|8638 |Injection set vial pdr 25mg and syringe solvent 4 |7.00 |MG |8,618 |15,902,548 |
|8778 |Injection set vial pdr 25mg and syringe solvent 4 |7.00 |MG |346 |943,179 |
|8779 |Injection set vial pdr 25mg and syringe solvent 4 |7.00 |MG |4,097 |7,545,459 |
|8861 |Injection set vial pdr 50mg and syringe solvent 4 |7.00 |MG |2,825 |5,064,718 |
|8862 |Injct set 4 vials pdr 50mg and 4 pre-filled syr |7.00 |MG |8,554 |15,286,694 |
|9035 |Injct set 4 vials pdr 25mg & 4 prefilled syr solv |7.00 |MG |303 |544,712 |
|9038 |Injct set 4 vials pdr 50mg & 4 prefilled syr solv |7.00 |MG |114 |199,139 |
|INFLIXIMAB |
|6397 |Powder for I.V. infusion 100mg 1 |3.75 |MG |1,465 |3,744,854 |
|6448 |Powder for I.V. infusion 100mg 1 |3.75 |MG |2,530 |10,323,380 |
|LEFLUNOMIDE |
|8373 |Pack 3 Tablets 100mg and 30 tablets 20mg |20.00 |MG |113 |26,883 |
|8374 |Tablet 10mg 30 |20.00 |MG |30,068 |3,191,026 |
|8375 |Tablet 20mg 30 |20.00 |MG |101,525 |15,699,951 |
|MYCOPHENOLIC ACID |
|6208 |Capsule 250mg |2.00 |GM |287 |141,080 |
|6209 |Tablet 500mg |2.00 |GM |1,050 |762,007 |
|8649 |Capsule 250mg 300 |2.00 |GM |772 |470,529 |
|8650 |Capsule 500mg 150 |2.00 |GM |3,988 |2,572,927 |
|8652 |Tablet (enteric coated) 180mg 120 |2.00 |GM |126 |34,281 |
|8653 |Tablet (enteric coated) 360mg 120 |2.00 |GM |498 |251,705 |
|SIROLIMUS |
|8724 |Tablet 1mg 100 |3.00 |MG |389 |349,199 |
|8833 |Tablet 2mg 100 |3.00 |MG |123 |186,900 |
|TACROLIMUS |
|6216 |Capsule 1mg |5.00 |MG |531 |448,045 |
|8646 |Capsule 500ug 100 |5.00 |MG |1,122 |259,605 |
|8647 |Capsule 1mg 100 |5.00 |MG |4,836 |3,115,971 |
|8648 |Capsule 5mg 100 |5.00 |MG |338 |542,023 |
|2687 |Tablet 50mg |0.15 |GM |106,040 |7,765,129 |
|2688 |Tablet 25mg |0.15 |GM |12,580 |559,919 |
|THALIDOMIDE |
|6469 |Capsules 50mg 28 |0.10 |GM |1,122 |1,405,262 |
|1299 |Tablet 25mg (enteric coated) |0.10 |GM |96,051 |1,274,945 |
|1300 |Tablet 50mg (enteric coated) 50 |0.10 |GM |1,207,018 |13,301,177 |
|1302 |Suppository 100mg 40 |0.10 |GM |20,261 |447,700 |
|5076 |Tablet 25mg (enteric coated) |0.10 |GM |160 |1,479 |
|5077 |Tablet 50mg (enteric coated) |0.10 |GM |2,853 |27,931 |
|5361 |Tablet 25mg (enteric coated) 100 |0.10 |GM |305 |– |
|5362 |Tablet 50mg (enteric coated) 50 |0.10 |GM |4,020 |71,400 |
|5364 |Tablet 25mg (enteric coated) 100 |0.10 |GM |190 |420 |
|5365 |Tablet 50mg (enteric coated) 50 |0.10 |GM |1,835 |32,173 |
|16918 |Tablet 25mg 20 |0.10 |GM |42,937 |– |
|16971 |Tablet 25mg 10 |0.10 |GM |11,654 |– |
|17454 |Tablet 25mg 30 |0.10 |GM |24,748 |– |
|18566 |Tablet 50mg 20 |0.10 |GM |357 |– |
|18567 |Tablet 50mg 20 |0.10 |GM |106,949 |– |
|18725 |Suppository 25mg 10 |0.10 |GM |169 |– |
|18726 |Suppository 50mg 10 |0.10 |GM |389 |– |
|M01AB55 |DICLOFENAC WITH MISOPROSTOL | | | | |
| |4190 Tablet 50mg 200ug |0.10 |MG |3,140 |113,712 |
|M01AB01 |INDOMETHACIN | | | | |
|2454 |Capsule 25mg |0.10 |GM |314,653 |2,816,320 |
|2757 |Suppository 100mg |0.10 |GM |66,563 |1,334,026 |
|5126 |Capsule 25mg |0.10 |GM |224 |1,779 |
|5377 |Capsule 25mg 100 |0.10 |GM |1,952 |23,738 |
|5378 |Suppository 100mg 40 |0.10 |GM |342 |9,962 |
|5379 |Capsule 25mg 100 |0.10 |GM |1,082 |10,927 |
|5380 |Suppository 100mg 40 |0.10 |GM |457 |9,840 |
|M01AB15 KETOROLAC |
|13986 |Ampoule 30mg per 1mL 5 |30.00 |MG |4,220 |– |
|14188 |Tablet 10mg 30 |30.00 |MG |4,653 |– |
|14950 |Ampoule 10mg per 1mL |30.00 |MG |218 |– |
|M01AB02 SULINDAC |
| |2047 |Tablet 100mg |0.40 |GM |4,692 |68,151 |
| |2048 |Tablet 200mg |0.40 |GM |14,892 |203,781 |
| |5382 |Tablet 200mg 50 |0.40 |GM |143 |1,390 |
| |19006 |Tablet 200mg |0.40 |GM |194 |– |
|OXICAMS | | | | | | |
|M01AC06 MELOXICAM |
|8561 |Tablet 7.5mg |15.00 |MG |597,792 |13,670,147 |
|8562 |Tablet 15mg |15.00 |MG |1,347,544 |41,776,867 |
|8887 |Capsule 7.5mg 30 |15.00 |MG |63,336 |1,438,022 |
|8888 |Capsule 15mg 30 |15.00 |MG |92,271 |2,837,568 |
|M01AC01 PIROXICAM |
|1895 |Dispersible tablet 10mg 50 |20.00 |MG |16,803 |216,346 |
|1896 |Dispersible tablet 20mg 25 |20.00 |MG |115,029 |1,440,576 |
|1897 |Capsule 10mg |20.00 |MG |37,850 |488,112 |
|1898 |Capsule 20mg |20.00 |MG |185,999 |2,330,907 |
|5201 |Dispersible tablet 10mg |20.00 |MG |285 |3,515 |
|5202 |Dispersible tablet 20mg |20.00 |MG |396 |4,468 |
|5203 |Capsule 10mg |20.00 |MG |560 |6,897 |
|5204 |Capsule 20mg |20.00 |MG |121 |903 |
|3190 |Tablet 400mg |1.20 |GM |256,795 |3,225,019 |
|3192 |Tablet 400mg 30 |1.20 |GM |121,200 |950,038 |
|3198 |Tablet 200mg |1.20 |GM |20,041 |181,066 |
|5121 |Tablet 200mg |1.20 |GM |771 |5,883 |
|5123 |Tablet 400mg |1.20 |GM |1,257 |11,779 |
|5124 |Tablet 400mg 30 |1.20 |GM |3,381 |26,461 |
|5368 |Tablet 400mg 100 |1.20 |GM |1,277 |20,531 |
|5369 |Tablet 200mg 100 |1.20 |GM |168 |23 |
|5370 |Tablet 400mg 100 |1.20 |GM |527 |5,818 |
|13267 |Tablet 200mg 12 |1.20 |GM |354 |– |
|13268 |Tablet 200mg 24 |1.20 |GM |3,911 |– |
|13372 |Tablet 200mg 48 |1.20 |GM |2,466 |– |
|15401 |Susp 0.1/5mL 100mL |1.20 |GM |2,243 |– |
|16004 |Tablet 200mg 24 |1.20 |GM |127 |– |
|16068 |Tablet 200mg 48 |1.20 |GM |146 |– |
|IBUPROFEN with CODEINE |
|17716 |Tablet 200mg 12.8mg 48 |– |– |64,957 |– |
|18882 |Tablet 200mg 12.8mg 48 |– |– |35,309 |– |
|18887 |Tablet 200mg 12.8mg 48 |– |– |286 |– |
|19795 |Tablet 200mg 12.8mg 75 |– |– |1,280 |– |
|KETOPROFEN |
|1588 |Suppository 100mg |0.15 |GM |2,881 |60,940 |
|1590 |Capsules 200mg (sustained release) 28 |0.15 |GM |225,512 |3,489,143 |
|5136 |Capsule 200mg (sustained release) |0.15 |GM |1,303 |18,954 |
|NAPROXEN |
|1614 |Tablets 750mg (sustained release) 28 |0.50 |GM |91,055 |1,158,943 |
|1615 |Tablets 1g (sustained release) 28 |0.50 |GM |243,697 |3,730,744 |
|1658 |Oral suspension 125mg per 5mL 474mL |0.50 |GM |213 |18,124 |
|1659 |Tablet 500mg |0.50 |GM |211,712 |2,840,676 |
|1674 |Tablet 250mg |0.50 |GM |45,278 |613,941 |
|1795 |Tablet 550mg 50 |0.50 |GM |44,606 |610,536 |
|5176 |Tablet 250mg |0.50 |GM |281 |2,687 |
|5177 |Tablet 500mg |0.50 |GM |143 |1,622 |
|5186 |Tablet 550mg |0.50 |GM |165 |2,114 |
|5345 |Tablets 250mg 100 |0.50 |GM |298 |1,668 |
|5346 |Tablets 500mg 50 |0.50 |GM |1,486 |29,182 |
|5347 |Tablets 750mg (sustained release) 28 |0.50 |GM |202 |2,972 |
|5348 |Tablets 1g (sustained release) 28 |0.50 |GM |769 |14,102 |
|5350 |Tablet 500mg 50 |0.50 |GM |463 |4,225 |
|5351 |Tablets 750mg (sustained release) 28 |0.50 |GM |230 |2,534 |
|5352 |Tablets 1g (sustained release) 28 |0.50 |GM |206 |2,482 |
|5353 |Tablet 550mg 50 |0.50 |GM |131 |436 |
|11401 |Tablet 275mg 12 |0.50 |GM |598 |– |
|1095 |Tablet 3mg |6.00 |MG |3,935 |253,656 |
|SODIUM AUROTHIOMALATE |
|2016 |Injection 10mg |2.40 |MG |199 |10,424 |
|2017 |Injection 20mg |2.40 |MG |377 |30,268 |
|2018 |Injection 50mg |2.40 |MG |2,413 |302,370 |
|14860 |Gel 50g 1 |– |– |5,157 |– |
|14861 |Gel 100g 1 |– |– |8,907 |– |
|14979 |Gel 20g 1 |– |– |2,926 |– |
|KETOPROFEN |
|14948 |Gel 2.5% 30g 1 |– |– |187 |– |
|14949 |Gel 2.5% 60g 1 |– |– |919 |– |
|PIROXICAM |
|15090 |Gel 0.5% 25g 1 |– |– |1,445 |– |
|15091 |Gel 0.5% 50g 1 |– |– |1,199 |– |
|11353 |Tablet 100mg 100 |0.12 |GM |6,604 |– |
|ORPHENADRINE CITRATE with PARACETAMOL |
|11354 |Tablet 100 |0.12 |GM |2,495 |– |
|8090 |Tablet 40mg |10.00 |MG |19,997 |3,235,180 |
|8511 |Tablet 70mg alendronic acid 4 |10.00 |MG |2,259,720 |120,175,835 |
|16442 |Tablet 5mg |10.00 |MG |148 |– |
|18558 |Tablet 10mg 30 |10.00 |MG |502 |– |
|CLODRONIC ACID |
|8132 |Capsule equivalent to 400mg sodium clodronate |1.60 |GM |872 |296,132 |
|8265 |Capsule equivalent to 800mg sodium clodronate |1.60 |GM |17,378 |6,757,885 |
|1215 |Tablet 30mg-500mg |– |– |3,052,162 |26,856,059 |
|3316 |Tablet 30mg-500mg |– |– |102,631 |737,251 |
|4170 |Tablet 15mg-500mg |– |– |24,240 |248,737 |
|8785 |Tablet 30mg-500mg 60 |– |– |504,332 |10,110,823 |
|12736 |Tablet 30mg-500mg 50 |– |– |3,419 |– |
|15994 |Tablet 50 |– |– |1,453 |– |
|17212 |Tablet 9.6mg-500mg 48 |– |– |10,705 |– |
|17267 |Caplet 8mg-500mg 48 |– |– |9,265 |– |
|17703 |Tablet 8mg-500mg 96 |– |– |200 |– |
|17819 |Tablet 8mg-500mg 24 |– |– |150 |– |
|17820 |Tablet 8mg-500mg 48 |– |– |1,429 |– |
|18734 |Tablet 15mg-500mg 12 |– |– |110,429 |– |
|DIHYDROCODEINE |
|11785 |Linctus 200mL 1 |– |– |37,445 |– |
|12825 |Linctus 100mL 1 |– |– |17,063 |– |
|HYDROMORPHONE |
|8420 |Injection 2mg in 1mL 5 |4.00 |MG |1,598 |29,994 |
|8421 |Injection 10mg in 1mL 5 |4.00 |MG |1,774 |90,329 |
|8422 |Injection 50mg in 5mL 5 |4.00 |MG |2,082 |256,941 |
|8423 |Injection 500mg in 50mL |4.00 |MG |489 |118,934 |
|8424 |Oral liquid 1mg per mL 473mL |20.00 |MG |2,163 |73,042 |
|8541 |Tablet 2mg 20 |20.00 |MG |626 |11,072 |
|8542 |Tablet 4mg |20.00 |MG |807 |24,481 |
|8543 |Tablet 8mg |20.00 |MG |1,475 |84,637 |
|8337 |Transdermal patch 2.5mg (25ug per hour) |1.20 |MG |18,979 |1,279,060 |
|8338 |Transdermal patch 5mg (50ug per hour) |1.20 |MG |12,264 |1,458,967 |
|8339 |Transdermal patch 7.5mg (75ug per hour) |1.20 |MG |6,547 |1,092,955 |
|8340 |Transdermal patch 10mg (100ug per hour) |1.20 |MG |8,576 |2,180,391 |
|8878 |Transdermal patch 2.1mg(12 ug per hour) 5 |1.20 |MG |15,353 |761,421 |
|8891 |Transdermal patch 4.2mg (25 ug per hour) 5 |1.20 |MG |25,581 |1,534,709 |
|8892 |Transdermal patch 8.4mg (50 ug per hour) 5 |1.20 |MG |18,630 |1,966,815 |
|8893 |Transdermal patch 12.6mg (75 ug per hour) 5 |1.20 |MG |9,081 |1,341,851 |
|8894 |Transdermal patch 16.8mg (100 ug per hour) 5 |1.20 |MG |11,038 |2,341,462 |
|17987 |Lozenge 200ug 3 |– |– |135 |– |
|PETHIDINE HYDROCHLORIDE |
|1828 |Injection 50mg in 1mL 5 |0.40 |GM |846 |9,450 |
|1829 |Injection 100mg in 2mL 5 |0.40 |GM |51,806 |570,546 |
|3483 |Injection 100mg in 2mL 5 |0.40 |GM |4,930 |56,677 |
|18990 |Injection 100mg in 2mL |0.40 |GM |464 |– |
|19593 |Injection 50mg in 1mL |0.40 |GM |5,811 |– |
|4081 |Capsule 100mg |300.00 |MG |26,369 |513,522 |
|DEXTROPROPOXYPHENE with PARACETAMOL |
|16347 |Capsule 20 |0.20 |GM |141,400 |– |
|16444 |Tablet 20 |0.20 |GM |450,563 |– |
|16650 |Tablet 20 |0.20 |GM |32,048 |– |
|CODEINE with PARACETAMOL |
|4171 |Tablet 8mg-500mg |– |– |39,441 |441,238 |
|10526 |Tablet 50 |– |– |204 |– |
|10527 |Tablet 100 |– |– |2,549 |– |
|11705 |Tablet 50 |– |– |29,337 |– |
|11706 |Tablet 100 |– |– |61,197 |– |
|11755 |Tablet soluble 24 |– |– |416 |– |
|12670 |Tablet 20 |– |– |252 |– |
|12692 |Tablet 100 |– |– |792 |– |
|14215 |Tablet 8mg - 500mg 50 |– |– |1,105 |– |
|14788 |Tablet 100 |– |– |4,086 |– |
|14978 |Caplet 50 |– |– |889 |– |
|18373 |Tablet 24 |– |– |185 |– |
|18374 |Tablet 48 |– |– |6,160 |– |
|18375 |Tablet 50 |– |– |2,582 |– |
|18376 |Tablet 96 |– |– |33,688 |– |
|18377 |Tablet 100 |– |– |2,443 |– |
|18379 |Tabsule 48 |– |– |1,377 |– |
|18380 |Tabsule 96 |– |– |786 |– |
|19039 |Caplet 8mg/500mg 24 |– |– |1,216 |– |
|19040 |Tablet 8mg/500mg 12 |– |– |173 |– |
|19041 |Tablet 8mg/500mg 24 |– |– |3,044 |– |
|METOCLOPRAMIDE and PARACETAMOL |
|18386 |Tablet 5mg/500mg 24 |– |– |3,463 |– |
|19053 |Tablet 5mg/500mg 8 |– |– |9,340 |– |
|PARACETAMOL with CODEINE with DOXYLAMINE |
|10870 |Tablet 24 |– |– |42,617 |– |
|12600 |Tablet 20 |– |– |249,429 |– |
|12932 |Capsule 24 |– |– |16,570 |– |
|13102 |Tablet 20 |– |– |137,292 |– |
|13200 |Capsule 20 |– |– |480 |– |
|13823 |Capsule 20 |– |– |4,998 |– |
|15286 |Tablet 24 |– |– |1,605 |– |
|15650 |Caplet 500mg-8mg-5mg |– |– |38,960 |– |
|17268 |Tablet 500mg-9.6mg-5.1mg 20 |– |– |20,787 |– |
|18372 |Cap 500mg-9.6mg-5.1mg 10 + cap 500mg-9.6mg 200 |– |– |3,691 |– |
|18387 |Capsule 24 |– |– |859 |– |
|18388 |Tablet 20 |– |– |2,906 |– |
|PARACETAMOL with PROMETHAZINE with CODEINE |
|14779 |Syrup 200mL 1 |– |– |17,443 |– |
|18358 |Syrup 120mg-6.5mg-5mg in 5mL 100mL |– |– |7,420 |– |
|NARATRIPTAN |
|8298 |Tablet 2.5mg (base) 4 (2 upto Feb 06) |2.50 |MG |79,756 |2,114,954 |
|16135 |Tablet 2.5mg 4 |2.50 |MG |4,268 |– |
|SUMATRIPTAN |
|8144 |Tablet 50mg (base) 4 (2 upto 4 Feb 06) |50.00 |MG |218,816 |5,792,884 |
|8341 |Nasal Spray 20mg per dose 2 |20.00 |MG |68,205 |1,073,520 |
|8885 |Tablet 50mg (base) (fast disinteg rating) 4 |50.00 |MG |3,518 |92,355 |
|14181 |Tablet 100mg |50.00 |MG |20,260 |– |
|15210 |Tablet 50mg |50.00 |MG |12,006 |– |
|15987 |Nasal Spray 10mg per dose 2 |20.00 |MG |1,104 |– |
|16720 |Injection 6mg in 0.5mL refill |6.00 |MG |749 |– |
|16730 |Injection 6mg in 0.5mL |6.00 |MG |642 |– |
|17455 |Tablet 50mg (base) 4 |50.00 |MG |2,589 |– |
|17456 |Tablet 100mg 2 |50.00 |MG |2,915 |– |
|19639 |Tablet 50mg 2 (Fast disintegrating) |50.00 |MG |617 |– |
|1850 |Tablet 30mg |0.10 |GM |16,175 |154,226 |
|1853 |Injection 200mg in 1mL |0.10 |GM |183 |4,957 |
|18751 |Elixir 15mg/5mL 100mL |100.00 |MG |530 |– |
|PRIMIDONE |
|1939 |Tablet 250mg |1.25 |GM |17,365 |892,953 |
|2419 |Tablet 200mg |1.00 |GM |146,880 |5,259,849 |
|2422 |Tablet 100mg |1.00 |GM |56,476 |1,206,498 |
|2426 |Tablet 200mg (controlled release) |1.00 |GM |69,377 |2,525,189 |
|2427 |Oral suspension 100mg per 5mL 300mL |1.00 |GM |27,861 |723,893 |
|2431 |Tablet 400mg (controlled release) |1.00 |GM |51,109 |3,298,332 |
|5039 |Tablet 100mg |1.00 |GM |348 |6,144 |
|OXCARBAZEPINE |
|8584 |Tablet 150mg 100 |1.00 |GM |1,492 |127,887 |
|8585 |Tablet 300mg 100 |1.00 |GM |4,993 |708,697 |
|8586 |Tablet 600mg 100 |1.00 |GM |2,990 |632,809 |
|8588 |Oral suspension 60mg per mL 250mL |1.00 |GM |481 |67,858 |
|1834 |Capsule 300mg 100 |1.80 |GM |52,102 |5,424,814 |
|1835 |Capsule 400mg 100 |1.80 |GM |14,867 |2,284,926 |
|4591 |Capsule 100mg 100 |1.80 |GM |6,714 |214,797 |
|4592 |Capsule 300mg 100 |1.80 |GM |24,828 |2,269,745 |
|4593 |Capsule 400mg 100 |1.80 |GM |3,893 |491,598 |
|4594 |Tablet 600mg 100 |1.80 |GM |4,388 |828,725 |
|4595 |Tablet 800mg 100 |1.80 |GM |2,161 |506,314 |
|8389 |Tablet 800mg 100 |1.80 |GM |10,779 |2,809,602 |
|8505 |Capsule 100mg 100 |1.80 |GM |11,594 |373,608 |
|8559 |Tablet 600mg 100 |1.80 |GM |10,682 |2,090,361 |
|LAMOTRIGINE |
|2848 |Tablet 25mg |0.30 |GM |38,726 |1,861,296 |
|2849 |Tablet 50mg |0.30 |GM |64,956 |4,423,625 |
|2850 |Tablet 100mg |0.30 |GM |99,307 |10,772,999 |
|2851 |Tablet 200mg |0.30 |GM |89,096 |14,885,768 |
|8063 |Tablet 5mg |0.30 |GM |6,217 |197,091 |
|LEVETIRACETAM |
|8654 |Tablet 250mg 60 |1.50 |GM |4,445 |319,845 |
|8655 |Tablet 500mg 60 |1.50 |GM |12,210 |1,462,407 |
|8656 |Tablet 1gm 60 |1.50 |GM |4,616 |787,441 |
|9708 |Tablet 250mg 60 |1.50 |GM |11,949 |1,028,197 |
|9709 |Tablet 500mg 60 |1.50 |GM |38,438 |5,703,494 |
|9710 |Tablet 1gm 60 |1.50 |GM |20,761 |4,061,031 |
|9724 |Tablet 250mg 60 |1.50 |GM |197 |18,265 |
|9725 |Tablet 500mg 60 |1.50 |GM |681 |103,446 |
|9726 |Tablet 1gm 60 |1.50 |GM |300 |57,653 |
|PREGABALIN |
|19043 |Capsules 75mg 56 |0.30 |GM |22,716 |– |
|19044 |Capsules 150mg 56 |0.30 |GM |9,783 |– |
|19045 |Capsules 300mg 56 |0.30 |GM |3,637 |– |
|SULTHIAME |
|2099 |Tablet 50mg |0.40 |GM |1,351 |51,528 |
|2100 |Tablet 200mg |0.40 |GM |1,649 |142,950 |
|TOPIRAMATE |
|8163 |Tablet 25mg |0.30 |GM |10,743 |574,069 |
|8164 |Tablet 50mg |0.30 |GM |14,297 |1,085,958 |
|8165 |Tablet 100mg |0.30 |GM |14,692 |1,707,972 |
|8166 |Tablet 200mg |0.30 |GM |8,624 |1,693,726 |
|8371 |Capsule 15mg |0.30 |GM |654 |32,675 |
|8372 |Capsule 25mg |0.30 |GM |790 |43,700 |
|8520 |Capsule 50mg |0.30 |GM |760 |70,157 |
|9701 |Capsule 15mg 60 |0.30 |GM |740 |42,992 |
|9702 |Capsule 25mg 60 |0.30 |GM |976 |63,566 |
|9703 |Capsule 50mg 60 |0.30 |GM |1,014 |98,051 |
|9704 |Tablet 25mg 60 |0.30 |GM |8,348 |492,975 |
|9705 |Tablet 50mg 60 |0.30 |GM |11,624 |937,676 |
|9706 |Tablet 100mg 60 |0.30 |GM |12,706 |1,558,747 |
|9707 |Tablet 200mg 60 |0.30 |GM |7,647 |1,608,640 |
|9720 |Tablet 25mg 60 |0.30 |GM |406 |26,004 |
|9721 |Tablet 50mg 60 |0.30 |GM |372 |31,019 |
|9722 |Tablet 100mg 60 |0.30 |GM |363 |46,778 |
|9723 |Tablet 200mg 60 |0.30 |GM |249 |49,640 |
|19562 |Tablet 50mg 60 |0.30 |GM |141 |– |
|19564 |Tablet 200mg 60 |0.30 |GM |268 |– |
|1109 |Tablet 2mg |10.00 |MG |12,655 |150,537 |
|1110 |Tablet 5mg |10.00 |MG |5,870 |81,419 |
|BIPERIDEN HYDROCHLORIDE |
|2544 |Tablet 2mg |10.00 |MG |15,428 |285,410 |
|2225 |Capsule 100mg-25mg |0.60 |GM |35,626 |1,371,630 |
|2226 |Capsule 200mg-50mg |0.60 |GM |18,075 |949,541 |
|2227 |Capsule 50mg-12.5mg |0.60 |GM |21,364 |464,813 |
|2228 |Tablet 200mg-50mg |0.60 |GM |36,862 |1,971,177 |
|2229 |Tablet 100mg-25mg |0.60 |GM |47,831 |1,871,243 |
|2231 |Capsule 100mg-25mg (sustained release) |0.60 |GM |12,232 |513,146 |
|8218 |Dispersible tablet 50mg 12.5mg |0.60 |GM |6,481 |148,501 |
|8219 |Dispersible tablet 100mg 12.5mg |0.60 |GM |7,853 |329,432 |
|LEVODOPA with CARBIDOPA |
|1242 |Tablet 100mg-25mg |0.60 |GM |178,222 |7,567,155 |
|1245 |Tablet 250mg-25mg |0.60 |GM |45,227 |2,208,348 |
|1255 |Tablet 200mg-50mg 100 |0.60 |GM |28,959 |2,183,561 |
|LEVODOPA,DECARBOXYLASE INHIBITOR and COMT INHIBITOR |
|8797 |Tablet 50mg-12.5mg-200mg |0.45 |GM |1,078 |340,972 |
|8798 |Tablet 100mg-25mg-200mg |0.45 |GM |7,591 |2,658,975 |
|8799 |Tablet 150mg-37.5mg-200mg |0.45 |GM |5,901 |2,233,745 |
|1443 |Capsule 2.5mg (base) |40.00 |MG |13,276 |481,143 |
|1445 |Capsule 10mg |40.00 |MG |1,602 |330,116 |
|1446 |Capsule 5mg |40.00 |MG |5,651 |387,110 |
|CABERGOLINE |
|8393 |Tablet 1mg 30 |3.00 |MG |38,019 |2,847,924 |
|8394 |Tablet 2mg 30 |3.00 |MG |32,534 |3,247,354 |
|8395 |Tablet 4mg 30 |3.00 |MG |25,695 |3,055,791 |
|PERGOLIDE |
|2808 |Tablet 50ug (base) |3.00 |MG |1,801 |105,306 |
|2809 |Tablet 250ug (base) |3.00 |MG |5,462 |387,643 |
|2810 |Tablet 1mg (base) |3.00 |MG |2,992 |772,655 |
|ROPINIROLE |
|18888 |Tablet 0.25mg 12 |6.00 |MG |265 |– |
|18889 |Tablet 0.5mg 28 |6.00 |MG |2,970 |– |
|18890 |Tablet 2mg 28 |6.00 |MG |1,011 |– |
|1001 |Injection 50mg in 2mL |1.00 |MG |4,545 |162,409 |
|1046 |Injection 12.5mg in 0.5mL |1.00 |MG |2,449 |42,724 |
|3098 |Injection 25mg in 1mL |1.00 |MG |5,467 |133,330 |
|PROCHLORPERAZINE |
|2369 |Injection 12.5mg in 1mL |50.00 |MG |8,054 |121,694 |
|2893 |Tablet 5mg |100.00 |MG |777,403 |6,242,987 |
|2894 |Suppositories 5mg 5 |100.00 |MG |5,711 |100,654 |
|2895 |Suppositories 25mg 5 |100.00 |MG |21,214 |442,443 |
|3477 |Injection 12.5mg in 1mL |50.00 |MG |12,749 |181,871 |
|5205 |Tablet 5mg |100.00 |MG |195 |1,481 |
|TRIFLUOPERAZINE HYDROCHLORIDE |
|2185 |Tablet 1mg (base) |20.00 |MG |14,994 |123,049 |
|2186 |Tablet 5mg (base) |20.00 |MG |17,376 |176,354 |
|2386 |Tablet 2mg (base) |20.00 |MG |8,635 |77,944 |
|3052 |Tablet 2.5mg |50.00 |MG |50,188 |437,868 |
|3053 |Tablet 10mg |50.00 |MG |18,028 |231,656 |
|THIORIDAZINE HYDROCHLORIDE |
|2163 |Tablet 10mg |0.30 |GM |3,761 |35,316 |
|2164 |Tablet 50mg |0.30 |GM |5,657 |84,079 |
|2165 |Tablet 100mg |0.30 |GM |5,045 |118,188 |
|2359 |Tablet 25mg |0.30 |GM |5,512 |61,910 |
|2255 |Injection oily I.M. 20mg in 1mL |4.00 |MG |5,540 |96,741 |
|2256 |Injection oily I.M. 40mg in 1mL |4.00 |MG |3,168 |76,112 |
|2257 |Injection oily I.M. 100mg in 1mL |4.00 |MG |4,965 |212,630 |
|ZUCLOPENTHIXOL |
|8097 |Oily I.M. injection 200mg in 1mL |15.00 |MG |22,524 |527,750 |
|6101 |Tablet 25mg |0.30 |GM |2,580 |173,084 |
|6102 |Tablet 100mg |0.30 |GM |12,658 |4,308,301 |
|6417 |Tablet 50mg 100 |0.30 |GM |941 |85,180 |
|6418 |Tablet 200mg 100 |0.30 |GM |2,065 |904,218 |
|6462 |Tablet 25mg 28 |0.30 |GM |600 |31,524 |
|6463 |Tablet 100mg 28 |0.30 |GM |1,632 |443,697 |
|19746 |Tablet 25mg 28 |0.30 |GM |194 |– |
|19747 |Tablet 100mg 28 |0.30 |GM |931 |– |
|OLANZAPINE |
|8170 |Tablet 2.5mg 30 |10.00 |MG |133,782 |9,274,658 |
|8185 |Tablet 5mg 30 |10.00 |MG |220,731 |29,739,879 |
|8186 |Tablet 7.5mg 30 |10.00 |MG |56,894 |12,618,118 |
|8187 |Tablet 10mg 30 |10.00 |MG |274,963 |91,654,760 |
|8433 |Wafer 5mg 28 |10.00 |MG |40,407 |5,235,820 |
|8434 |Wafer 10mg 28 |10.00 |MG |44,498 |14,329,236 |
|18356 |Vial 10mg (solvent required) |10.00 |MG |111 |– |
|QUETIAPINE |
|8456 |Tablet 25mg (base) 60 |0.40 |GM |80,026 |5,463,878 |
|8457 |Tablet 100mg (base) 90 |0.40 |GM |58,056 |9,214,478 |
|8458 |Tablet 200mg (base) 60 |0.40 |GM |73,137 |20,330,120 |
|8580 |Tablet 300mg (base) 60 |0.40 |GM |44,199 |16,134,537 |
|8717 |Tablet 10mg 30 |15.00 |MG |21,968 |3,922,639 |
|8718 |Tablet 15mg 30 |15.00 |MG |31,797 |8,106,747 |
|8719 |Tablet 20mg 30 |15.00 |MG |10,329 |2,964,099 |
|8720 |Tablet 30mg 30 |15.00 |MG |17,415 |6,187,864 |
|RISPERIDONE |
|3169 |Tablet 1mg |5.00 |MG |85,843 |6,699,983 |
|3170 |Tablet 2mg |5.00 |MG |71,532 |10,750,879 |
|3171 |Tablet 3mg |5.00 |MG |31,726 |6,796,433 |
|3172 |Tablet 4mg |5.00 |MG |25,998 |7,351,017 |
|8100 |Oral solution 1mg per mL 100mL |5.00 |MG |5,481 |744,916 |
|8780 |Pdr for I.M. injection 25mg/2mL diluent syringe |1.80 |MG |28,737 |9,250,751 |
|8781 |Pdr for I.M. injection 37.5mg/2mL diluent syringe |1.80 |MG |23,455 |10,214,815 |
|8782 |Pdr for I.M. injection 50mg/2mL diluent syringe |1.80 |MG |27,637 |14,108,658 |
|8787 |Tablet 0.5mg 60 |5.00 |MG |50,339 |2,017,566 |
|8788 |Tablet 0.5mg (orally disintegrating)56 |5.00 |MG |8,316 |317,941 |
|8789 |Tablet 1mg 60 |5.00 |MG |48,146 |3,688,367 |
|8790 |Tablet 1mg (orally disintegrating) 56 |5.00 |MG |3,147 |228,029 |
|8791 |Oral solution 1mg per mL 30mL |5.00 |MG |4,570 |216,053 |
|8792 |Tablet 1mg (orally disintegrating) 56 |5.00 |MG |3,543 |255,952 |
|8794 |Tablet 2mg (orally disintegrating) 56 |5.00 |MG |4,666 |643,013 |
|8869 |Tablet 0.5mg 60 |5.00 |MG |11,171 |447,967 |
|8870 |Tablet 0.5mg (orally disintegrating) 56 |5.00 |MG |1,637 |63,356 |
|2130 |Tablet 250ug |1.00 |MG |69,446 |707,194 |
|2131 |Tablet 500ug |1.00 |MG |161,464 |2,207,748 |
|2132 |Tablet 1mg |1.00 |MG |194,359 |4,133,679 |
|8118 |Tablet 2mg |1.00 |MG |107,426 |3,317,931 |
|BROMAZEPAM |
|4150 |Tablet 3mg |10.00 |MG |19,634 |502,786 |
|4151 |Tablet 6mg |10.00 |MG |25,028 |766,516 |
|2558 |Injection 10mg in 2mL |10.00 |MG |5,645 |64,157 |
|3161 |Tablet 2mg |10.00 |MG |233,619 |1,645,841 |
|3162 |Tablet 5mg |10.00 |MG |1,785,775 |12,997,102 |
|3458 |Injection 10mg in 2mL |10.00 |MG |16,464 |176,908 |
|5071 |Tablet 2mg |10.00 |MG |952 |6,412 |
|5072 |Tablet 5mg |10.00 |MG |4,306 |28,344 |
|5355 |Tablet 2mg 50 |10.00 |MG |756 |6,395 |
|5356 |Tablet 5mg 50 |10.00 |MG |3,615 |33,788 |
|5357 |Tablet 2mg 50 |10.00 |MG |346 |3,070 |
|5358 |Tablet 5mg 50 |10.00 |MG |2,226 |23,734 |
|13803 |Injection 10mg in 2mL |10.00 |MG |408 |– |
|15450 |Elixir 0.1% 100mL |10.00 |MG |3,428 |– |
|LORAZEPAM |
|13807 |Tablet 1mg 50 |2.50 |MG |60,784 |– |
|13808 |Tablet 2.5mg 50 |2.50 |MG |32,477 |– |
|OXAZEPAM |
|3132 |Tablet 15mg |50.00 |MG |199,537 |1,259,845 |
|3133 |Tablet 30mg |50.00 |MG |1,158,428 |7,550,600 |
|3134 |Tablet 15mg |50.00 |MG |9,143 |73,788 |
|3135 |Tablet 30mg |50.00 |MG |15,130 |126,625 |
|5193 |Tablet 30mg |50.00 |MG |169 |1,063 |
|5371 |Tablet 15mg 50 |50.00 |MG |366 |2,884 |
|5372 |Tablet 30mg 50 |50.00 |MG |1,551 |12,508 |
|5373 |Tablet 15mg 50 |50.00 |MG |222 |2,128 |
|5374 |Tablet 30mg 50 |50.00 |MG |1,540 |15,846 |
146
2006
atc code form and strength ddd units scripts cost($)
A
|11021 |Ampoule 15mg/3mL 5 |15.00 |MG |1,079 |– |
|12645 |Ampoule 5mg/mL 10 |15.00 |MG |5,143 |– |
|13771 |Ampoule 5mg/mL 10 |15.00 |MG |1,636 |– |
|17973 |Ampoule 5mg/mL 5 |15.00 |MG |379 |– |
|18505 |Ampoule 5mg/mL 10 |15.00 |MG |876 |– |
|NITRAZEPAM |
|2723 |Tablet 5mg 25 |5.00 |MG |651,732 |4,530,496 |
|2732 |Tablet 5mg 50 |5.00 |MG |14,180 |132,666 |
|5189 |Tablet 5mg |5.00 |MG |148 |615 |
|5359 |Tablet 5mg 50 |5.00 |MG |1,525 |13,492 |
|5360 |Tablet 5mg 50 |5.00 |MG |941 |10,828 |
|TEMAZEPAM |
|2088 |Tablet 10mg |20.00 |MG |80,090 |721,416 |
|2089 |Tablet 10mg 25 |20.00 |MG |2,618,382 |18,204,887 |
|5221 |Tablet 10mg |20.00 |MG |1,579 |10,647 |
|5375 |Tablet 10mg 50 |20.00 |MG |4,322 |39,083 |
|5376 |Tablet 10mg 50 |20.00 |MG |1,989 |19,954 |
|18587 |Capsule 10mg 25 |20.00 |MG |1,301 |– |
|16809 |Tablet 10mg 7 |10.00 |MG |62,002 |– |
|17644 |Tablet 10mg 20 |10.00 |MG |586,964 |– |
|19763 |Tablet 6.25mg 21 |10.00 |MG |9,303 |– |
|19764 |Tablet 12.5mg 7 |10.00 |MG |1,350 |– |
|19765 |Tablet 12.5mg 21 |10.00 |MG |68,311 |– |
|19787 |Tablet 10mg 20 |10.00 |MG |7,895 |– |
|19797 |Tablet 10mg 7 |10.00 |MG |193 |– |
|19803 |Tablet 10mg 7 |10.00 |MG |133 |– |
|19804 |Tablet 10mg 20 |10.00 |MG |4,725 |– |
|19818 |Tablet 10mg 20 |10.00 |MG |3,486 |– |
|19893 |Tablet 10mg 20 |10.00 |MG |1,086 |– |
|ZOPICLONE |
|4522 |Tablet 7.5mg |7.50 |MG |66,793 |1,492,811 |
|14925 |Tablet 7.5mg 10 |7.50 |MG |4,996 |– |
|19034 |Tablet 7.5mg 30 |7.50 |MG |497 |– |
|8220 |Tablet 20mg (base) 28 |20.00 |MG |1,559,235 |54,664,575 |
|8702 |Tablet 10mg (base) 28 |20.00 |MG |14,952 |298,036 |
|8703 |Tablet 40mg (base) 28 |20.00 |MG |62,501 |2,774,315 |
|ESCITALOPRAM |
|8700 |Tablet 10mg (base) 28 |10.00 |MG |534,823 |15,877,638 |
|8701 |Tablet 20mg (base) 28 |10.00 |MG |336,564 |15,883,108 |
|8849 |Oral solution 10mg (base) per mL 28mL |10.00 |MG |831 |30,396 |
|9700 |Oral solution 10mg (base) per mL 28mL |10.00 |MG |194 |10,925 |
|9711 |Tablet 10mg (base) 28 |10.00 |MG |30,587 |1,221,650 |
|9712 |Tablet 20mg (base) 28 |10.00 |MG |54,240 |3,850,444 |
|9727 |Tablet 10mg (base) 28 |10.00 |MG |12,167 |386,941 |
|9728 |Tablet 20mg (base) 28 |10.00 |MG |6,999 |361,731 |
|19554 |Tablet 10mg 28 |10.00 |MG |749 |– |
|19556 |Tablet 10mg 28 |10.00 |MG |204 |– |
|19847 |Tablet 10mg (base) 28 |10.00 |MG |142 |– |
|19848 |Tablet 20mg (base) 28 |10.00 |MG |243 |– |
|1434 |Capsule 20mg (base)28 |20.00 |MG |778,278 |30,480,296 |
|1809 |Oral solution 20mg (base) per 5 mL 140mL |20.00 |MG |3,393 |134,801 |
|8270 |Tablet 20mg (base) (dispersible) 28 |20.00 |MG |228,994 |8,052,657 |
|19584 |Oral solution 20mg (base) per 5 mL 140mL |20.00 |MG |1,770 |– |
|FLUVOXAMINE |
|8174 |Tablet 100mg 30 |0.10 |GM |315,976 |12,997,009 |
|8512 |Tablet 50mg 30 |0.10 |GM |119,070 |2,901,862 |
|2856 |Tablet 15mg (base) 100 |60.00 |MG |7,285 |891,736 |
|TRANYLCYPROMINE SULPHATE |
|2444 |Tablet 10mg (base) 50 |10.00 |MG |17,879 |947,732 |
|1627 |Tablet 10mg 50 |60.00 |MG |23,703 |356,210 |
|1628 |Tablet 20mg 50 |60.00 |MG |49,027 |1,707,671 |
|MIRTAZAPINE |
|8513 |Tablet 30mg 30 |30.00 |MG |870,831 |32,059,452 |
|8855 |Tablet 15mg (orally disintegrating) 30 |30.00 |MG |22,731 |527,801 |
|8856 |Tablet 30mg (orally disintegrating) 30 |30.00 |MG |19,509 |678,518 |
|8857 |Tablet 45mg (orally disintegrating) 30 |30.00 |MG |9,149 |476,304 |
|8883 |Tablet 45mg 30 |30.00 |MG |16,484 |841,150 |
|18482 |Capsule 10mg 28 |80.00 |MG |421 |– |
|18484 |Capsule 18mg 28 |80.00 |MG |2,572 |– |
|18486 |Capsule 25mg 28 |80.00 |MG |1,651 |– |
|18488 |Capsule 40mg 28 |80.00 |MG |6,579 |– |
|18490 |Capsule 60mg 28 |80.00 |MG |6,327 |– |
|8839 |Tablet 10mg 100 |30.00 |MG |114,326 |2,061,301 |
|17704 |Capsule controlled release 20mg |30.00 |MG |32,677 |– |
|17705 |Capsule controlled release 30mg |30.00 |MG |36,755 |– |
|17706 |Capsule controlled release 40mg |30.00 |MG |37,909 |– |
|18284 |Tablet controlled release 18mg 30 |30.00 |MG |7,617 |– |
|18285 |Tablet controlled release 36mg 30 |30.00 |MG |24,032 |– |
|18384 |Tablet controlled release 54mg 30 |30.00 |MG |16,567 |– |
|MODAFINIL |
|8816 |Tablet 100mg 120 |0.30 |GM |1,145 |361,029 |
|17624 |Tablet 100mg 30 |0.30 |GM |5,885 |– |
|17626 |Tablet 100mg 90 |0.30 |GM |1,511 |– |
|8495 |Tablet 5mg 28 |7.50 |MG |57,050 |9,162,964 |
|8496 |Tablet 10mg 28 |7.50 |MG |163,253 |25,609,990 |
|GALANTAMINE |
|8536 |Tablet 4mg (base) 56 |16.00 |MG |5,862 |785,593 |
|8537 |Tablet 8mg (base) 56 |16.00 |MG |23,949 |3,837,669 |
|8756 |Tablet 12mg (base) 56 |16.00 |MG |2,710 |515,071 |
|8770 |Tablet 8mg (base) (prolonged release) 28 |16.00 |MG |15,421 |2,166,027 |
|8771 |Tablet 16mg (base) (prolonged release) 28 |16.00 |MG |49,292 |7,831,604 |
|8772 |Tablet 24mg (base) (prolonged release) 28 |16.00 |MG |9,605 |1,815,417 |
|RIVASTIGMINE |
|8497 |Capsule 1.5mg 56 |9.00 |MG |3,032 |494,768 |
|8498 |Capsule 3mg 56 |9.00 |MG |6,463 |1,043,374 |
|8499 |Capsule 4.5mg 56 |9.00 |MG |3,154 |495,597 |
|8500 |Capsule 6mg 56 |9.00 |MG |4,506 |707,332 |
|8563 |Oral solution 2mg (base) per mL 120mL |9.00 |MG |678 |115,055 |
|8465 |Tablet 150mg (sustained release) |0.30 |GM |64,399 |5,269,043 |
|8710 |Tablet 150mg (sustained release) 90 |0.30 |GM |37,311 |6,675,614 |
|NICOTINE |
|4571 |Transdermal patch 7 cm releasing ~7mg/24hr 7 |14.00 |MG |1,118 |77,543 |
|4572 |Transdermal patch 14 cm releasing ~14mg/24hr 7 |14.00 |MG |1,473 |105,178 |
|4573 |Transdermal patch 21 cm releasing ~21mg/24hr 7 |14.00 |MG |4,232 |301,676 |
|4577 |Transdermal patch releasing 10mg/16hr 7 |14.00 |MG |326 |17,233 |
|4578 |Transdermal patch releasing 15mg/16hr 7 |14.00 |MG |772 |45,219 |
|18359 |Tablet-sublingual 30 |30.00 |MG |181 |– |
|18360 |Tab-sublingual 105 |30.00 |MG |312 |– |
|6307 |Sublingual tablet 0.4mg (base) |8.00 |MG |135 |– |
|6308 |Sublingual tablet 2mg (base) |8.00 |MG |2,557 |– |
|6309 |Sublingual tablet 8mg (base) |8.00 |MG |7,930 |– |
|BUPRENORPHINE HYDROCHLORIDE with NALOXONE HYDROCHLORIDE |
|6470 |Sublingual tablet 2mg (base) - 0.5mg (base) |– |– |545 |– |
|6471 |Sublingual tablet 8mg (base) - 2mg (base) |– |– |454 |– |
|METHADONE HYDROCHLORIDE |
|1606 |Injection 10mg in 1mL |25.00 |MG |679 |127,043 |
|1609 |Tablet 10mg |25.00 |MG |92,651 |2,726,456 |
|5399 |Syrup 25mg per 5mL 200mL |75.00 |MG |138 |3,264 |
|6171 |Syrup 25mg per 5mL 200mL |25.00 |MG |18,644 |– |
|6172 |Syrup 25mg per 5mL 1 L |25.00 |MG |1,485 |– |
|17513 |Syrup 25mg per 5mL 200mL |25.00 |MG |75,607 |– |
|14495 |Tablet 250mg 8 |1.00 |GM |12,401 |– |
|QUININE |
|1972 |Tablet 300mg |1.50 |GM |70,470 |737,723 |
|1975 |Tablet 300mg |1.50 |GM |140,780 |1,470,028 |
|8459 |Tablet 400mg |4.00 |GM |545 |86,761 |
|8503 |Tablet 200mg 6 |0.40 |GM |1,185 |34,455 |
|MEBENDAZOLE |
|4325 |Tablet 100mg |0.20 |GM |360 |6,393 |
|OXYMETAZOLINE |
|4377 |Nasal drops 500ug per mL (0.05%) 15 mL |0.40 |MG |317 |4,683 |
|4378 |Nasal spray 500ug per mL (0.05%) 15 mL |0.40 |MG |2,189 |32,461 |
|4379 |Nasal spray 500ug per mL (0.05%) 18 mL |0.40 |MG |507 |8,085 |
|10688 |Nasal drop infant 15mL 1 |0.40 |MG |1,203 |– |
|10690 |Nasal spray pump 15mL 1 |0.40 |MG |585 |– |
|XYLOMETAZOLINE |
|11436 |Nasal spray 15mL 1 |0.80 |MG |1,465 |– |
|4089 |Aqueous nasal spray(pump pack) 21ug per dose |0.24 |MG |11,548 |232,137 |
|4090 |Aqueous nasal spray(pump pack) 42ug per dose |0.24 |MG |11,337 |297,059 |
|16829 |Aqueous nasal spray(pump pack) 42ug per dose 10mL |0.24 |MG |1,154 |– |
|SODIUM CHLORIDE |
|16067 |Aqueous nasal spray (pump pack) |– |– |2,275 |– |
|8136 |Capsule contain powder oral inhalation 12ug |24.00 |UG |20,814 |769,431 |
|8239 |Powder oral inhalation breath actuated 6ug |24.00 |UG |13,916 |341,723 |
|8240 |Powder oral inhalation breath actuated 12ug |24.00 |UG |83,629 |3,034,915 |
|SALBUTAMOL |
|1099 |Capsule 200 ug (base) (oral inhalation) |0.80 |MG |3,782 |76,941 |
|2000 |Nebuliser solution single dose 2.5mg(base) |10.00 |MG |111,695 |2,610,052 |
|2001 |Nebuliser solution single dose 5mg(base) |10.00 |MG |527,785 |13,195,765 |
|2003 |Nebuliser solution 5mg (base) per mL(0.5%) |10.00 |MG |367 |5,070 |
|3495 |Oral pressurised inhalant 100ug (base) CFC-free |0.80 |MG |17,667 |195,905 |
|3496 |Nebuliser solution single dose 2.5mg(base) |10.00 |MG |6,745 |100,825 |
|3497 |Nebuliser solution single dose 5mg(base) |10.00 |MG |10,536 |163,245 |
|8288 |Oral pressurised inhalant 100ug (base) CFC-free |0.80 |MG |3,130,264 |51,288,644 |
|8354 |Oral pressurised inhalant breath actuated 100ug |0.80 |MG |95,213 |3,427,973 |
|16297 |Oral pressurised inhalation 100 ug per |0.80 |MG |184 |– |
|17489 |Powder for oral inhalation refill disks 200ug |0.80 |MG |125 |– |
|SALMETEROL |
|3027 |Oral pressurised inhalation 25ug (base) |0.10 |MG |70,694 |2,427,939 |
|8141 |Powder inhal in breath actu dev 50ug/dose 60 doses |0.10 |MG |27,770 |972,476 |
|TERBUTALINE SULPHATE |
|1251 |Nebuliser solution single dose 5mg in 2mL |20.00 |MG |3,246 |88,667 |
|1252 |Pdr for inhalation in breath actu dev 500ug/dose |2.00 |MG |375,371 |6,044,628 |
|8625 |Pdr oral inhal in breath actu dev 200ug-6ug/dose |– |– |415,051 |24,138,796 |
|8750 |Pdr oral inhal in breath actu dev 400ug-12ug/dose |– |– |233,951 |20,292,360 |
|8796 |Pdr oral inhal in breath actu dev 6ug-100ug/dose |– |– |14,500 |777,457 |
|18544 |Pdr oral inhal in breath actu dev 400ug-12ug/dose |– |– |302 |– |
|8406 |Oral press inhal 50ug/dose(200 doses) CFC free |0.80 |MG |15,128 |265,100 |
|8407 |Oral press inhal 100ug/dose(200 doses)CFC free |0.80 |MG |80,782 |2,530,691 |
|8408 |Oral press inhal in breath actv dev 50ug CFC free |0.80 |MG |3,255 |84,273 |
|8409 |Oral press inhal in breath actu dev 100ug CFC free |0.80 |MG |35,325 |1,301,408 |
|BUDESONIDE |
|2065 |Nebuliser suspn single dose units 500ug in 2mL 30 |1.50 |MG |6,133 |344,808 |
|2066 |Nebuliser suspn single dose units 1mg in 2mL 30 |1.50 |MG |15,063 |1,201,158 |
|2070 |Pder for oral inhal in breath actu dev 100ug/dose |0.80 |MG |11,365 |243,866 |
|2071 |Pder oral inhal in breath actu dev 200ug/dose |0.80 |MG |72,436 |2,096,855 |
|2072 |Pder oral inhal in breath actu dev 400ug/dose |0.80 |MG |177,529 |7,813,696 |
|CICLESONIDE |
|8853 |Oral pressurised inhalation 80ug/dose 120 doses |0.16 |MG |6,960 |165,776 |
|8854 |Oral pressurised inhalation 160ug/dose 120 doses |0.16 |MG |31,867 |1,262,856 |
|FLUTICASONE |
|8147 |Powder for oral inhalation 100ug/dose 60 doses |0.60 |MG |13,847 |213,780 |
|8148 |Powder for oral inhalation 250ug/dose 60 doses |0.60 |MG |64,400 |1,853,620 |
|8149 |Powder for oral inhalation 500ug/dose 60 doses |0.60 |MG |23,840 |1,199,286 |
|8345 |Oral pressurised inhalation 125ug/dose 120 doses |0.60 |MG |134,102 |3,835,671 |
|8346 |Oral pressurised inhalation 250ug/dose 120 doses |0.60 |MG |151,531 |7,384,566 |
|8516 |Oral pressurised inhalation 50ug/dose 120 doses |0.60 |MG |120,702 |1,853,811 |
|16949 |Oral pressurised inhalation 50ug/dose 60 doses |0.60 |MG |158 |– |
|17314 |Oral pressurised inhalation 50ug/dose 120 doses |0.60 |MG |240 |– |
|1541 |Nebuliser solution 250ug per mL (0.025%) |0.30 |MG |1,105 |21,351 |
|1542 |Nebuliser solution single dose 250ug/mL 30 |0.30 |MG |50,440 |2,271,110 |
|8238 |Nebuliser solution single dose 500ug in 1mL 30 |0.30 |MG |270,294 |14,347,868 |
|8671 |Oral pressurised inhalation 21ug/dose 200 doses |0.12 |MG |123,790 |4,823,296 |
|TIOTROPIUM BROMIDE |
|8626 |Capsule 18ug (base)(oral inhalation) 30 |18.00 |UG |1,234,414 |94,592,932 |
|8365 |Oral pressurised inhalation 2mg/dose 112 doses |8.00 |MG |64,699 |2,182,930 |
|SODIUM CROMOGLYCATE |
|1124 |Nebuliser solution ampoule 20mg/2ml |80.00 |MG |7,187 |418,585 |
|2872 |Oral pressurised inhalation 1mg/dose 200 doses |40.00 |MG |815 |22,910 |
|2878 |Capsule 20mg (oral inhalation) |80.00 |MG |2,678 |84,875 |
|8334 |Oral pressurised inhalation 5mg/dose 112 doses |40.00 |MG |40,926 |1,391,564 |
|8767 |Oral pressurised inhalation 1mg/dose 200 doses |40.00 |MG |6,871 |193,074 |
|1103 |Syrup 2mg (base) per 5mL 300mL |12.00 |MG |45,884 |565,411 |
|TERBUTALINE SULPHATE |
|1034 |Injection 500ug in 1mL |15.00 |MG |224 |36,084 |
|3491 |Injection 500ug in 1mL |15.00 |MG |4,161 |103,666 |
|17236 |Elixir 0.3mg/mL 300mL |2.00 |MG |24,248 |– |
|8627 |Chewable tablet 4mg (base) 28 |10.00 |MG |59,981 |2,781,702 |
|8628 |Chewable tablet 5mg (base) 28 |10.00 |MG |78,702 |3,652,054 |
|16115 |Chewable tablet 10mg 28 |10.00 |MG |29,028 |– |
|ZAFIRLUKAST |
|16282 |Tablet 20mg 56 |40.00 |MG |1,115 |– |
|R05CB01 |ACETYLCYSTEINE | | | | |
| |8747 Sterile inhalation solution 200mg per mL(20%) 5mL |1.60 |GM |5,879 |791,151 |
|R05CB02 |BROMHEXINE HYDROCHLORIDE | | | | |
| |10212 Elx 4mg/5mL 1 |24.00 |MG |12,601 |– |
| |13662 Tablet 8mg 100 |24.00 |MG |4,309 |– |
|1214 |Tablet 30mg |100.00 |MG |68,936 |1,190,096 |
|12817 |Linctus 0.5% 100mL 1 |100.00 |MG |2,433 |– |
|16517 |Tablet 30mg 100 |100.00 |MG |1,159 |– |
|10584 |Tablet 24 |– |– |86,483 |– |
|14778 |Tablet 48 |– |– |6,352 |– |
|19469 |Tablet 24 |– |– |55,974 |– |
|19471 |Tablet 48 |– |– |1,707 |– |
|CODEINE with PSEUDOEPHEDRINE |
|11364 |Mixture 200mL |100.00 |MG |2,925 |– |
|12608 |Linct 100mL 1 |100.00 |MG |1,304 |– |
|19472 |Mixture 200mL |– |– |499 |– |
|DEXTROMETHORPHAN with BROMPHENIRAMINE with PHENYLEPHRINE |
|14751 |Elixir sugar free 200mL |– |– |391 |– |
|14785 |Elixir sugar free 100mL |– |– |161 |– |
|17186 |Elixir sugar and colour free 50mL |– |– |3,561 |– |
|R05DA20 |DEXTROMETHORPHAN with DIPHENHHYDRAMINE | | | | |
| |18877 Linctus 100mL 1 |– |– |2,018 |– |
| |18878 Linctus 200mL 1 |– |– |1,405 |– |
|R05DA20 DEXTROMETHORPHAN with DIPHENHHYDRAMINE with PSEUDOEPHEDRINE |
|19463 |Syrup 100mL |– |– |7,518 |– |
|19464 |Syrup 200mL |– |– |862 |– |
|4071 |Linctus 1mg per mL (0.1%) 100mL |50.00 |MG |9,629 |112,402 |
|10723 |Linctus 200mL 1 |50.00 |MG |2,234 |– |
|12611 |Linctus 200mL 1 |50.00 |MG |2,507 |– |
|12921 |Expectorant 200mL 1 |50.00 |MG |3,143 |– |
|13809 |Linctus 1mg per mL (0.1%) 100mL |50.00 |MG |1,556 |– |
|10663 |Elixir 100mL 1 |24.00 |MG |420 |– |
|10665 |Drop 30mL 1 |24.00 |MG |14,223 |– |
|10713 |Elixir 200mL 1 |24.00 |MG |331 |– |
|14816 |Drop 50mL |– |– |4,711 |– |
|10604 |Syrup 100mL 1 |– |– |537 |– |
|10605 |Syrup 200mL 1 |– |– |996 |– |
|16069 |Syrup 100mL 1 |– |– |605 |– |
|16070 |Syrup Infant 50mL 1 |– |– |38,750 |– |
|CHLORPHENIRAMINE with PHOLCODEINE with PSEUDOEPHRINE |
|19542 |Syrup 100mL |– |– |2,231 |– |
|19543 |Syrup 200mL |– |– |1,456 |– |
|CHLORPHENIRAMINE with PSEUDOEPHEDRINE |
|10606 |Tablet 30 |– |– |7,707 |– |
|13477 |Syrup infant 50mL 1 |– |– |14,697 |– |
|11600 |Tablet 6mg 50 |6.00 |MG |171 |– |
|11602 |Syrup 2mg/5mL 1 |6.00 |MG |20,037 |– |
|12592 |Tablet 6mg 20 |6.00 |MG |20,301 |– |
|12822 |Tablet 2mg 50 |6.00 |MG |33,068 |– |
|19058 |Tablet 2mg 25 |6.00 |MG |47,794 |– |
|19059 |Tablet 6mg 40 |6.00 |MG |10,548 |– |
|16167 |Tablet 4mg 100 |16.00 |MG |230 |– |
|16168 |Tablet 8mg 100 |16.00 |MG |130 |– |
|PROMETHAZINE |
|1948 |Injection 50mg in 2mL |25.00 |MG |13,018 |266,945 |
|3488 |Injection 50mg in 2mL |25.00 |MG |16,393 |284,727 |
|4072 |Tablet 10mg |25.00 |MG |47,936 |625,580 |
|4073 |Tablet 25mg |25.00 |MG |71,262 |1,075,011 |
|5325 |Tablet 10mg 50 |25.00 |MG |2,114 |29,996 |
|5326 |Tablet 25mg 50 |25.00 |MG |2,204 |35,568 |
|5327 |Oral liquid 5mg per 5mL 100mL |25.00 |MG |33,472 |507,863 |
|5328 |Tablet 10mg 50 |25.00 |MG |1,226 |16,898 |
|5329 |Tablet 25mg 50 |25.00 |MG |1,368 |14,899 |
|5330 |Oral liquid 5mg per 5mL 100mL |25.00 |MG |13,776 |154,826 |
|11576 |Ampoule 25mg/mL 10 |25.00 |MG |149 |– |
|12553 |Elixir 100mL 1 |25.00 |MG |1,809 |– |
|15810 |Tablet 25mg 30 |25.00 |MG |4,942 |– |
|11574 |Linctus 200mL 1 |– |– |133 |– |
|12066 |Linctus 100mL 1 |– |– |1,826 |– |
|12923 |Linctus 100mL 1 |– |– |113 |– |
|TRIMEPRAZINE |
|12156 |Syrup 7.5mg/5 1 |30.00 |MG |6,003 |– |
|12157 |Syrup 30mg/5 1 |30.00 |MG |1,583 |– |
|CETIRIZINE |
|4175 |Tablet 10mg 30 |10.00 |MG |17,134 |631,671 |
|14363 |Tablet 10mg |10.00 |MG |8,688 |– |
|16121 |Oral drops 10mg per mL 20mL |10.00 |MG |285 |– |
|16122 |Oral solution 1mg/mL 75mL |10.00 |MG |5,723 |– |
|16123 |Oral solution 1mg/mL 200mL |10.00 |MG |247 |– |
|1171 |Eye ointment 10mg per g (1%) 4g |– |– |517,045 |4,199,997 |
|2360 |Eye drops 5mg per mL (0.5%) 10mL |– |– |1,004,025 |7,877,849 |
|5055 |Eye drops 5mg per mL (0.5%) 10mL |– |– |272 |2,133 |
|14670 |Eye drops Minims 0.5% 20 |– |– |545 |– |
|S01AA30 POLYMYXIN B SULPHATE with BACITRACIN and NEOMYCIN SULPHATE | |
|1910 Eye ointment 5,000units-400 units-5mg per g 4g – – 268 |2,055 |
|S01AA12 TOBRAMYCIN | |
|2328 Eye drops 3mg per mL (0.3%) 5mL – – 67,501 |1,145,151 |
|2329 Eye ointment 3mg per g (0.3%) 3.5 g – – 20,293 |401,655 |
|SULFONAMIDES | |
|1217 |Eye drops 3mg per mL (0.3%) 5mL |– |– |14,348 |389,559 |
|17303 |Eye drops 3mg per mL (0.3%) 5mL |– |– |215 |– |
|OFLOXACIN |
|8383 |Eye drops 3mg per mL (0.3%) 5mL |– |– |18,853 |500,694 |
|2535 |Eye drops 15mg per mL (1.5%) 15mL |6.00 |MG |196 |4,663 |
|2536 |Eye drops 30mg per mL (3%) 15mL |12.00 |MG |309 |7,532 |
|19578 |Eye drops 15mg per mL (1.5%) 15mL |6.00 |MG |208 |– |
|PILOCARPINE |
|2595 |Eye drops 10mg per mL (1%) 15mL |4.00 |MG |13,981 |148,882 |
|2596 |Eye drops 20mg per mL (2%) 15mL |8.00 |MG |34,789 |409,657 |
|2597 |Eye drops 30mg per mL (3%) 15mL |12.00 |MG |2,510 |36,217 |
|2598 |Eye drops 40mg per mL (4%) 15mL |16.00 |MG |31,078 |446,690 |
|2778 |Eye drops 5mg per mL (0.5%) 15mL |2.00 |MG |4,937 |52,411 |
|2779 |Eye drops 60mg per mL (6%) 15mL |24.00 |MG |4,830 |89,497 |
|19845 |Eye drops 30mg per mL (3%) 15mL |12.00 |MG |162 |– |
|8620 |Eye drops 300ug per mL (0.03%) 3mL |30.00 |UG |283,272 |10,229,291 |
|LATANOPROST |
|8243 |Eye drops 50ug per mL (0.005%) 2.5mL |5.00 |UG |1,553,056 |56,059,690 |
|6416 |Tablet 500mg 100 |– |– |114 |138,098 |
|DESFERRIOXAMINE |
|6113 |Powder for injection 500mg vial |– |– |140 |37,776 |
|6270 |Powder for injection 2g vial |– |– |150 |90,968 |
-----------------------
35
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- net scheme hk
- monthly income scheme in bank
- benefits of buying a home with cash
- benefits of home ownership
- benefits of first time home buyers programs
- tax benefits of home ownership
- tax benefits of home ownership 2019
- tax benefits for home business
- benefits of first time home buyers progra
- medicare home care benefits for elderly
- att employee benefits home page
- at t benefits center home page